Artificial Intelligence Technology Solutions (AITX) POS AM 20 Jul 23 Prospectus update (post-effective amendment) Financial data

Cover

Cover	3 Months Ended
	May 31, 2023
Entity Addresses [Line Items]
Document Type	POS AM
Amendment Flag	true
Amendment Description	EXPLANATORY NOTE: On July 19, 2023, we mistakenly titled our filing as “Form S-1/A – Post-Effective Amendment”, submission form type “S-1/A”. We are amending our July 19, 2023 filing to correctly state that our filing is “Post-Effective Amendment No. 1 to Form S-1”, submission form type “POS AM”. We filed a Form S-1 Registration Statement on March 31, 2023, which was declared effective by the SEC on April 12, 2023. We are filing herein Post-Effective Amendment No. 1 to Form S-1 to update our disclosure, including our audited financials for our fiscal year ending February 28, 2023 and our unaudited quarterly financials for the three months ended May 31, 2023.
Entity Registrant Name	ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
Entity Central Index Key	0001498148
Entity Primary SIC Number	3714
Entity Tax Identification Number	27-2343603
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10800 Galaxie Avenue
Entity Address, City or Town	Ferndale
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48220
City Area Code	(877)
Local Phone Number	787-6268
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Document Creation Date	Jul. 20, 2023
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	10800 Galaxie Avenue
Entity Address, City or Town	Ferndale
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48220
City Area Code	(877)
Local Phone Number	787-6268
Contact Personnel Name	Steven Reinharz

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	May 31, 2023	Feb. 28, 2023		May 31, 2022	Feb. 28, 2022	Jan. 28, 2022	Mar. 10, 2021	Feb. 28, 2021	Dec. 18, 2020
Current assets:
Cash	$ 287,202	$ 939,759	[1]		$ 4,648,146
Accounts receivable, net	391,823	265,024	[1]		429,469
Device parts inventory, net	1,489,429	1,637,899	[1]		1,530,657
Prepaid expenses and deposits	521,501	596,310	[1]		442,164
Total current assets	2,689,955	3,438,992	[1]		7,050,436
Operating lease asset	1,179,673	1,208,440	[1]		1,331,605
Revenue earning devices, net of accumulated depreciation of $902,680 and $778,839, respectively	1,556,790	1,235,219	[1]		709,063
Fixed assets, net of accumulated depreciation of $227,103 and $182,002, respectively	302,960	315,888	[1]		137,952
Trademarks	27,080	27,080	[1]		28,723
Investment at cost	50,000	50,000	[1]
Security deposit	21,239	21,239	[1]		21,239	$ 1,500	$ 15,880		$ 3,859
Total assets	5,827,697	6,296,858	[1]		9,279,018
Current liabilities:
Accounts payable and accrued expenses	1,336,023	1,343,379	[1]		968,853
Advances payable- related party	1,594	1,594	[1]		1,594
Customer deposits	36,460	9,900	[1]		10,000
Current operating lease liability	244,169	248,670	[1]		254,027
Current portion of deferred variable payment obligation	604,811	542,177	[1]		325,600
Loan payable - related party	243,256	206,516	[1]		193,556
Incentive compensation plan payable	1,042,000	979,000	[1]		479,500
Current portion of loans payable, net of discount of $1,348,996 and $1,651,597	16,220,989	9,918,389	[1]		1,004,708
Vehicle loan - current portion	38,522	38,522	[1]		38,522
Current portion of accrued interest payable	4,741,347	2,761,446	[1]		1,260,271
Total current liabilities	24,509,171	16,049,593	[1]		4,547,718
Non-current operating lease liability	926,274	950,541	[1]		1,057,579
Loans payable, net of discount of $4,973,120 and $4,130,291, respectively	9,884,241	15,554,069	[1]		20,309,069
Deferred variable payment obligation	2,525,000	2,525,000	[1]		2,525,000
Accrued interest payable	2,062,128	3,060,656	[1]		1,816,009
Total liabilities	39,906,814	38,139,859	[1]		30,255,375
Stockholders' deficit:
Preferred stock, value			[1]
Common Stock, $0.00001 par value; 7,225,000,000 shares authorized 6,129,670,689 and 5,848,741,599 shares issued, issuable and outstanding, respectively	61,298	58,489	[1]		47,353
Additional paid-in capital	82,563,520	80,247,252	[1]		73,015,576
Preferred stock to be issued	99,086	99,086	[1]		99,086
Accumulated deficit	(116,808,904)	(112,253,711)	[1]		(94,144,254)
Total stockholders' deficit	(34,079,117)	(31,843,001)	[1]	$ (24,002,822)	(20,976,357)			$ (14,543,687)
Total liabilities and stockholders' deficit	5,827,697	6,296,858	[1]		9,279,018
Series G Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value			[1]
Total stockholders' deficit
Series E Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	3,350	3,350	[1]		3,350
Total stockholders' deficit	3,350	3,350		3,350	3,350			4,350
Series F Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	2,533	2,533	[1]		2,532
Total stockholders' deficit	$ 101,619	$ 101,619		$ 101,618	$ 101,618			$ 176,869
[1]Derived from audited information

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated depreciation, revenue earning devices	$ 902,680	$ 778,839	$ 434,661
Accumulated depreciation, fixed assets	227,103	182,002	49,065
Discount of current portion of loans payable	1,348,996	1,651,597	14,745
Discount of loans payable	$ 4,973,120	$ 4,130,291	$ 4,905,076
Preferred stock, authorized	15,545,650	15,545,650	15,545,650
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Preferred stock, par value (in dollars per shares)		$ 0.001
Common stock, par value (in dollars per shares)	$ 0.00001	$ 0.00001	$ 0.00001
Common stock, authorized	7,225,000,000	7,225,000,000	7,225,000,000
Common stock, shares, issued	6,129,670,689	5,848,741,599	4,735,210,360
Common stock, shares, outstanding	6,129,670,689	5,848,741,599	4,735,210,360
Series G Preferred Stock [Member]
Preferred stock, authorized	100,000	100,000	100,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001	$ 0.001
Series E Preferred Stock [Member]
Preferred stock, authorized	4,350,000	4,350,000	4,350,000
Preferred stock, shares issued	3,350,000	3,350,000	3,350,000
Preferred stock, shares outstanding	3,350,000	3,350,000	3,350,000
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001	$ 0.001
Series F Preferred Stock [Member]
Preferred stock, authorized	4,350	4,350	4,350
Preferred stock, shares issued	2,533	2,533	2,532
Preferred stock, shares outstanding	2,533	2,533	2,532
Preferred stock, par value (in dollars per shares)	$ 1	$ 1	$ 1

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Income Statement [Abstract]
Revenues	$ 385,208	$ 385,157	$ 1,331,956	$ 1,447,109
Cost of Goods Sold	91,511	293,724	678,073	472,926
Gross Profit	293,697	91,433	653,883	974,183
Operating expenses:
Research and development (including related party charges of $882,015 (2022-$1,001,734))	891,757	1,023,735	3,625,468	2,961,394
General and administrative	2,120,433	2,400,392	8,980,709	10,905,129
Depreciation and amortization	167,942	93,995	478,115	232,886
Operating lease cost and rent	62,542	69,967	260,271	275,785
Total operating expenses	3,242,674	3,588,089	13,344,563	14,346,069
Loss from operations	(2,948,977)	(3,496,656)	(12,690,680)	(13,371,886)
Other income (expense), net:
Interest expense	(1,606,216)	(1,175,030)	(5,426,364)	(16,129,499)
Total other income (expense), net	(1,606,216)	(1,175,030)	(5,418,777)	(48,825,598)
Net income (loss)	$ (4,555,193)	$ (4,671,686)	$ (18,109,457)	$ (62,197,484)
Net income (loss) per share - basic	$ 0	$ 0	$ 0	$ (0.02)
Net income (loss) per share - diluted	$ 0	$ 0	$ 0	$ (0.02)
Weighted average common share outstanding - basic	5,964,709,322	4,798,657,871	5,091,857,082	4,029,658,082
Weighted average common share outstanding - diluted	5,964,709,322	4,798,657,871	5,091,857,082	4,029,658,082

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) - USD ($)	3 Months Ended
	May 31, 2023	May 31, 2022
Income Statement [Abstract]
Related party charges	$ 882,015	$ 1,001,734

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDER'S DEFICIT (Unaudited) - USD ($)	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Feb. 28, 2021	$ 4,350	$ 176,869	$ 32,294	$ 16,764,554	$ (31,521,754)	$ (14,543,687)
Beginning balance, (in shares) at Feb. 28, 2021	4,350,000	2,799	3,229,426,884
Issuance of shares, net of $81,285 issuance costs			$ 6,452	12,515,480		12,521,932
Issuance of shares, net of issuance costs (in shares)			645,168,473
Stock based compensation				69,350		69,350
Net income					(62,197,484)	(62,197,484)
Ending balance, value at Feb. 28, 2022	$ 3,350	$ 101,618	$ 47,353	73,015,576	(94,144,254)	(20,976,357)
Ending balance, (in shares) at Feb. 28, 2022	3,350,000	2,532	4,735,210,360
Issuance of shares, net of $81,285 issuance costs			$ 1,339	1,643,883		1,645,222
Issuance of shares, net of issuance costs (in shares)			133,881,576
Rounding				(1)		(1)
Net income					(4,671,686)	(4,671,686)
Ending balance, value at May. 31, 2022	$ 3,350	$ 101,618	$ 48,692	74,659,458	(98,815,940)	(24,002,822)
Ending balance, (in shares) at May. 31, 2022	3,350,000	2,532	4,869,091,936
Beginning balance, value at Feb. 28, 2022	$ 3,350	$ 101,618	$ 47,353	73,015,576	(94,144,254)	(20,976,357)
Beginning balance, (in shares) at Feb. 28, 2022	3,350,000	2,532	4,735,210,360
Issuance of shares, net of issuance costs (in shares)			1,057,841,576
Rounding				(1)		(1)
Stock based compensation				122,050		122,050
Net income					(18,109,457)	(18,109,457)
Ending balance, value at Feb. 28, 2023	$ 3,350	$ 101,619	$ 58,489	80,247,252	(112,253,711)	(31,843,001)	[1]
Ending balance, (in shares) at Feb. 28, 2023	3,350,000	2,533	5,848,741,599
Issuance of shares, net of $81,285 issuance costs			$ 2,809	1,316,100		1,318,909
Issuance of shares, net of issuance costs (in shares)			280,929,190
Stock based compensation				52,721		52,721
Net income					(4,555,193)	(4,555,193)
Ending balance, value at May. 31, 2023	$ 3,350	$ 101,619	$ 61,298	$ 82,563,520	$ (116,808,904)	$ (34,079,117)
Ending balance, (in shares) at May. 31, 2023	3,350,000	2,533	6,129,670,789
[1]Derived from audited information

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDER'S DEFICIT (Unaudited) (Parenthetical) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2022
Statement of Stockholders' Equity [Abstract]
Issuance cost of shares	$ 81,285	$ 117,157	$ 253,811

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (4,555,193)	$ (4,671,686)	$ (18,109,457)	$ (62,197,484)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	167,942	93,995	478,115	232,886
Bad debts expense	16,000	105,000	(45,110)	(9,022)
Inventory provision		25,000	130,000	65,000
Reduction of right of use asset	28,767	30,046	112,396	110,148
Accretion of lease liability	33,775	36,355	141,631	122,930
Stock based compensation	115,721	161,500	740,050	2,158,050
Amortization of debt discounts	557,219	415,029	1,980,033	7,597,242
Increase in related party accrued payroll and interest	36,740	3,240	12,960	264,331
Changes in operating assets and liabilities:
Accounts receivable	(142,799)	(40,251)	119,335	(339,947)
Prepaid expenses and deposits on inventory	74,809	126,610	(141,734)	(442,164)
Device parts inventory	(324,652)	(283,209)	(1,161,047)	(2,191,571)
Accounts payable and accrued expenses	(7,354)	101,557	374,529	(596,615)
Customer deposits	26,560	(10,000)	(100)	(500)
Operating lease liability payments	(62,542)	(66,401)	(254,028)	(233,078)
Current portion of deferred variable payment obligations for payments	62,634	62,627	216,577	234,013
Accrued interest payable	981,370	289,016	2,745,822	2,606,097
Net cash used in operating activities	(2,991,003)	(3,621,572)	(12,577,395)	(14,825,442)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(3,463)	(88,214)	(258,402)	(115,493)
Net cash (used in) investing activities	(3,463)	(88,214)	(308,402)	(129,200)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs	1,318,909	1,645,222	7,771,169	12,521,932
Proceeds from loans payable	1,050,000		3,300,000	9,426,146
Repayment of loans payable	(27,000)	(1,661,953)	(1,763,009)	(516,314)
Net cash provided by (used in) financing activities	2,341,909	(16,731)	9,177,410	18,558,370
Net change in cash	(652,557)	(3,726,517)	(3,708,387)	3,603,728
Cash, beginning of period	939,759	4,648,146	4,648,146	1,044,418
Cash, end of period	287,202	921,629	939,759	4,648,146
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	1,375	342,138	451,192	225,003
Cash paid for income taxes
Noncash investing and financing activities:
Transfer from device parts inventory to fixed assets	473,122	179,619	(932,805)	(659,985)
Discount applied to face value of loans	$ 150,000		$ 1,797,645	$ 6,162,945

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Feb. 28, 2023		Feb. 28, 2022
Current assets:
Cash	$ 939,759	[1]	$ 4,648,146
Accounts receivable, net	265,024	[1]	429,469
Device parts inventory, net	1,637,899	[1]	1,530,657
Prepaid expenses and deposits	596,310	[1]	442,164
Total current assets	3,438,992	[1]	7,050,436
Operating lease asset	1,208,440	[1]	1,331,605
Revenue earning devices, net of accumulated depreciation of $778,839 and $434,661, respectively	1,235,219	[1]	709,063
Fixed assets, net of accumulated depreciation of $182,002 and $49,065, respectively	315,888	[1]	137,952
Trademarks	27,080	[1]	28,723
Investment at cost	50,000	[1]
Security deposit	21,239	[1]	21,239
Total assets	6,296,858	[1]	9,279,018
Current liabilities:
Accounts payable and accrued expenses	1,343,379	[1]	968,853
Advances payable- related party	1,594	[1]	1,594
Customer deposits	9,900	[1]	10,000
Current operating lease liability	248,670	[1]	254,027
Current portion of deferred variable payment obligation	542,177	[1]	325,600
Current portion of convertible notes payable, net of discount of $0 and $0, respectively			3,500
Loan payable - related party	206,516	[1]	193,556
Incentive compensation plan payable	979,000	[1]	479,500
Current portion of loans payable, net of discount of $1,651,597 and $14,745	9,918,389	[1]	1,004,708
Vehicle loan - current portion	38,522	[1]	38,522
Current portion of accrued interest payable	2,761,446	[1]	1,260,271
Derivative liability			7,587
Total current liabilities	16,049,593	[1]	4,547,718
Non-current operating lease liability	950,541	[1]	1,057,579
Loans payable, net of discount of $4,130,291 and $4,905,076, respectively	15,554,069	[1]	20,309,069
Deferred variable payment obligation	2,525,000	[1]	2,525,000
Accrued interest payable	3,060,656	[1]	1,816,009
Total liabilities	38,139,859	[1]	30,255,375
Stockholders' deficit:
Preferred stock, value		[1]
Common Stock, $0.00001 par value; 7,225,000,000 shares authorized 5,848,741,599 and 4,735,210,360 shares issued, issuable and outstanding, respectively	58,489	[1]	47,353
Additional paid-in capital	80,247,252	[1]	73,015,576
Preferred stock to be issued	99,086	[1]	99,086
Accumulated deficit	(112,253,711)	[1]	(94,144,254)
Total stockholders' deficit	(31,843,001)	[1]	(20,976,357)
Total liabilities and stockholders' deficit	6,296,858	[1]	9,279,018
Series G Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value		[1]
Total stockholders' deficit
Series E Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	3,350	[1]	3,350
Total stockholders' deficit	3,350		3,350
Series F Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	2,533	[1]	2,532
Total stockholders' deficit	$ 101,619		$ 101,618
[1]Derived from audited information

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Feb. 28, 2023	Feb. 28, 2022
Accumulated depreciation, revenue earning devices	$ 778,839	$ 434,661
Accumulated depreciation, fixed assets	182,002	49,065
Discount of current portion of convertible notes payable	0	0
Discount of current portion of loans payable	1,651,597	14,745
Discount of loans payable	$ 4,130,291	$ 4,905,076
Preferred stock, authorized	15,545,650	15,545,650
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, par value (in dollars per shares)	$ 0.001
Common stock, par value (in dollars per shares)	$ 0.00001	$ 0.00001
Common stock, authorized	7,225,000,000	7,225,000,000
Common stock, shares, issued	5,848,741,599	4,735,210,360
Common stock, shares, outstanding	5,848,741,599	4,735,210,360
Series G Preferred Stock [Member]
Preferred stock, authorized	100,000	100,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001
Series E Preferred Stock [Member]
Preferred stock, authorized	4,350,000	4,350,000
Preferred stock, shares issued	3,350,000	3,350,000
Preferred stock, shares outstanding	3,350,000	3,350,000
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001
Series F Preferred Stock [Member]
Preferred stock, authorized	4,350	4,350
Preferred stock, shares issued	2,533	2,532
Preferred stock, shares outstanding	2,533	2,532
Preferred stock, par value (in dollars per shares)	$ 1	$ 1

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Income Statement [Abstract]
Revenues	$ 1,331,956	$ 1,447,109
Cost of Goods Sold	678,073	472,926
Gross Profit	653,883	974,183
Operating expenses:
Research and development	3,625,468	2,961,394
General and administrative	8,980,709	10,905,129
Depreciation and amortization	478,115	232,886
Operating lease cost and rent	260,271	275,785
(Gain) loss on disposal of fixed assets		(29,125)
Total operating expenses	13,344,563	14,346,069
Loss from operations	(12,690,680)	(13,371,886)
Other income (expense), net:
Change in fair value of derivative liabilities	3,595	372,214
Interest expense	(5,426,364)	(16,129,499)
Gain (loss) on settlement of debt	3,992	(33,068,313)
Total other income (expense), net	(5,418,777)	(48,825,598)
Net income (loss)	$ (18,109,457)	$ (62,197,484)
Net loss per share - basic	$ 0	$ (0.02)
Net loss per share - diluted	$ 0	$ (0.02)
Weighted average common share outstanding - basic	5,091,857,082	4,029,658,082
Weighted average common share outstanding - diluted	5,091,857,082	4,029,658,082

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($)	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]	Series G Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Feb. 28, 2021	$ 4,350	$ 176,869		$ 32,294	$ 16,764,554	$ (31,521,754)	$ (14,543,687)
Beginning balance, (in shares) at Feb. 28, 2021	4,350,000	2,799		3,229,426,884
Cancellation of Series E Shares	$ (1,000)				1,000
Cancellation of Series E Preferred Shares Shares	(1,000,000)
Series F Preferred Shares issued with amendment agreement		$ 40			3,244,700		3,244,740
Stock Issued During Period, Shares, Issued for Services		40
Series F Preferred Shares Warrants issued with amendment agreement					29,770,474		29,770,474
Series F Preferred Shares cancelled in exchange for promissory notes		$ (83)			(6,732,752)		(6,732,835)
Stock Repurchase and Retired During Period Shares		(83)
Series F preferred shares issued on exercise of warrants		$ 38			(38)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period		38
Series F Preferred Shares converted to common shares		$ (78)		$ 3,164	(3,086)
Stock Issued During Period Shares New Issues1		(78)		316,345,998
Redemption of 19 Issuable Series F shares		$ (74,984)				(425,016)	(500,000)
Exchange of Series F Preferred Shares for debt		$ (184)			(3,999,976)		(4,000,160)
Exchange of Series F Preferred Shares for Debt Shares		(184)
Issuance of Series G preferred as equity awards per employment agreement			$ 1,500,000				1,500,000
Issuance of Series G Preferred as Equity Awards Per Employment Agreement Shares			1,500
Redemption of Series G shares as compensation payment			$ (1,500,000)				(1,500,000)
Redemption of Series G Shares as Compensation Payment Shares			(1,500)
Adjustment to derivative liability					422,272		422,272
Common stock issued for debt conversion				$ 310	898,395		898,705
Stock Issued During Period Value Conversion of Units Shares				31,042,436
Exercise of warrants				$ 3,003	(3,003)
Exercise of Warrants Shares				300,251,561
Exchange of debt for common shares				$ 1,161	$ 6,454,235		$ 6,455,396
Exchange of Debt for Common Shares Shares				116,104,232
Stock based compensation on issuable shares				21	109,179		109,200
Stock Based Compensation on Issuable Shares Shares				2,100,000
Issuance of shares, net of $253,811 issuance costs				$ 6,452	$ 12,515,480		$ 12,521,932
Issuance of Shares Net of inssuance Costs Shares				645,168,473
Cashless exercise of 100,000,000 warrants				$ 948	(948)
Cashless Exercise of Warrants Shares				94,770,776
Relative fair value of warrants issued with debt					3,319,816		3,319,816
Warrants issued as part of debt					4,749,006		4,749,006
Warrants as issuance cost					21,918		21,918
Warrants as consideration for debt extensions					5,415,000		5,415,000
Stock based compensation - employee stock option plan					69,350		69,350
Net income						(62,197,484)	(62,197,484)
Ending balance, value at Feb. 28, 2022	$ 3,350	$ 101,618		$ 47,353	73,015,576	(94,144,254)	(20,976,357)
Ending balance, (in shares) at Feb. 28, 2022	3,350,000	2,532		4,735,210,360
Issuance of shares, net of $253,811 issuance costs				$ 1,339	1,643,883		1,645,222
Issuance of Shares Net of inssuance Costs Shares				133,881,576
Net income						(4,671,686)	(4,671,686)
Rounding					(1)		(1)
Ending balance, value at May. 31, 2022	$ 3,350	$ 101,618		$ 48,692	74,659,458	(98,815,940)	(24,002,822)
Ending balance, (in shares) at May. 31, 2022	3,350,000	2,532		4,869,091,936
Beginning balance, value at Feb. 28, 2022	$ 3,350	$ 101,618		$ 47,353	73,015,576	(94,144,254)	(20,976,357)
Beginning balance, (in shares) at Feb. 28, 2022	3,350,000	2,532		4,735,210,360
Issuance of Shares Net of inssuance Costs Shares				1,057,841,576
Cashless Exercise of Warrants Shares				45,306,557
Relative fair value of warrants issued with debt					990,467		990,467
Stock based compensation - employee stock option plan					122,050		122,050
Net income						(18,109,457)	(18,109,457)
Issuance of shares net of $447,858 issuance costs				10,579	7,760,590		7,771,169
Cashless exercise of 108,378,210 warrants				453	(453)
Penalty shares issued pursuant to a share purchase agreement				$ 175	(175)
Penalty Shares Issued Pursuant to A Share Purchase Agreement Shares				17,500,000
Relative fair value of Series F warrants issued with debt		$ 1			1,201,127		1,201,128
Relative Fair Value of Series F Warrants Issued with Debt Shares		1
Fair value of 955,000,000 warrants cancelled for debt issuance					(2,960,500)		(2,960,500)
Shares issued for services				$ 100	118,400		118,500
Shares Issued for Services Shares				10,000,000
Cancelled shares				$ (171)	171
Cancelled Shares Shares				(17,116,894)
Rounding					(1)		(1)
Ending balance, value at Feb. 28, 2023	$ 3,350	$ 101,619		$ 58,489	80,247,252	(112,253,711)	(31,843,001)	[1]
Ending balance, (in shares) at Feb. 28, 2023	3,350,000	2,533		5,848,741,599
Issuance of shares, net of $253,811 issuance costs				$ 2,809	1,316,100		1,318,909
Issuance of Shares Net of inssuance Costs Shares				280,929,190
Stock based compensation - employee stock option plan					52,721		52,721
Net income						(4,555,193)	(4,555,193)
Ending balance, value at May. 31, 2023	$ 3,350	$ 101,619		$ 61,298	$ 82,563,520	$ (116,808,904)	$ (34,079,117)
Ending balance, (in shares) at May. 31, 2023	3,350,000	2,533		6,129,670,789
[1]Derived from audited information

CONSOLIDATED STATEMENT OF STO_2

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Parenthetical) - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Statement of Stockholders' Equity [Abstract]
Issuance cost of shares		$ 253,811
Warrants		$ 100,000,000
Issuance cost of shares	$ 447,858
Warrants	$ 108,378,210
Warrants cancelled for debt issuance	955,000,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (18,109,457)	$ (62,197,484)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	478,115	232,886
Inventory provision	130,000	65,000
(Gain) loss on disposal of fixed assets		(29,125)
Bad debts expense	45,110	9,022
Revenue earning device sold and expensed in cost of sales		3,410
Reduction of right of use asset	112,396	110,148
Accretion of lease liability	141,631	122,930
Stock based compensation	740,050	2,158,050
Interest expense related to the issuance of warrants for debt extensions		5,415,000
Interest expense related to penalties from debt defaults
Change in fair value of derivative liabilities	(3,595)	(372,214)
Amortization of debt discounts	1,980,033	7,597,242
(Gain) loss on settlement of debt	(3,992)	33,068,313
Increase (decrease) in related party accrued payroll and interest	12,960	264,331
Changes in operating assets and liabilities:
Accounts receivable	119,335	(339,947)
Prepaid expenses	(141,734)	(442,164)
Deposit on right of use asset		(19,999)
Device parts inventory	(1,161,047)	(2,191,571)
Accounts payable and accrued expenses	374,529	(596,615)
Accrued expense, related party		(167,187)
Customer deposits	(100)	(500)
Operating lease liability payments	(254,028)	(233,078)
Balance owed WeSecure		(122,000)
Current portion of deferred variable payment obligations for Payments	216,577	234,013
Accrued interest payable	2,745,822	2,606,097
Net cash used in operating activities	(12,577,395)	(14,825,442)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(258,402)	(115,493)
Purchase of investment	(50,000)
Acquisition of trademarks		(26,327)
Cash paid for security deposit		(17,380)
Proceeds on disposal of fixed assets		30,000
Net cash (used in) investing activities	(308,402)	(129,200)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs	7,771,169	12,521,932
Proceeds from convertible notes payable	619,250
Repayment of convertible debt	(750,000)	(65,000)
Proceeds from loans payable	3,300,000	9,426,146
Repayment of loans payable	(1,763,009)	(516,314)
Series G preferred shares redeemed as payment on incentive plan payable		(1,500,000)
Dividend upon redemption of cancelled issuable Series F shares		(500,000)
Net borrowings(repayments) on loan payable - related party		(808,394)
Net cash provided by (used in) financing activities	9,177,410	18,558,370
Net change in cash	(3,708,387)	3,603,728
Cash, beginning of period	4,648,146	1,044,418
Cash, end of period	939,759	4,648,146
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	451,192	225,003
Cash paid for income taxes
Noncash investing and financing activities:
Right of use asset for lease liability		1,374,002
Transfer from device parts inventory to fixed assets	932,805	659,985
Conversion of convertible notes and interest to shares of common stock		898,705
Release of derivative liability on conversion of convertible notes payable		422,272
Derivative debt discount on revaluation of loan amendment		438,835
Exchange of notes payable for Series F preferred shares		6,732,835
Discount applied to face value of loans	1,797,645	6,162,945
Warrants issued as part of debt issuance		8,068,822
Exchange of warrants for debt	3,000,000
Refund on abandoned trademarks	1,643
Penalty shares pursuant to a share purchase agreement	171
Exercise of warrants	453	3,951
Series F preferred shares issued for debt		4,000,160
Cancellation of Series E preferred shares		1,000
Issuance of Series G preferred shares as payment on incentive plan payable		1,500,000
Series F preferred shares converted to common shares		3,086
Series F preferred shares issued on exercise of warrants		$ 38

GENERAL INFORMATION

GENERAL INFORMATION	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL INFORMATION	1. GENERAL INFORMATION Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”). Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as an LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 2,450 The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.	1. GENERAL INFORMATION AND GOING CONCERN Artificial Intelligence Technology Solutions Inc. (formerly known as On the Move Systems Corp.) (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”). Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc. through the issuance of 10,000 On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 2,450 The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company. GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. For the year ended February 28, 2023, the Company had negative cash flow from operating activities of $ 12,577,395 112,253,711 12,610,601 The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows: Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $ 30,000,000 200,000 300,000

GOING CONCERN

GOING CONCERN	3 Months Ended
	May 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	2. GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. For the three months ended May 31, 2023, the Company had negative cash flow from operating activities of $ 2,991,003 116,808,904 21,819,216 The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. Management has plans to address the Company’s financial situation as follows: Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $ 30,000,000 200,000 300,000 Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. The Company this fiscal period through to June 30, 2023 has raised an additional $ 3.5

ACCOUNTING POLICIES

ACCOUNTING POLICIES	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Accounting Policies [Abstract]
ACCOUNTING POLICIES	3. ACCOUNTING POLICIES Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three months ended May 31, 2023 are not necessarily indicative of the results that may be expected for the entire year. Use of Estimates In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities. Concentrations Loans payable At May 31, 2023 there were $ 32,427,346 28,090,506 87 31,254,345 26,540,506 85 Cash The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances. Accounts Receivable Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $ 16,000 39,000 51 59 Device Parts Inventory Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of both May 31, 2023 and February 28, 2023 there was a valuation reserve of $ 195,000 195,000 Revenue Earning Devices Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 Fixed Assets Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three five Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Fixed assets consisted of the following: Computer equipment and software 2 3 Office equipment 4 years Manufacturing equipment 7 years Warehouse equipment 5 years Tooling 2 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 years, the life of the lease The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income. Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development no Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Sales of Future Revenues The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt: ● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return is implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt. Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” Revenue Recognition (Topic 605) three 57 two 29 Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. Leases Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset. If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease. Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities. Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our CEO and Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company. Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses). Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows: ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 – Inputs that are unobservable for the asset or liability. Measured on a Recurring Basis The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 May 31, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 1,042,000 $ — $ — $ 1,042,000 February 28, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments. Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. Recently Issued Accounting Pronouncements Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (FASB) issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. The Company adopted the new guidance effective February 1, 2021. There was no impact to the Company’s consolidated financial statements upon adoption. In January 2020, the FASB issued new guidance intended to clarify certain interactions between accounting standards related to equity securities, equity method investments and certain derivatives. The guidance addresses accounting for the transition into and out of the equity method of accounting and measuring certain purchased options and forward contracts to acquire investments. The Company adopted the new guidance effective February 1, 2021. There was no impact to the Company’s consolidated financial statements upon adoption. In August 2020, the FASB issued amended guidance on the accounting for convertible instruments and contracts in an entity’s own equity. The guidance removes the separation model for convertible debt instruments and preferred stock, amends requirements for conversion options to be classified in equity as well as amends diluted earnings per share (EPS) calculations for certain convertible debt instruments. The amended guidance is effective for interim and annual periods in 2022. The application of the amendments in the new guidance are to be applied either on a modified retrospective or a retrospective basis. We are currently assessing the effect that the adoption of this standard will have on the Company’s consolidated financial statements upon adoption. Recently Issued Accounting Standards Not Yet Adopted In March 2020, the FASB issued optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting and subsequently issued clarifying amendments. The guidance provides optional expedients and exceptions for accounting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. The optional guidance is effective upon issuance and can be applied on a prospective basis at any time between January 1, 2020 through December 31, 2022. The Company is currently evaluating the impact of adoption on its consolidated financial statements. In October 2021, the FASB issued amended guidance that requires acquiring entities to recognize and measure contract assets and liabilities in a business combination in accordance with existing revenue recognition guidance. The amended guidance is effective for interim and annual periods in 2023 and is to be applied prospectively. Early adoption is permitted on a retrospective basis to the beginning of the fiscal year of adoption. The adoption of this guidance will not have a material impact on the Company’s consolidated financial statements for prior acquisitions; however, the impact in future periods will be dependent upon the contract assets and contract liabilities acquired in future business combinations. In November 2021, the FASB issued new guidance to increase the transparency of transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. The guidance requires annual disclosures of such transactions to include the nature of the transactions and the significant terms and conditions, the accounting treatment and the impact to the company’s financial statements. The guidance is effective for annual periods beginning in 2022 and is to be applied on either a prospective or retrospective basis. The Company is currently evaluating the impact of adoption on its consolidated financial statements.	2. ACCOUNTING POLICIES Basis of Presentation and Consolidation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the instructions on Form 10-K of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). The audited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile , Inc. , On the Move Experience, LLC and OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates In order to prepare financial statements in conformity with accounting principals generally accepted in the United States, management must make estimates , judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions. Concentrations Loans payable At February 28, 2023 there were $ 31,254,345 26,540,506 85 26,233,598 21,709,459 83 Cash The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances. Accounts Receivable Accounts receivable are comprised of balances due from customers, net of estimated allowances for credit losses. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $ 39,000 33,890 48 63 Device Parts Inventory Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. At February 28, 2023 and at February 28, 2022 there was a valuation reserve of $ 195,000 65,000 Revenue Earning Devices Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 Fixed Assets Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three five Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Computer equipment 3 years Furniture and fixtures 3 years Office equipment 4 years Warehouse equipment 5 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 years, the life of the lease The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income. Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development no Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Sales of Future Revenues The Company has entered into transactions, as more fully described in footnote 10, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt: ● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt. Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” Revenue Recognition (Topic 605) two 45 43 Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. Leases Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset. If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease. Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities. Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our CEO and Chairman holds sufficient shares of the Company’s voting stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company without the need to call a general meeting of common shareholders of the Company. Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses). Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows: ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 – Inputs that are unobservable for the asset or liability. Measured on a Recurring Basis The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 February 28, 2023 Liabilities Incentive compensation plan payable – revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 February 28, 2022 Liabilities Incentive compensation plan payable – revaluation of equity awards payable in Series G shares $ 479,500 $ — $ — $ 479,500 Derivative liability – conversion features pursuant to convertible notes payable $ 7,587 $ — $ — $ 7,587 The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments. Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. Recently Issued Accounting Pronouncements Recently Adopted Accounting Standards In January 2020, the FASB issued new guidance intended to clarify certain interactions between accounting standards related to equity securities, equity method investments and certain derivatives. The guidance addresses accounting for the transition into and out of the equity method of accounting and measuring certain purchased options and forward contracts to acquire investments. The Company adopted the new guidance effective February 1, 2021. There was no impact to the Company’s consolidated financial statements upon adoption. In August 2020, the FASB issued amended guidance on the accounting for convertible instruments and contracts in an entity’s own equity. The guidance removes the separation model for convertible debt instruments and preferred stock, amends requirements for conversion options to be classified in equity as well as amends diluted earnings per share (EPS) calculations for certain convertible debt instruments. The amended guidance is effective for interim and annual periods in 2022. The application of the amendments in the new guidance are to be applied either on a modified retrospective or a retrospective basis. We are currently assessing the effect that the adoption of this standard will have on the Company’s consolidated financial statements upon adoption. Recently Issued Accounting Standards Not Yet Adopted In March 2020, the FASB issued optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting and subsequently issued clarifying amendments. The guidance provides optional expedients and exceptions for accounting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. The optional guidance is effective upon issuance and can be applied on a prospective basis at any time between January 1, 2020 through December 31, 2022. The Company is currently evaluating the impact of adoption on its consolidated financial statements. In October 2021, the FASB issued amended guidance that requires acquiring entities to recognize and measure contract assets and liabilities in a business combination in accordance with existing revenue recognition guidance. The amended guidance is effective for interim and annual periods in 2023 and is to be applied prospectively. Early adoption is permitted on a retrospective basis to the beginning of the fiscal year of adoption. The adoption of this guidance will not have a material impact on the Company’s consolidated financial statements for prior acquisitions; however, the impact in future periods will be dependent upon the contract assets and contract liabilities acquired in future business combinations.

REVENUE FROM CONTRACTS WITH CUS

REVENUE FROM CONTRACTS WITH CUSTOMERS	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Revenue from Contract with Customer [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	4. REVENUE FROM CONTRACTS WITH CUSTOMERS Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019). As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected. The following table presents revenues from contracts with customers disaggregated by product/service: Three Months Ended Three Months Ended Device rental activities $ 238,149 $ 239,805 Direct sales of goods and services 147,059 145,352 Revenues $ 385,208 $ 385,157	3. REVENUE FROM CONTRACTS WITH CUSTOMERS Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 which was adopted. On March 1, 2019. As disclosed in the revenue recognition section of Note 2 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 2 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Upon adoption of Topic 842, also referred to above in Note 2, the Company accounts for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset for periods greater than one year. To date none of the lease agreements entered into have been for periods longer than one year or greater, and the Company has availed itself of the practical expedient to exclude such leases from ASC 84 2accountiong and instead has accounted for these leases under ASC 606. The following table presents revenues from contracts with customers disaggregated by product/service: Year Ended Year Ended Device rental activities $ 754,126 $ 592,401 Direct sales of goods and services 577,830 854,708 Revenues $ 1,331,956 $ 1,447,109

LEASES

LEASES	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Leases
LEASES	5. LEASES We lease certain warehouses, and office space. Leases with an initial term of 12 There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Below is a summary of our lease assets and liabilities at May 31, 2023 and February 28, 2023. Leases Classification May 31, 2023 February 28, 2023 Assets Operating Operating Lease Assets $ 1,179,673 $ 1,208,440 Liabilities Current Operating Current Operating Lease Liability $ 244,169 $ 248,670 Noncurrent Operating Noncurrent Operating Lease Liabilities 926,274 950,541 Total lease liabilities $ 1,170,443 $ 1,199,211 Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred. Operating lease cost and rent was $ 62,542 69,967	4. LEASES We lease certain warehouses, and office space. Leases with an initial term of 12 There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Below is a summary of our lease assets and liabilities at February 28, 2023 and February 28, 2022. Leases Classification February 28, 2023 February 28, 2022 Assets Operating Operating Lease Assets $ 1,208,440 $ 1,331,605 Liabilities Current Operating Current Operating Lease Liability $ 248,670 $ 254,027 Noncurrent Operating Noncurrent Operating Lease Liabilities 950,541 1,057,579 Total lease liabilities $ 1,199,211 $ 1,311,606 Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred. Operating lease cost and rent was $ 260,271 275,785

REVENUE EARNING DEVICES

REVENUE EARNING DEVICES	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Revenue Earning Devices
REVENUE EARNING DEVICES	6. REVENUE EARNING DEVICES Revenue earning devices consisted of the following: May 31, 2023 February 28, 2023 Revenue earning devices $ 2,459,470 $ 2,015,058 Less: Accumulated depreciation (902,680 ) (779,839 ) Total $ 1,556,790 $ 1,235,219 During the three months ended May 31, 2023 the Company made total additions to revenue earning devices of $ 444,412 174,101 Depreciation expense was $ 122,841 71,414	6. REVENUE EARNING ROBOTS Revenue earning robots consisted of the following: February 28, 2022 February 28, 2021 Revenue earning devices $ 2,015,058 $ 1,143,724 Less: Accumulated depreciation (779,839 ) (434,661 ) $ 1,235,219 $ 709,063 During the year ended February 28, 2023, the Company made total additions to revenue earning devices of $ 871,334 647,116 647,116 3,255 30,600 3,255 Depreciation expense for these devices was $ 345,178 208,510

FIXED ASSETS

FIXED ASSETS	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Property, Plant and Equipment [Abstract]
FIXED ASSETS	7. FIXED ASSETS Fixed assets consisted of the following: May 31, 2023 February 28, 2023 Automobile $ 101,680 $ 101,680 Demo devices 97,720 69,010 Tooling 101,322 101,322 Machinery and equipment 8,825 8,825 Computer equipment 150,387 150,387 Office equipment 15,312 15,312 Furniture and fixtures 21,225 21,225 Warehouse equipment 14,561 14,561 Leasehold improvements 19,031 15,568 530,063 497,890 Less: Accumulated depreciation (227,103 ) (182,002 ) $ 302,960 $ 315,888 During the three months ended May 31, 2023 the Company made additions of $ 32,173 28,710 3,463 93,730 5,516 88,214 Depreciation expense was $ 45,101 22,581	7. FIXED ASSETS Fixed assets consisted of the following: February 28, 2023 February 28, 2022 Automobile $ 101,680 $ 101,680 Demo devices 69,010 16,539 Tooling 101,322 — Machinery and equipment 8,825 — Computer equipment 150,387 36,742 Office equipment 15,312 15,312 Furniture and fixtures 21,225 — Warehouse equipment 14,561 11,415 Leasehold improvements 15,568 5,329 497,890 187,017 Less: Accumulated depreciation (182,002 ) (49,065 ) $ 315,888 $ 137,952 During the year ended February 28, 2023, the Company made additions to fixed assets of $ 258,402 52,471 During the year ended February 28, 2022, the Company made additions to fixed assets of $ 115,493 12,868 875 30,000 29,125 Depreciation expense was $ 132,937 24,376

DEFERRED VARIABLE PAYMENT OBLIG

DEFERRED VARIABLE PAYMENT OBLIGATION	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Deferred Variable Payment Obligation
DEFERRED VARIABLE PAYMENT OBLIGATION	8. DEFERRED VARIABLE PAYMENT OBLIGATION On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $ 900,000 9 February 29, 2020 On May 9, 2019 the Company entered into two similar arrangements with two investors: (1) The investor would pay up to $ 400,000 4 400,000 (2) The investor would pay up to $ 50,000 1.11 50,000 These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount. In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. On November 18, 2019 the Company entered into an arrangement similar to the (February 1, 2019 agreement above) investor above whereby the investor would advance up to $ 225,000 2.25 109,000 116,000 On December 30, 2019 the Company entered into an arrangement with a new investor whereby the investor would advance up to $ 100,000 1.00 On April 22, 2020 the Company entered into an arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $ 100,000 1.00 On July 1, 2020 the Company entered into an agreement with the first investor whereby the investor would pay up to $ 800,000 2.75 If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment On August 27, 2020 the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $ 900,000 225,000 800,000 1,925,000 14.25 In summary of all agreements mentioned above if in the event that at least 10 The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77% The Payments will first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and will accrue every quarter thereafter. As of May 31, 2023, the Company has accrued approximately $ 604,811 388,226 542,177 325,600 On March 1, 2021 the first investor referred to above whose aggregate investment is $ 1,925,000 1) The rate payment was reduced from 14.25 9.65 2) The asset disposition % (see below) was reduced from 31 21 In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 1.00 38 33,015,214 The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of February 28, 2023, and February 28, 2022, the long-term balances other than Payments already owed is the cash received of $ 2,525,000 2,525,000 For both the years ended February 28, 2023 and February 28, 2022, the Company has received $ 0 2,525,000 For the three months ended May 31, 2023 and year ended February 28, 2023 , the Company has received $ 0 2,525,000 The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of May 31, 2023, the Company has accrued $ 388,227 542,177 388,226 325,600	8. DEFERRED VARIABLE PAYMENT OBLIGATION On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $ 900,000 9 February 29, 2020 On May 9, 2019 the Company entered into two similar arrangements with two investors: (1) The investor would pay up to $ 400,000 4 400,000 (2) The investor would pay up to $ 50,000 1.11 50,000 These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount. In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. On November 18, 2019 the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $ 225,000 2.25 109,000 116,000 On December 30, 2019 the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $ 100,000 1.00 On April 22, 2020 the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $ 100,000 1.00 On July 1, 2020 the Company entered into a similar agreement with the first investor whereby the investor would pay up to $ 800,000 2.75 If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment On August 27, 2020 the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $ 1,925,000 14.25 In summary of all agreements mentioned above if in the event that at least 10 The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77% The Payments will first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and will accrue every quarter thereafter. As of February 28, 2023, the Company has accrued approximately $542,1777 in Payments, of which $325,600 is in arrears. As of February 28, 2022, the Company has accrued approximately $325,600 in Payments, of which $90,300 is in arrears. No notices have been received by the Company. On March 1, 2021 the first investor referred to above whose aggregate investment is $ 1,925,000 1) The rate payment was reduced from 14.25 9.65 2) The asset disposition % (see below) was reduced from 31 21 In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 1.00 38 33,015,214 The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of February 28, 2023, and February 28, 2022, the long-term balances other than Payments already owed is the cash received of $ 2,525,000 2,525,000 For both the years ended February 28, 2023 and February 28, 2022, the Company has received $ 0 2,525,000

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	9. RELATED PARTY TRANSACTIONS For both the three months ended May 31, 2023 and May 31, 2022 , the Company had no 243,256 206,516 139,250 133,000 12 108,000 108,000 12 19,275 15,660 Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months ended May 31, 2023 the Company accrued $ 63,000 161,500 1,000 1,042,000 979,000 During the three months ended May 31, 2023 and 2022, the Company was charged $ 882,015 1,001,734	10. RELATED PARTY TRANSACTIONS For the years ended February 28, 2023 and February 28, 2022, the Company made net repayments of $ 0 803,394 206,516 193,556 108,000 12 108,000 90,000 12 15,660 2,700 During the year ended February 28, 2023 pursuant to the amended Employment Agreement with its Chief Executive Officer the Company accrued $ 499,500 979,000 479,500 1,000 During the year ended February 28, 2022, pursuant to the amended Employment Agreement with its Chief Executive Officer, the Company issued 1,500 1,000 1,500,000 1,500,000 479,500 During the years ended February 28, 2023 and February 28, 2022, the Company was charged $ 3,578,981 2,258,819

OTHER DEBT _ VEHICLE LOAN

OTHER DEBT – VEHICLE LOAN	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Other Debt Vehicle Loan
OTHER DEBT – VEHICLE LOAN	10. OTHER DEBT – VEHICLE LOAN In December 2016, RAD entered into a vehicle loan for $ 47,704 5 November 9, 20 1,019 47,661 5 October 24, 2022 923 0 21,907 3,257 21,578 18,766 5,515 13,251 16,944 38,522 38,522	11. OTHER DEBT – VEHICLE LOANS In December 2016, RAD entered into a vehicle loan for $ 47,704 5 1,019 47,661 5 October 24, 2022 923 21,907 3,257 21,578 18,766 5,515 13,251 16,944 38,522 38,522

LOANS PAYABLE

LOANS PAYABLE	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Loans Payable
LOANS PAYABLE	11. LOANS PAYABLE Loans payable at May 31, 2023 consisted of the following: Annual Date Maturity Description Principal Interest Rate July 18, 2016 July 18, 2017 Promissory note (1) * $ 3,500 22% December 10, 2020 December 10, 2023 Promissory note (2) 3,921,168 12% December 10, 2020 December 10, 2023 Promissory note (3) 3,054,338 12% December 10, 2020 December 10, 2023 Promissory note (4) 165,605 12% December 14, 2020 December 14, 2023 Promissory note (5) 310,375 12% December 30, 2020 December 30, 2023 Promissory note (6) 350,000 12% January 1, 2021 January 1, 2024 Promissory note (7) 25,000 12% January 1, 2021 January 1, 2024 Promissory note (8) 145,000 12% January 14, 2021 January 14, 2024 Promissory note (9) 550,000 12% February 22, 2021 February 22, 2024 Promissory note (10) 1,650,000 12% March 1, 2021 March 1, 2024 Promissory note (11) 6,000,000 12% June 8, 2021 June 8, 2024 Promissory note (12) 2,750,000 12% July 12, 2021 July 26, 2026 Promissory note (13) 3,857,360 7% September 14, 2021 September 14, 2024 Promissory note (14) 1,650,000 12% July 28, 2022 July 28, 2023 Promissory note (15) 170,000 15% August 30, 2022 August 30,2024 Promissory note (16) 3,000,000 15% September 7, 2022 September 7, 2023 Promissory note (17) 400,000 15% September 8, 2022 September 8, 2023 Promissory note (18) 475,000 15% October 13, 2022 October 13, 2023 Promissory note (19) 350,000 15% October 28, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 9, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 10, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 15, 2022 October 31, 2026 Promissory note (20) 400,000 15% January 11, 2023 October 31,2026 Promissory note (20) 400,000 15% February 6, 2023 October 31, 2026 Promissory note (20) 400,000 15% April 5. 2023 October 31, 2026 Promissory note (20) 400,000 15% April 20, 23 October 31, 2026 Promissory note (20) 400,000 15% May 11, 2023 October 31, 2026 Promissory note (20) 400,000 15% $ 32,427,346 Less: current portion of loans payable (17,569,985 ) Less: discount on non-current loans payable (4,973,120 ) Non-current loans payable, net of discount $ 9,884,241 Current portion of loans payable $ 17,569,985 Less: discount on current portion of loans payable (1,348,996 ) Current portion of loans payable, net of discount $ 16,220,989 * In default (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. (2) This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 (3) This promissory note was issued as part of a debt settlement whereby $ 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 (4) This promissory note was issued as part of a debt settlement whereby $ 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 (5) This promissory note was issued as part of a debt settlement whereby $ 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 (6) The note, with an original principal amount of $ 350,000 35,000 50,000,000 0.025 3 271,250 271,250 39,904 153,611 (7) This promissory note was issued as part of a debt settlement whereby $ 9,200 6,944 16,144 25,000 (8) This promissory note was issued as part of a debt settlement whereby $ 79,500 28,925 108,425 145,000 (9) The note, with an original principal amount of $ 550,000 250,000 50,000,000 0.025 3 380,174 380,174 51,045 188,291 (10) The note, with an original principal balance of $ 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 50,000,000 .0164 3 950,000 159,064 953,197 (11) The unsecured note may be pre-payable at any time. Cash proceeds of $ 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 (12) The note, with an original principal balance of $ 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 154,910 639,308 (13) This loan, with an original principal balance of $ 4,000,160 27,000 (14) The note, with an original principal balance of $ 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 86,930 1,27,501 (15) Original $ 170,000 20,000 5,287 3,739 (16) A warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 4,557 26,312 (17) Original $ 400,000 50,000 12,342 15,479 (18) Original $ 475,000 75,000 18,930 17,799 (19) Original $ 350,000 50,000 12,290 20,620 (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. 400,000 50,000 1,866 346,157 400,000 50,000 1,838 346,600 400,000 50,000 16,678 349,214 400,000 50,000 1,881 345,914 400,000 50,000 1,925 345,265 400,000 50,000 1,836 346,590 400,000 50,000 751 345,494 400,000 50,000 196 352,023 400,000 50,000 0 398,983	12. LOANS PAYABLE Loans payable at February 28, 2023 consisted of the following: Annual Date Maturity Description Principal Interest Rate July 18, 2016 July 18, 2017 Promissory note (35) * $ 3,500 22 June 11, 2018 June 11, 2019 Promissory note (2) (#) — 25 January 31, 2019 June 30, 2019 Promissory note (1) (#) — 15 May 9, 2019 June 30, 2019 Promissory note (3) (#) — 15 May 31, 2019 June 30, 2019 Promissory note (4) (#) — 15 June 26, 2019 June 26, 2020 Promissory note (5) (#) — 15 September 24, 2019 June 24, 2020 Promissory note (6) (#) — 15 January 30, 2020 January 30, 2021 Promissory note (7) (#) — 15 February 27, 2020 February 27, 2021 Promissory note (8) (#) — 15 April 16, 2020 April 16, 2021 Promissory note (9) (#) — 15 May 12, 2020 May 12, 2021 Promissory note (11) (#) — 15 May 22, 2020 May 22, 2021 Promissory note (12) (#) — 15 June 2, 2020 June 2, 2021 Promissory note (13) (#) — 15 June 9, 2020 June 9, 2021 Promissory note (14) (#) — 15 June 12, 2020 June 12, 2021 Promissory note (15) (#) — 15 June 16, 2020 June 16, 2021 Promissory note (16) (#) — 15 September 15, 2020 September 15, 2022 Promissory note (17) (#) — 10 October 6, 2020 March 6, 2023 Promissory note (18) (#) — 12 November 12, 2020 November 12, 2023 Promissory note (19) (#) — 12 November 23, 2020 October 23, 2022 Promissory note (20) (#) — 15.5 November 23, 2020 November 23, 2023 Promissory note (21) (#) — 15 December 10, 2020 December 10, 2023 Promissory note (22) (#) — 12 December 10, 2020 December 10, 2023 Promissory note (23) 3,921,168 12 December 10, 2020 December 10, 2023 Promissory note (24) 3,054,338 12 December 10, 2020 December 10, 2023 Promissory note (25) 165,605 12 December 14, 2020 December 14, 2023 Promissory note (26) 310,375 12 December 30, 2020 December 30, 2023 Promissory note (27) 350,000 12 December 31, 2021 December 31, 2024 Promissory note (28) 25,000 12 December 31, 2021 December 31, 2024 Promissory note (29) 145,000 12 January 14, 2021 January 14, 2024 Promissory note (30) 550,000 12 February 22, 2021 February 22, 2024 Promissory note (31) 1,650,000 12 March 1, 2021 March 1, 2024 Promissory note (10) 6,000,000 12 June 8, 2021 June 8, 2024 Promissory note (32) 2,750,000 12 July 12, 2021 July 26, 2026 Promissory note (33) 3,884,360 7 September 14, 2021 September 14, 2024 Promissory note (34) 1,650,000 12 July 28, 2022 July 28, 2023 Promissory note (36) 170,000 15 August 30, 2022 August 30,2024 Promissory note (38) 3,000,000 15 September 7, 2022 September 7, 2023 Promissory note (37) 400,000 15 September 8, 2022 September 8, 2023 Promissory note (39) 475,000 15 October 13, 2022 October 13, 2023 Promissory note (40) 350,000 15 October 28, 2022 October 31, 2026 Promissory note (41) 400,000 15 November 9, 2022 October 31, 2026 Promissory note (41) 400,000 15 November 10, 2022 October 31, 2026 Promissory note (41) 400,000 15 November 15, 2022 October 31, 2026 Promissory note (41) 400,000 15 January 11, 2023 October 31,2026 Promissory note (41) 400,000 15 February 6, 2023 October 31,2026 Promissory note (41) 400,000 15 $ 31,254,346 Less: current portion of loans payable (11,569,986 ) Less: discount on non-current loans payable (4,130,291 ) Non-current loans payable, net of discount $ 15,554,069 Current portion of loans payable $ 11,569,986 Less: discount on current portion of loans payable (1,651,597 ) Current portion of loans payable, net of discount $ 9,918,389 * In default. Default interest rate 22 (#) Loans with a principal balance of $ 1,661,953 342,138 2,004,091 62,979 (1) Original $ 78,432 33 25,882 (2) Repayable in 12 4,562 48,000 (3) Original $ 7,850 33 2,590 (4) Original $ 86,567 33 28,567 (5) Original $ 79,104 33 26,104 (6) Original $ 12,000 3,000 (7) Original $ 11,000 2,450 (8) Original $ 5,000 1,200 (9) Original $ 13,000 3,850 (10) The unsecured note may be pre-payable at any time. Cash proceeds of $ 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 0 0 150,000,000 .0164 3 2,850,000 (11) Original $ 43,500 8,000 (12) Original $ 85,000 15,000 (13) Original $ 62,000 12,000 (14) Original $ 31,000 6,000 (15) Original $ 50,000 10,000 (16) Original $ 42,000 7,000 (17) Original $ 300,000 50,000 (18) Original principal of $ 150,000 2,000 8,500 (19) Original $ 110,000 10,000 70,000,000 0.00165 3 41,176 41,176 (20) Original principal of $ 65,000 4,060 (21) Original $ 300,000 25,000 230,000,000 0.00165 3 125,814 125,814 (22) Original $ 82,500 7,500 100,000,000 0.002 3 54,545 54,545 (23) This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 (24) This promissory note was issued as part of a debt settlement whereby $ 1,460,794 1,593,544 3,054,338 3,054,338 550,000 (25) This promissory note was issued as part of a debt settlement whereby $ 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 (26) This promissory note was issued as part of a debt settlement whereby $ 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 (27) The note, with an original principal amount of $ 350,000 35,000 50,000,000 0.025 3 271,250 271,250 83,338 193,515 (28) This promissory note was issued as part of a debt settlement whereby $ 9,200 6,944 16,144 25,000 (29) This promissory note was issued as part of a debt settlement whereby $ 79,500 28,925 108,425 145,000 (30) The note, with an original principal amount of $ 550,000 250,000 50,000,000 0.025 3 380,174 380,174 127,897 239,336 (31) The note, with an original principal balance of $ 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 2,995,719 1,112,261 50,000,000 .0164 3 950,000 (32) The note, with an original principal balance of $ 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 455,527 794,218 85,000,000 .0164 3 1,615,000 (33) This loan, with an original principal balance of $ 4,000,160 115,800 (34) The note, with an original principal balance of $ 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 188,002 1,214,431 (35) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. (36) Original $ 170,000 20,000 10,974 9,026 (37) Original $ 400,000 50,000 22,179 27,821 (38) A warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 8,632 30,868 (39) Original $ 475,000 75,000 38,271 32,909 (40) Original $ 350,000 50,000 17,091 46,407 (41) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each trance of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. October 28, 2022, $ 400,000 50,000 1,375 348,024 November 9, 2022, $ 400,000 50,000 1,312 348,438 November 10, 2022, $ 400,000 50,000 1,139 350,881 November 15, 2022, $ 400,000 50,000 2,143 347,815 January 11, 2023, $ 400,000 50,000 802 347,189 February 6, 2023, $ 400,000 50,000 100 348,426

STOCKHOLDERS_ EQUITY (DEFICIT)

STOCKHOLDERS’ EQUITY (DEFICIT)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Equity [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	12. STOCKHOLDERS’ EQUITY (DEFICIT) Summary or Preferred Stock Activity No preferred stock activity during the period. Summary of Preferred Stock Warrant Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2023 695 $1.00 10.00 Issued 183 1.00 9.88 Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 878 $1.00 9.75 During the three months ended May 31, 2023, as part of debt issuance the Company issued 183 Series F Preferred Warrants to a lender for a relative fair value of $ 947,447 Summary of Common Stock Activity For the three months ended May 31, 2023 , the Company issued 280,929,190 1,400,094 1,318,809 81,285 The table below represent the common shares issued, issuable and outstanding at May 31, 2023 and February 28, 2023: Common shares May 31, 2023 February 28, 2023 Issued 6,117,570,789 5,836,641,599 Issuable 12,100,000 12,100,000 Issued, issuable and outstanding 6,129,670,789 5,848,741,599 Summary of Common Stock Warrant Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28, 2023 314,217,451 $0.114 1.95 Issued — — — Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 314,217,451 $0.114 1.70 For the three months ended May 31, 2022 and May 31, 2021, the Company recorded a total of $ 0 0 Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28 , 2023 95,725,000 $0.02 4.75 Issued — — — Exercised — — — Forfeited, extinguished and cancelled (13,025,000 ) $0.02 (4.75) Outstanding at May 31, 2023 82,700,000 $0.02 4.50	14. STOCKHOLDERS’ DEFICIT Preferred Stock: 20,000,000 0.001 Series E Preferred Stock The board of directors has designated 4,350,000 3,350,000 Series F Convertible Preferred Stock The board of directors has designated 4,350 1.00 2,533 Series G Preferred Stock The board of directors has designated 100,000 1,000 Summary of Preferred Stock Activity Series E Preferred Stock During the year ended February 28, 2023 there was no Series E share activity. During the year ended February 28, 2022 Series E shareholders had the following activity: — A shareholder cancelled 1,000,000 Series F Preferred Shares Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis. On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Summary or Preferred Stock Activity During the year ended February 28, 2023 Series F shareholders had the following activity: — 1 366 During the year ended February 28, 2022 Series F shareholders had the following activity: — 40 367 1.00 33,015,214 — The warrant holder exercised the warrant in part to acquire 38 — The shareholder above converted 78 — Two Series F Preferred shareholders exchanged 83 Series F Preferred Shares for two promissory notes on March 23, 2021. The notes are non-interest bearing, have a one-year maturity and total $7,546,775. These notes were subsequently exchanged on June 2, 2021 for a total of 116,104.232 common shares. — On July 12, 2021, the former director agreed to surrender his remaining 184 Series F preferred shares in exchange for a note payable from the Company of $4,000,160 bearing interest at 7% per annum with a 5 year term, maturing July 12, 2026. — On August 24, 2021the Series F preferred warrant holder agreed to not exercise his warrant privileges on his remaining 329 warrant shares before September 1, 2023. Unissued Series F Preferred Stock At both February 28, 2023 and February 28, 2022 there remains 46 issuable Series F preferred stock at a value of $99,086. During the year ending February 28, 2022 the Company redeemed (through cancellation) 19 shares of issuable Series F preferred stock having a value of $ 74,984 for $500,000, with the difference of $425,016 recorded as a dividend. On October 28, 2022 as part of a $4,000,000 loan facility (described in Note 12) the Company extended the maturity date of the 329 existing Series F Preferred Warrants currently held by the lender to October 31, 2033 from October 31, 2026. Summary of Preferred Stock Warrant Activity Schedule of Summary of stock Option Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 329 $1.00 11.50 Issued 366 $1.00 10.00 Exercised — — — Forfeited and cancelled — — — Outstanding at February 28, 2023 695 $1.00 10.00 Series G Preferred Stock During the year ended February 28, 2023 there was no Series G share activity. During the year ending February 28, 2022 Series G shareholders had the following activity: — On achievement of objectives 3,4,5 and 8 of the equity awards described below the CEO was granted 1500 Series G Preferred shares which were redeemed immediately for $1,500,000 — The Company has accrued $ 1,979,500 Summary of Common Stock Activity The Company increased authorized common shares from 5,000,000,000 6,000,000,000 6,000,000,000 7,225,000,000 Summary of Common Stock Activity During the year ended, February 28, 2023, common shareholders had the following activity: — the Company issued 1,057,841,576 8,21,027 7,771,169 447,858 — the Company issued 17,500,000 — the Company issued 45,306,557 shares through the cashless exercise of 108,378,210 warrants. — the Company cancelled 17,116,894 10,000,000 118,500 During the year ending February 28, 2022, common shareholders had the following activity: — A Series F Preferred shareholder converted 78 316,345,998 — holders of certain convertible notes payable elected to convert a total of $ 825,000 71,955 1,750 31,042,436 — in June 2021, lenders exchanged debt having a face value of $ 7,546,775 6,894,099 116,104,232 6,455,396 438,703 — the Company entered into an investor relations contract whereby 2,100,000 109,200 — the Company issued 645,168,473 13,108,624 12,521,932 586,692 — warrant holders exercised warrants to acquire 411,000,000 395,022,447 The table below represent the common shares issued, issuable and outstanding at February 28, 2023 and February 28, 2022: Common shares February 28, 2023 February 28, 2022 Issued 5,836,641,599 4,733,110,360 Issuable 12,100,000 2,100,000 Issued, issuable and outstanding 5,848,741,599 4,735,210,360 Summary of Warrant and Stock Option Activity Number of Weighted Average Weighted Average Outstanding at February 29, 2021 619,523,492 $0.03 2.81 Issued 1,008,324,212 0.06 2.47 Exercised (411,000,000) 0.06 1.70 Forfeited and cancelled (2,043) — — Outstanding at February 28, 2022 1,216,845,661 $0.06 2.38 Adjusted (1) 66,750,000 0.011 1.41 Issued 94,000,000 0.010 4.69 Exercised (108,378,210) (0.011) 2.44 Forfeited and cancelled (955,000,000) (0.008) 1.33 Outstanding at February 28, 2023 314,217,451 $0.114 1.95 __________ (1) Required dilution adjustment per warrant agreement For the years ended February 28, 2023 and February 28, 2022, the Company recorded a total of $ 0 0 For the years ended February 28, 2023 and February 28, 2022 the Company recorded a total of $ 240,550 1,678,550 499,500 479,500 During the year ended February 28, 2023 warrant holders had the following activity: — On August 30, 2022 a warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 — On August 9, 2022 as part of a debt issuance the Company issued two 47,000,000 0.01 0.008 5 393,949 Schedule of valuation techniques Strike price $ 0.008 0.01 Fair value of Company’s common stock $ 0.012 Dividend yield 0.00 Expected volatility 88.2 90.00 Risk free interest rate 2.98 Expected term (years) 5.00 — Cashless exercise of 108,378,210 warrants for 45,306,557 common shares During the year ended February 28, 2022 warrant holders had the following activity: — warrant holders exercised warrants to acquire 411,000,000 — in conjunction with debt disclosed in Note 11 (44), the Company issued warrants to a lender to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033, in conjunction with debt disclosed in Note 11 (10), the Company issued warrants to a lender to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005,and in conjunction with debt disclosed in Note 11 (46), the Company issued warrants to a lender to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783 Schedule of valuation techniques for warrants Strike price $ 0.135 0.037 Fair value of Company’s common stock $ 0.146 0.0071 Dividend yield 0.00 Expected volatility 411.0 403.33 Risk free interest rate 0.43 0.27 Expected term (years) 3.00 — in conjunction with debt extensions on notes payable disclosed in Note 12 (10, 43, 44), the Company issued warrants to a lender to purchase a total 285,000,000 0.164 3 5,415,000 Strike price $ 0.0164 Fair value of Company’s common stock $ 0.019 Dividend yield 0.00 Expected volatility 385.60 Risk free interest rate 1.62 Expected term (years) 3.00 — As share issuance costs to a broker the company issued warrants to acquire a total of 3,324,212 21,929 Strike price $ 0.041 0.029 Fair value of Company’s common stock $ 0.039 0.028 Dividend yield 0.00 Expected volatility 35.30 35.90 Risk free interest rate 0.46 0.95 Expected term (years) 3.00 Summary of Common Stock Option Activity Summary of CEO Compensation Grant On April 9, 2021 the Company entered into an Employment Agreement with Chief Executive Officer, Steven Reinharz with a three- year term under the following terms whereby stock option awards will be granted if certain conditions are met: — A stock option award (option 1) will be granted to the employee to purchase 10,000,000 0.15 0.30 — A stock option award (option 2) will be granted to the employee to purchase 30,000,000 0.25 0.50 Objective #3 Sales in any fiscal quarter exceed the total sales in fiscal year 2021 for the first time. Award #3 Five hundred (500) shares of Series G preferred stock. Objective #4 One hundred fifty (150) devices are deployed in the marketplace. Award #4 Two hundred fifty (250) shares of Series G preferred stock. Objective #5 Year-to-date sales at any point in fiscal year 2022 exceed One Million Dollars ($1,000,000). Award #5 Two hundred fifty (250) shares of Series G preferred stock. Objective #6 The price per share of common stock has increased to and maintains a price of Ten Cents ($0.10) or more for ten (10) days in a thirty (30) day period. Award #6 Two hundred fifty (250) shares of Series G preferred stock. Objective #7 The price per share of common stock has increased to and maintains a price of Twenty Cents ($0.20) or more for ten (10) days in a thirty (30) day period. Award #7 Five hundred (500) shares of Series G preferred stock. Objective #8 The RAD 3.0 products are launched into the marketplace by November 30, 2021. Award #8 Five hundred (500) shares of Series G preferred stock. Objective #9 RAD receives an order for fifty (50) units from a single customer. Award #9 Five hundred (500) shares of Series G preferred stock. The fair value of the first two awards was obtained through the use of the Monte Carlo method was $ 69,350 499,500 1,979,500 1,500 1,500,000 On April 14, 2021, the Shareholders of Series E Preferred Stock and the Board of Directors of our Company (“Board”) approved and adopted the 2021 Incentive Stock Plan (the “2021 Plan”). On August 11, 2022 the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 5,000,000 to 100,000,000. The purpose of the 2021 Plan is to promote the success of the Company by authorizing incentive awards to retain Directors, executives, selected Employees and Consultants, and reward participants for making major contributions to the success of the Company. The 2021 Plan authorizes the granting of stock options, restricted stock, restricted stock units, stock appreciation rights and stock awards. A total of one hundred million (100,000,000) shares of common stock may be issued under the 2021 Plan. All awards under the 2021 Plan, whether vested or unvested, are subject to the terms of any recoupment, clawback or similar policy of the Company in effect from time to time, as well as any similar provisions of applicable law, which could in certain circumstances require repayment or forfeiture of awards or any shares of stock or other cash or property received with respect to the awards, including any value received from a disposition of the shares acquired upon payment of the awards. The 2021 Plan will be administered by the Board or any Committee authorized by the Board, if applicable, which will have the sole authority to, among other things: construe and interpret the 2021 Plan; make rules and regulations relating to the administration of the 2021 Plan; select participants; and establish the terms and conditions of awards, all in accordance with the terms of the 2021 Plan. The 2021 Plan will remain in effect until April 14, 2031, unless sooner terminated by the Board. Termination will not affect awards then outstanding. During the year ended February 28, 2023 the Company had the following common stock option activity: — On September 1, 2022, the Company as part of the afore-mentioned Incentive Stock Option Plan issued 100,000,000 shares to 64 employees. The shares were issued with an exercise price of $0.02, vest after 4 years with a 5 year term having a fair value of $1,020,000 Strike price $ 0.02 Fair value of Company’s common stock $ 0.01 Dividend yield 0.00 Expected volatility 340.9 Risk free interest rate 3.39 Expected term (years) 4.50 The Company recorded $ 122,050 — Options to purchase 4,275,000 During the year ended February 28, 2022 the Company had no common stock option activity: Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 — $ — — Issued 100,000,000 $0.02 4.75 Exercised — — — Forfeited, extinguished and cancelled (4,275,000 ) $0.02 (4.75) Outstanding at November 30, 2022 95,725,000 $0.02 4.75

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES Litigation Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. The related legal costs are expensed as incurred. Operating Lease On December 18, 2020, the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $3,859 per month. 3,859 On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $ 15,880 15,880 On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462. On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $ 1,500 1,500 The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $ 62,542 69,967 Maturity of Lease Liabilities Operating May 31, 2024 $ 244,169 May 31, 2025 213,711 May 31, 2026 207,558 May 31, 2027 207,557 May 31, 2028 207,558 May 31, 2029 and after 605,378 Total lease payments 1,685,931 Less: Interest (515,488 ) Present value of lease liabilities $ 1,170,443	15. COMMITMENTS AND CONTINGENCIES Litigation Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. The related legal costs are expensed as incurred. Operating Lease On December 18, 2020, the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $ 3,859 3,859 On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $ 15,880 15,880 On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462. On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 1,500 1,500 The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $ 260,271 275,785 Maturity of Lease Liabilities Operating February 28, 2024 $ 248,669 February 28, 2025 219,863 February 28, 2026 207,558 February 28, 2027 207,558 February 28, 2028 207,558 February 28, 2029 and after 657,268 Total lease payments 1,748,474 Less: Interest (549,263 ) Present value of lease liabilities $ 1,199,211

EARNINGS (LOSS) PER SHARE

EARNINGS (LOSS) PER SHARE	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	14. EARNINGS (LOSS) PER SHARE The net income (loss) per common share amounts were determined as follows: For the Three Months Ended May 31, 2023 May 31, 2022 Numerator: Net income (loss) available to common shareholders $ (4,555,193 ) $ (4,671,686 ) Effect of common stock equivalents Add: interest expense on convertible debt — — Net income (loss) adjusted for common stock equivalents (4,555,193 ) (4,671,686 ) Denominator: Weighted average shares – basic 5,964,709,322 4,798,657,871 Net income (loss) per share – basic $ (0.00 ) $ (0.00 ) Denominator: Weighted average shares – diluted 5,964,709,322 4,798,657,871 Net income (loss) per share – diluted $ (0.00 ) $ (0.00 ) The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2023 and 2022 were as follows: For the Three Months Ended May 31, 2023 May 31, 2022 Convertible notes and accrued interest — 7,093,255 Convertible Series F Preferred Shares — — Stock options and warrants 396,917,451 1,216,845,661 Total 396,917,451 1,223,938,916 * On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at May 31, 2023 and 2022 the dilutive effects would be as follows: Series F Preferred shares been convertible the dilutive effects would be as follows: For the Three Months Ended May 31, 2023 May 31, 2022 Convertible Series F Preferred Shares 21,147,364,222 16,798,367,179	16. EARNINGS (LOSS) PER SHARE The net income (loss) per common share amounts were determined as follows: For the Year Ended February 28, February 28, 2023 2022 Numerator: Net income (loss) available to common shareholders $ (18,109,457 ) $ (62,197,484 ) Effect of common stock equivalents Add: interest expense on convertible debt 47,075 24,954 Add (less) loss (gain) on change of derivative liabilities (3,595 ) (372,214 ) Net income (loss) adjusted for common stock equivalents (18,065,977 ) (62,544,744 ) Denominator: Weighted average shares - basic 5,091,857,082 4,029,658,082 Net income (loss) per share – basic $ (0.00 ) $ (0.02 ) Denominator: Weighted average shares – diluted 5,091,857,082 4,029,658,082 Net income (loss) per share – diluted $ (0.00 ) $ (0.02 ) The anti-dilutive shares of common stock equivalents for the years ended February 28, 2023 and February 28, 2022 were as follows For the Year Ended February 28, February 28, 2023 2022 Convertible notes and accrued interest — 4,927,561 Convertible Class F Preferred Shares * — — Stock options and warrants 496,942,251 1,256,845,661 Total 496,942,251 1,261,773,222 __________ * On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at February 28, 2023 and 2022 the dilutive effects would be as follows: Series F Preferred shares been convertible the dilutive effects would be as follows: For the Year Ended February 28 2023 2022 Convertible Series F Preferred Shares 20,178,158,517 16,336,475,742

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	15. SUBSEQUENT EVENTS Subsequent to May 31, 2023 through to July 14, 2023: — the Company issued 441,502,460 2,922,520 132,591 2,789,929	18. SUBSEQUENT EVENTS Subsequent to February 28, 2023 through to June 5, 2023, — the Company issued 280,929,190 1,400,194 81,285 1,318,909 — on March 19 ,2023 the shareholders approved an increase to its authorized common stock by 1,225,000,000 — on March 22, 2023 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $30,000,000 over the course of twenty four (24) month at a purchase price of eighty percent (80%) of the lowest trade price in the 9 day preceding period. If the average Closing Price for the Common Stock during the three (3) trading days preceding a purchase is equal to or greater than one cent ($.01) per share, the applicable purchase price shall equal eighty five percent (85%) of the lowest trade price in the 9 day preceding period. Following an up-list to the NASDAQ or an equivalent national exchange by the Company, the purchase price shall equal ninety percent (90%) of the lowest Volume Weighted Average Price (“VWAP”) for the Common Stock during the 9 day preceding period subject to a floor of $4.50 per share, below which the Company shall not be required to sell shares. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement

GENERAL INFORMATION AND GOING C

GENERAL INFORMATION AND GOING CONCERN	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL INFORMATION AND GOING CONCERN	1. GENERAL INFORMATION Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”). Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as an LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 2,450 The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.	1. GENERAL INFORMATION AND GOING CONCERN Artificial Intelligence Technology Solutions Inc. (formerly known as On the Move Systems Corp.) (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”). Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc. through the issuance of 10,000 On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 2,450 The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company. GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. For the year ended February 28, 2023, the Company had negative cash flow from operating activities of $ 12,577,395 112,253,711 12,610,601 The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows: Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $ 30,000,000 200,000 300,000

INVESTMENT

INVESTMENT	12 Months Ended
	Feb. 28, 2023
Investments, All Other Investments [Abstract]
INVESTMENT	5. INVESTMENT On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $ 50,000

REVENUE EARNING ROBOTS

REVENUE EARNING ROBOTS	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Revenue Earning Robots
REVENUE EARNING ROBOTS	6. REVENUE EARNING DEVICES Revenue earning devices consisted of the following: May 31, 2023 February 28, 2023 Revenue earning devices $ 2,459,470 $ 2,015,058 Less: Accumulated depreciation (902,680 ) (779,839 ) Total $ 1,556,790 $ 1,235,219 During the three months ended May 31, 2023 the Company made total additions to revenue earning devices of $ 444,412 174,101 Depreciation expense was $ 122,841 71,414	6. REVENUE EARNING ROBOTS Revenue earning robots consisted of the following: February 28, 2022 February 28, 2021 Revenue earning devices $ 2,015,058 $ 1,143,724 Less: Accumulated depreciation (779,839 ) (434,661 ) $ 1,235,219 $ 709,063 During the year ended February 28, 2023, the Company made total additions to revenue earning devices of $ 871,334 647,116 647,116 3,255 30,600 3,255 Depreciation expense for these devices was $ 345,178 208,510

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	12 Months Ended
	Feb. 28, 2023
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	9. CONVERTIBLE NOTES PAYABLE Convertible notes payable consisted of the following: Balance Balance Interest Conversion February 28, February 28, Issued Maturity Rate Rate per Share 2023 2022 July 18, 2016 July 18, 2017 * 8% $ 0.003 (1) $ — $ 3,500 August 9, 2022 August 9, 2023 12% $ 0.009 (2) — — $ — $ 3,500 (Less): current portion of convertible notes payable — (3,500 ) (Less): discount on noncurrent convertible notes payable — — Noncurrent convertible notes payable, net of discount $ — $ — Current portion of convertible notes payable $ — $ 3,500 (Less): discount on current portion of convertible notes payable — — Current portion of convertible notes payable, net of discount $ — $ 3,500 * This note was in default as of February 28, 2022. Default interest rate 22% (1) The conversion price was not subject to adjustment from forward or reverse stock splits. Effective in August 2022 this note (and accrued interest) was no longer convertible. (2) Subject to adjustment for dilutive issuances During the years ended February 28, 2023 and February 28, 2022, the Company incurred original issue discounts of $75,000 0 $393,949 438,835 524,699 775,986 All the notes above are unsecured. As of February 28, 2023, the Company had total accrued interest payable of $ 28,104 28,104 Convertible notes issued During the year ended February 28, 2023, the Company had the following convertible note activity: ● The Company transferred the above July 18, 2016 $3,500 note to loans payable as the note was no longer convertible. This was a result of an SEC action against the debt holder who was also a common stockholder. ● On August 9, 2022 the Company entered into a new convertible note for $750,000 with a one year maturity, interest rate of 12%, with a warrant (Warrant 1) to purchase 47,000,000 common shares with a five year maturity and an exercise price of $0.01, and an additional warrant (Warrant 2) to purchase 47,000,000 common shares with a five year maturity and an exercise price of $0.008 to be cancelled and extinguished if the note balance is $375,000 or less by February 9. 2023. The Company received $619,250 in cash proceeds, recorded an original issue discount of $75,000, recognized $393,949 based on a relative fair value calculation as debt discount with a corresponding adjustment to paid-in capital for the attached warrants, and transaction fees of $55,750. The discount is amortized over the term of the loan. This note and related accrued interest have been fully repaid at February 28, 2023. The Company determined that the embedded conversion features which result in a variable conversion rate, in the convertibles notes described below should be accounted for as derivative liabilities as a result of their variable conversion rates. During the year ended February 28, 2022, the Company had the following convertible note activity: ● the Company amended the January 27, 2021 agreement with the lender whereby the conversion rate was changed from $0.10 to $0.03 as a result of a dilutive issuance. This resulted a derivative discount of $438,835 and a loss on extinguishment of $360,125. ● holders of certain convertible notes payable elected to convert a total of $825,000 of principal and $71,955 accrued interest, and $1,750 of fees into 31,042,436 shares of common stock. No gain or loss was recognized on conversions as these conversions occurred within the terms of the agreement that provided for conversion. ● the conversion rate of the January 19, 2021 note included above was reduced to $0.027 due to the dilutive issuance provision in the January 19, 2021 agreement.

OTHER DEBT _ VEHICLE LOANS

OTHER DEBT – VEHICLE LOANS	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Other Debt Vehicle Loans
OTHER DEBT – VEHICLE LOANS	10. OTHER DEBT – VEHICLE LOAN In December 2016, RAD entered into a vehicle loan for $ 47,704 5 November 9, 20 1,019 47,661 5 October 24, 2022 923 0 21,907 3,257 21,578 18,766 5,515 13,251 16,944 38,522 38,522	11. OTHER DEBT – VEHICLE LOANS In December 2016, RAD entered into a vehicle loan for $ 47,704 5 1,019 47,661 5 October 24, 2022 923 21,907 3,257 21,578 18,766 5,515 13,251 16,944 38,522 38,522

DERIVATIVE LIABILITIES

DERIVATIVE LIABILITIES	12 Months Ended
	Feb. 28, 2023
Derivative Liabilities
DERIVATIVE LIABILITIES	13. DERIVATIVE LIABILITIES As of February 28, 2023, and February 28, 2022, the Company revalued the fair value of all of the Company’s derivative liabilities associated with the conversion features on the convertible notes payable and determined that it had a total derivative liability of $ 0 7,587 0 3,595 0 3,992 372,214 81,228

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	12. STOCKHOLDERS’ EQUITY (DEFICIT) Summary or Preferred Stock Activity No preferred stock activity during the period. Summary of Preferred Stock Warrant Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2023 695 $1.00 10.00 Issued 183 1.00 9.88 Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 878 $1.00 9.75 During the three months ended May 31, 2023, as part of debt issuance the Company issued 183 Series F Preferred Warrants to a lender for a relative fair value of $ 947,447 Summary of Common Stock Activity For the three months ended May 31, 2023 , the Company issued 280,929,190 1,400,094 1,318,809 81,285 The table below represent the common shares issued, issuable and outstanding at May 31, 2023 and February 28, 2023: Common shares May 31, 2023 February 28, 2023 Issued 6,117,570,789 5,836,641,599 Issuable 12,100,000 12,100,000 Issued, issuable and outstanding 6,129,670,789 5,848,741,599 Summary of Common Stock Warrant Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28, 2023 314,217,451 $0.114 1.95 Issued — — — Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 314,217,451 $0.114 1.70 For the three months ended May 31, 2022 and May 31, 2021, the Company recorded a total of $ 0 0 Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28 , 2023 95,725,000 $0.02 4.75 Issued — — — Exercised — — — Forfeited, extinguished and cancelled (13,025,000 ) $0.02 (4.75) Outstanding at May 31, 2023 82,700,000 $0.02 4.50	14. STOCKHOLDERS’ DEFICIT Preferred Stock: 20,000,000 0.001 Series E Preferred Stock The board of directors has designated 4,350,000 3,350,000 Series F Convertible Preferred Stock The board of directors has designated 4,350 1.00 2,533 Series G Preferred Stock The board of directors has designated 100,000 1,000 Summary of Preferred Stock Activity Series E Preferred Stock During the year ended February 28, 2023 there was no Series E share activity. During the year ended February 28, 2022 Series E shareholders had the following activity: — A shareholder cancelled 1,000,000 Series F Preferred Shares Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis. On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Summary or Preferred Stock Activity During the year ended February 28, 2023 Series F shareholders had the following activity: — 1 366 During the year ended February 28, 2022 Series F shareholders had the following activity: — 40 367 1.00 33,015,214 — The warrant holder exercised the warrant in part to acquire 38 — The shareholder above converted 78 — Two Series F Preferred shareholders exchanged 83 Series F Preferred Shares for two promissory notes on March 23, 2021. The notes are non-interest bearing, have a one-year maturity and total $7,546,775. These notes were subsequently exchanged on June 2, 2021 for a total of 116,104.232 common shares. — On July 12, 2021, the former director agreed to surrender his remaining 184 Series F preferred shares in exchange for a note payable from the Company of $4,000,160 bearing interest at 7% per annum with a 5 year term, maturing July 12, 2026. — On August 24, 2021the Series F preferred warrant holder agreed to not exercise his warrant privileges on his remaining 329 warrant shares before September 1, 2023. Unissued Series F Preferred Stock At both February 28, 2023 and February 28, 2022 there remains 46 issuable Series F preferred stock at a value of $99,086. During the year ending February 28, 2022 the Company redeemed (through cancellation) 19 shares of issuable Series F preferred stock having a value of $ 74,984 for $500,000, with the difference of $425,016 recorded as a dividend. On October 28, 2022 as part of a $4,000,000 loan facility (described in Note 12) the Company extended the maturity date of the 329 existing Series F Preferred Warrants currently held by the lender to October 31, 2033 from October 31, 2026. Summary of Preferred Stock Warrant Activity Schedule of Summary of stock Option Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 329 $1.00 11.50 Issued 366 $1.00 10.00 Exercised — — — Forfeited and cancelled — — — Outstanding at February 28, 2023 695 $1.00 10.00 Series G Preferred Stock During the year ended February 28, 2023 there was no Series G share activity. During the year ending February 28, 2022 Series G shareholders had the following activity: — On achievement of objectives 3,4,5 and 8 of the equity awards described below the CEO was granted 1500 Series G Preferred shares which were redeemed immediately for $1,500,000 — The Company has accrued $ 1,979,500 Summary of Common Stock Activity The Company increased authorized common shares from 5,000,000,000 6,000,000,000 6,000,000,000 7,225,000,000 Summary of Common Stock Activity During the year ended, February 28, 2023, common shareholders had the following activity: — the Company issued 1,057,841,576 8,21,027 7,771,169 447,858 — the Company issued 17,500,000 — the Company issued 45,306,557 shares through the cashless exercise of 108,378,210 warrants. — the Company cancelled 17,116,894 10,000,000 118,500 During the year ending February 28, 2022, common shareholders had the following activity: — A Series F Preferred shareholder converted 78 316,345,998 — holders of certain convertible notes payable elected to convert a total of $ 825,000 71,955 1,750 31,042,436 — in June 2021, lenders exchanged debt having a face value of $ 7,546,775 6,894,099 116,104,232 6,455,396 438,703 — the Company entered into an investor relations contract whereby 2,100,000 109,200 — the Company issued 645,168,473 13,108,624 12,521,932 586,692 — warrant holders exercised warrants to acquire 411,000,000 395,022,447 The table below represent the common shares issued, issuable and outstanding at February 28, 2023 and February 28, 2022: Common shares February 28, 2023 February 28, 2022 Issued 5,836,641,599 4,733,110,360 Issuable 12,100,000 2,100,000 Issued, issuable and outstanding 5,848,741,599 4,735,210,360 Summary of Warrant and Stock Option Activity Number of Weighted Average Weighted Average Outstanding at February 29, 2021 619,523,492 $0.03 2.81 Issued 1,008,324,212 0.06 2.47 Exercised (411,000,000) 0.06 1.70 Forfeited and cancelled (2,043) — — Outstanding at February 28, 2022 1,216,845,661 $0.06 2.38 Adjusted (1) 66,750,000 0.011 1.41 Issued 94,000,000 0.010 4.69 Exercised (108,378,210) (0.011) 2.44 Forfeited and cancelled (955,000,000) (0.008) 1.33 Outstanding at February 28, 2023 314,217,451 $0.114 1.95 __________ (1) Required dilution adjustment per warrant agreement For the years ended February 28, 2023 and February 28, 2022, the Company recorded a total of $ 0 0 For the years ended February 28, 2023 and February 28, 2022 the Company recorded a total of $ 240,550 1,678,550 499,500 479,500 During the year ended February 28, 2023 warrant holders had the following activity: — On August 30, 2022 a warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 — On August 9, 2022 as part of a debt issuance the Company issued two 47,000,000 0.01 0.008 5 393,949 Schedule of valuation techniques Strike price $ 0.008 0.01 Fair value of Company’s common stock $ 0.012 Dividend yield 0.00 Expected volatility 88.2 90.00 Risk free interest rate 2.98 Expected term (years) 5.00 — Cashless exercise of 108,378,210 warrants for 45,306,557 common shares During the year ended February 28, 2022 warrant holders had the following activity: — warrant holders exercised warrants to acquire 411,000,000 — in conjunction with debt disclosed in Note 11 (44), the Company issued warrants to a lender to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033, in conjunction with debt disclosed in Note 11 (10), the Company issued warrants to a lender to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005,and in conjunction with debt disclosed in Note 11 (46), the Company issued warrants to a lender to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783 Schedule of valuation techniques for warrants Strike price $ 0.135 0.037 Fair value of Company’s common stock $ 0.146 0.0071 Dividend yield 0.00 Expected volatility 411.0 403.33 Risk free interest rate 0.43 0.27 Expected term (years) 3.00 — in conjunction with debt extensions on notes payable disclosed in Note 12 (10, 43, 44), the Company issued warrants to a lender to purchase a total 285,000,000 0.164 3 5,415,000 Strike price $ 0.0164 Fair value of Company’s common stock $ 0.019 Dividend yield 0.00 Expected volatility 385.60 Risk free interest rate 1.62 Expected term (years) 3.00 — As share issuance costs to a broker the company issued warrants to acquire a total of 3,324,212 21,929 Strike price $ 0.041 0.029 Fair value of Company’s common stock $ 0.039 0.028 Dividend yield 0.00 Expected volatility 35.30 35.90 Risk free interest rate 0.46 0.95 Expected term (years) 3.00 Summary of Common Stock Option Activity Summary of CEO Compensation Grant On April 9, 2021 the Company entered into an Employment Agreement with Chief Executive Officer, Steven Reinharz with a three- year term under the following terms whereby stock option awards will be granted if certain conditions are met: — A stock option award (option 1) will be granted to the employee to purchase 10,000,000 0.15 0.30 — A stock option award (option 2) will be granted to the employee to purchase 30,000,000 0.25 0.50 Objective #3 Sales in any fiscal quarter exceed the total sales in fiscal year 2021 for the first time. Award #3 Five hundred (500) shares of Series G preferred stock. Objective #4 One hundred fifty (150) devices are deployed in the marketplace. Award #4 Two hundred fifty (250) shares of Series G preferred stock. Objective #5 Year-to-date sales at any point in fiscal year 2022 exceed One Million Dollars ($1,000,000). Award #5 Two hundred fifty (250) shares of Series G preferred stock. Objective #6 The price per share of common stock has increased to and maintains a price of Ten Cents ($0.10) or more for ten (10) days in a thirty (30) day period. Award #6 Two hundred fifty (250) shares of Series G preferred stock. Objective #7 The price per share of common stock has increased to and maintains a price of Twenty Cents ($0.20) or more for ten (10) days in a thirty (30) day period. Award #7 Five hundred (500) shares of Series G preferred stock. Objective #8 The RAD 3.0 products are launched into the marketplace by November 30, 2021. Award #8 Five hundred (500) shares of Series G preferred stock. Objective #9 RAD receives an order for fifty (50) units from a single customer. Award #9 Five hundred (500) shares of Series G preferred stock. The fair value of the first two awards was obtained through the use of the Monte Carlo method was $ 69,350 499,500 1,979,500 1,500 1,500,000 On April 14, 2021, the Shareholders of Series E Preferred Stock and the Board of Directors of our Company (“Board”) approved and adopted the 2021 Incentive Stock Plan (the “2021 Plan”). On August 11, 2022 the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 5,000,000 to 100,000,000. The purpose of the 2021 Plan is to promote the success of the Company by authorizing incentive awards to retain Directors, executives, selected Employees and Consultants, and reward participants for making major contributions to the success of the Company. The 2021 Plan authorizes the granting of stock options, restricted stock, restricted stock units, stock appreciation rights and stock awards. A total of one hundred million (100,000,000) shares of common stock may be issued under the 2021 Plan. All awards under the 2021 Plan, whether vested or unvested, are subject to the terms of any recoupment, clawback or similar policy of the Company in effect from time to time, as well as any similar provisions of applicable law, which could in certain circumstances require repayment or forfeiture of awards or any shares of stock or other cash or property received with respect to the awards, including any value received from a disposition of the shares acquired upon payment of the awards. The 2021 Plan will be administered by the Board or any Committee authorized by the Board, if applicable, which will have the sole authority to, among other things: construe and interpret the 2021 Plan; make rules and regulations relating to the administration of the 2021 Plan; select participants; and establish the terms and conditions of awards, all in accordance with the terms of the 2021 Plan. The 2021 Plan will remain in effect until April 14, 2031, unless sooner terminated by the Board. Termination will not affect awards then outstanding. During the year ended February 28, 2023 the Company had the following common stock option activity: — On September 1, 2022, the Company as part of the afore-mentioned Incentive Stock Option Plan issued 100,000,000 shares to 64 employees. The shares were issued with an exercise price of $0.02, vest after 4 years with a 5 year term having a fair value of $1,020,000 Strike price $ 0.02 Fair value of Company’s common stock $ 0.01 Dividend yield 0.00 Expected volatility 340.9 Risk free interest rate 3.39 Expected term (years) 4.50 The Company recorded $ 122,050 — Options to purchase 4,275,000 During the year ended February 28, 2022 the Company had no common stock option activity: Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 — $ — — Issued 100,000,000 $0.02 4.75 Exercised — — — Forfeited, extinguished and cancelled (4,275,000 ) $0.02 (4.75) Outstanding at November 30, 2022 95,725,000 $0.02 4.75

INCOME TAXES

INCOME TAXES	12 Months Ended
	Feb. 28, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	17. INCOME TAXES The Company has adopted ASC 740-10, “ Income Taxes” The income tax expense (benefit) consisted of the following for the fiscal years ended February 28, 2023 and February 28, 2022: Schedule of income tax expense February 28, 2023 February 28, 2023 Total current $ — $ — Total deferred — — Total $ — $ — Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following is a reconciliation of the expected statutory federal income tax provision to the actual income tax benefit for the fiscal years ended February 28, 2023 and February 28, 2022: Schedule of federal statutory income tax February 28, 2023 Federal statutory rate $ (3,803,000 ) State income tax benefit, net of federal benefit (859,400 ) Non deductible interest 415,800 Non deductible stock based compensation 155,400 Change in valuation allowance 4,091,200 Total $ — February 28, 2022 Federal statutory rate $ (13,061,500 ) State income tax benefit, net of federal benefit (2,954,400 ) Non deductible interest 4,027,800 Non deductible settlement losses 8,515,100 Non deductible stock based compensation 169,400 Non deductible changes in fair value of instruments (95,800 ) Other non deductible expenses 600 Change in valuation allowance 3,398,800 Total $ — For the year ended February 28, 2023 and February 28, 2022, the expected tax benefit, temporary timing differences and long-term timing differences are calculated at the 21 Significant components of the Company’s deferred tax assets and liabilities were as follows for the fiscal years February 28, 2023 and February 28, 2022: Schedule of deferred income tax assets February 28, 2023 February 28, 2022 Deferred tax assets: Net operating loss carryforwards $ 12,651,115 $ 8,445,915 Debt discount 114,000 Total deferred tax assets 12,651,115 8,559,915 Deferred tax liabilities: Depreciation — — Deferred revenue — — Total deferred tax liabilities — — Net deferred tax assets: Less valuation allowance (12,651,115 ) (8,559,915 ) Net deferred tax assets (liabilities) $ — $ — The Company has incurred losses since inception, therefore, the Company has no federal tax liability. Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes which occurred in the Company on August 28, 2017. The net deferred tax asset generated by the loss carryforward has been fully reserved. The cumulative net operating loss carryforward was approximately $ 44,448,800 28,200,000 2030 Although the Company has tax loss carry-forwards, there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance. The Company has maintained a full valuation allowance against its deferred tax assets at February 28, 2023 and February 28, 2022. A valuation allowance is required to be recorded when it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Since the Company cannot be assured of realizing the net deferred tax asset, a full valuation allowance has been provided. The Company does not have any uncertain tax positions at February 28, 2023 and February 28, 2022 that would affect its effective tax rate. The Company does not anticipate a significant change in the amount of unrecognized tax benefits over the next twelve months. Because the Company is in a loss carryforward position, the Company is generally subject to US federal and state income tax examinations by tax authorities for all years for which a loss carryforward is available. If and when applicable, the Company will recognize interest and penalties as part of income tax expense. The Company’s tax returns for the years ended February 28, 2022, and February 28, 2021, and February 29, 2020 are open for examination under Federal statute of limitations.

ACCOUNTING POLICIES (Policies)

ACCOUNTING POLICIES (Policies)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three months ended May 31, 2023 are not necessarily indicative of the results that may be expected for the entire year.	Basis of Presentation and Consolidation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the instructions on Form 10-K of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). The audited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile , Inc. , On the Move Experience, LLC and OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.	Use of Estimates In order to prepare financial statements in conformity with accounting principals generally accepted in the United States, management must make estimates , judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.
Concentrations	Concentrations Loans payable At May 31, 2023 there were $ 32,427,346 28,090,506 87 31,254,345 26,540,506 85	Concentrations Loans payable At February 28, 2023 there were $ 31,254,345 26,540,506 85 26,233,598 21,709,459 83
Cash	Cash The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.	Cash The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.
Accounts Receivable	Accounts Receivable Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $ 16,000 39,000 51 59	Accounts Receivable Accounts receivable are comprised of balances due from customers, net of estimated allowances for credit losses. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $ 39,000 33,890 48 63
Device Parts Inventory	Device Parts Inventory Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of both May 31, 2023 and February 28, 2023 there was a valuation reserve of $ 195,000 195,000	Device Parts Inventory Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. At February 28, 2023 and at February 28, 2022 there was a valuation reserve of $ 195,000 65,000
Revenue Earning Devices	Revenue Earning Devices Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48	Revenue Earning Devices Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48
Fixed Assets	Fixed Assets Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three five Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Fixed assets consisted of the following: Computer equipment and software 2 3 Office equipment 4 years Manufacturing equipment 7 years Warehouse equipment 5 years Tooling 2 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 years, the life of the lease The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.	Fixed Assets Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three five Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Computer equipment 3 years Furniture and fixtures 3 years Office equipment 4 years Warehouse equipment 5 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 years, the life of the lease The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.
Research and Development	Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development no	Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development no
Contingencies	Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.	Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.
Sales of Future Revenues	Sales of Future Revenues The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt: ● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return is implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.	Sales of Future Revenues The Company has entered into transactions, as more fully described in footnote 10, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt: ● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.
Revenue Recognition	Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” Revenue Recognition (Topic 605) three 57 two 29	Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” Revenue Recognition (Topic 605) two 45 43
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Leases	Leases Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset. If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease. Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.	Leases Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset. If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease. Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.
Distinguishing Liabilities from Equity	Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our CEO and Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company. Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).	Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our CEO and Chairman holds sufficient shares of the Company’s voting stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company without the need to call a general meeting of common shareholders of the Company. Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows: ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 – Inputs that are unobservable for the asset or liability. Measured on a Recurring Basis The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 May 31, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 1,042,000 $ — $ — $ 1,042,000 February 28, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.	Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows: ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 – Inputs that are unobservable for the asset or liability. Measured on a Recurring Basis The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 February 28, 2023 Liabilities Incentive compensation plan payable – revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 February 28, 2022 Liabilities Incentive compensation plan payable – revaluation of equity awards payable in Series G shares $ 479,500 $ — $ — $ 479,500 Derivative liability – conversion features pursuant to convertible notes payable $ 7,587 $ — $ — $ 7,587 The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.
Earnings (Loss) per Share	Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.	Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (FASB) issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. The Company adopted the new guidance effective February 1, 2021. There was no impact to the Company’s consolidated financial statements upon adoption. In January 2020, the FASB issued new guidance intended to clarify certain interactions between accounting standards related to equity securities, equity method investments and certain derivatives. The guidance addresses accounting for the transition into and out of the equity method of accounting and measuring certain purchased options and forward contracts to acquire investments. The Company adopted the new guidance effective February 1, 2021. There was no impact to the Company’s consolidated financial statements upon adoption. In August 2020, the FASB issued amended guidance on the accounting for convertible instruments and contracts in an entity’s own equity. The guidance removes the separation model for convertible debt instruments and preferred stock, amends requirements for conversion options to be classified in equity as well as amends diluted earnings per share (EPS) calculations for certain convertible debt instruments. The amended guidance is effective for interim and annual periods in 2022. The application of the amendments in the new guidance are to be applied either on a modified retrospective or a retrospective basis. We are currently assessing the effect that the adoption of this standard will have on the Company’s consolidated financial statements upon adoption. Recently Issued Accounting Standards Not Yet Adopted In March 2020, the FASB issued optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting and subsequently issued clarifying amendments. The guidance provides optional expedients and exceptions for accounting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. The optional guidance is effective upon issuance and can be applied on a prospective basis at any time between January 1, 2020 through December 31, 2022. The Company is currently evaluating the impact of adoption on its consolidated financial statements. In October 2021, the FASB issued amended guidance that requires acquiring entities to recognize and measure contract assets and liabilities in a business combination in accordance with existing revenue recognition guidance. The amended guidance is effective for interim and annual periods in 2023 and is to be applied prospectively. Early adoption is permitted on a retrospective basis to the beginning of the fiscal year of adoption. The adoption of this guidance will not have a material impact on the Company’s consolidated financial statements for prior acquisitions; however, the impact in future periods will be dependent upon the contract assets and contract liabilities acquired in future business combinations. In November 2021, the FASB issued new guidance to increase the transparency of transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. The guidance requires annual disclosures of such transactions to include the nature of the transactions and the significant terms and conditions, the accounting treatment and the impact to the company’s financial statements. The guidance is effective for annual periods beginning in 2022 and is to be applied on either a prospective or retrospective basis. The Company is currently evaluating the impact of adoption on its consolidated financial statements.	Recently Issued Accounting Pronouncements Recently Adopted Accounting Standards In January 2020, the FASB issued new guidance intended to clarify certain interactions between accounting standards related to equity securities, equity method investments and certain derivatives. The guidance addresses accounting for the transition into and out of the equity method of accounting and measuring certain purchased options and forward contracts to acquire investments. The Company adopted the new guidance effective February 1, 2021. There was no impact to the Company’s consolidated financial statements upon adoption. In August 2020, the FASB issued amended guidance on the accounting for convertible instruments and contracts in an entity’s own equity. The guidance removes the separation model for convertible debt instruments and preferred stock, amends requirements for conversion options to be classified in equity as well as amends diluted earnings per share (EPS) calculations for certain convertible debt instruments. The amended guidance is effective for interim and annual periods in 2022. The application of the amendments in the new guidance are to be applied either on a modified retrospective or a retrospective basis. We are currently assessing the effect that the adoption of this standard will have on the Company’s consolidated financial statements upon adoption. Recently Issued Accounting Standards Not Yet Adopted In March 2020, the FASB issued optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting and subsequently issued clarifying amendments. The guidance provides optional expedients and exceptions for accounting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. The optional guidance is effective upon issuance and can be applied on a prospective basis at any time between January 1, 2020 through December 31, 2022. The Company is currently evaluating the impact of adoption on its consolidated financial statements. In October 2021, the FASB issued amended guidance that requires acquiring entities to recognize and measure contract assets and liabilities in a business combination in accordance with existing revenue recognition guidance. The amended guidance is effective for interim and annual periods in 2023 and is to be applied prospectively. Early adoption is permitted on a retrospective basis to the beginning of the fiscal year of adoption. The adoption of this guidance will not have a material impact on the Company’s consolidated financial statements for prior acquisitions; however, the impact in future periods will be dependent upon the contract assets and contract liabilities acquired in future business combinations.

ACCOUNTING POLICIES (Tables)

ACCOUNTING POLICIES (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Accounting Policies [Abstract]
Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.	Fixed assets consisted of the following: Computer equipment and software 2 3 Office equipment 4 years Manufacturing equipment 7 years Warehouse equipment 5 years Tooling 2 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 years, the life of the lease	Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three five Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Computer equipment 3 years Furniture and fixtures 3 years Office equipment 4 years Warehouse equipment 5 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 years, the life of the lease
The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:	The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 May 31, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 1,042,000 $ — $ — $ 1,042,000 February 28, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000	The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 February 28, 2023 Liabilities Incentive compensation plan payable – revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 February 28, 2022 Liabilities Incentive compensation plan payable – revaluation of equity awards payable in Series G shares $ 479,500 $ — $ — $ 479,500 Derivative liability – conversion features pursuant to convertible notes payable $ 7,587 $ — $ — $ 7,587

REVENUE FROM CONTRACTS WITH C_2

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Revenue from Contract with Customer [Abstract]
The following table presents revenues from contracts with customers disaggregated by product/service:	The following table presents revenues from contracts with customers disaggregated by product/service: Three Months Ended Three Months Ended Device rental activities $ 238,149 $ 239,805 Direct sales of goods and services 147,059 145,352 Revenues $ 385,208 $ 385,157	The following table presents revenues from contracts with customers disaggregated by product/service: Year Ended Year Ended Device rental activities $ 754,126 $ 592,401 Direct sales of goods and services 577,830 854,708 Revenues $ 1,331,956 $ 1,447,109

LEASES (Tables)

LEASES (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Leases
Below is a summary of our lease assets and liabilities at February 28, 2023 and February 28, 2022.	Below is a summary of our lease assets and liabilities at May 31, 2023 and February 28, 2023. Leases Classification May 31, 2023 February 28, 2023 Assets Operating Operating Lease Assets $ 1,179,673 $ 1,208,440 Liabilities Current Operating Current Operating Lease Liability $ 244,169 $ 248,670 Noncurrent Operating Noncurrent Operating Lease Liabilities 926,274 950,541 Total lease liabilities $ 1,170,443 $ 1,199,211	Below is a summary of our lease assets and liabilities at February 28, 2023 and February 28, 2022. Leases Classification February 28, 2023 February 28, 2022 Assets Operating Operating Lease Assets $ 1,208,440 $ 1,331,605 Liabilities Current Operating Current Operating Lease Liability $ 248,670 $ 254,027 Noncurrent Operating Noncurrent Operating Lease Liabilities 950,541 1,057,579 Total lease liabilities $ 1,199,211 $ 1,311,606

REVENUE EARNING DEVICES (Tables

REVENUE EARNING DEVICES (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Revenue Earning Devices
Revenue earning devices consisted of the following:	Revenue earning devices consisted of the following: May 31, 2023 February 28, 2023 Revenue earning devices $ 2,459,470 $ 2,015,058 Less: Accumulated depreciation (902,680 ) (779,839 ) Total $ 1,556,790 $ 1,235,219	Revenue earning robots consisted of the following: February 28, 2022 February 28, 2021 Revenue earning devices $ 2,015,058 $ 1,143,724 Less: Accumulated depreciation (779,839 ) (434,661 ) $ 1,235,219 $ 709,063

FIXED ASSETS (Tables)

FIXED ASSETS (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Property, Plant and Equipment [Abstract]
Fixed assets consisted of the following:	Fixed assets consisted of the following: May 31, 2023 February 28, 2023 Automobile $ 101,680 $ 101,680 Demo devices 97,720 69,010 Tooling 101,322 101,322 Machinery and equipment 8,825 8,825 Computer equipment 150,387 150,387 Office equipment 15,312 15,312 Furniture and fixtures 21,225 21,225 Warehouse equipment 14,561 14,561 Leasehold improvements 19,031 15,568 530,063 497,890 Less: Accumulated depreciation (227,103 ) (182,002 ) $ 302,960 $ 315,888	Fixed assets consisted of the following: February 28, 2023 February 28, 2022 Automobile $ 101,680 $ 101,680 Demo devices 69,010 16,539 Tooling 101,322 — Machinery and equipment 8,825 — Computer equipment 150,387 36,742 Office equipment 15,312 15,312 Furniture and fixtures 21,225 — Warehouse equipment 14,561 11,415 Leasehold improvements 15,568 5,329 497,890 187,017 Less: Accumulated depreciation (182,002 ) (49,065 ) $ 315,888 $ 137,952

LOANS PAYABLE (Tables)

LOANS PAYABLE (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Loans Payable
Loans payable at February 28, 2023 consisted of the following:	Loans payable at May 31, 2023 consisted of the following: Annual Date Maturity Description Principal Interest Rate July 18, 2016 July 18, 2017 Promissory note (1) * $ 3,500 22% December 10, 2020 December 10, 2023 Promissory note (2) 3,921,168 12% December 10, 2020 December 10, 2023 Promissory note (3) 3,054,338 12% December 10, 2020 December 10, 2023 Promissory note (4) 165,605 12% December 14, 2020 December 14, 2023 Promissory note (5) 310,375 12% December 30, 2020 December 30, 2023 Promissory note (6) 350,000 12% January 1, 2021 January 1, 2024 Promissory note (7) 25,000 12% January 1, 2021 January 1, 2024 Promissory note (8) 145,000 12% January 14, 2021 January 14, 2024 Promissory note (9) 550,000 12% February 22, 2021 February 22, 2024 Promissory note (10) 1,650,000 12% March 1, 2021 March 1, 2024 Promissory note (11) 6,000,000 12% June 8, 2021 June 8, 2024 Promissory note (12) 2,750,000 12% July 12, 2021 July 26, 2026 Promissory note (13) 3,857,360 7% September 14, 2021 September 14, 2024 Promissory note (14) 1,650,000 12% July 28, 2022 July 28, 2023 Promissory note (15) 170,000 15% August 30, 2022 August 30,2024 Promissory note (16) 3,000,000 15% September 7, 2022 September 7, 2023 Promissory note (17) 400,000 15% September 8, 2022 September 8, 2023 Promissory note (18) 475,000 15% October 13, 2022 October 13, 2023 Promissory note (19) 350,000 15% October 28, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 9, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 10, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 15, 2022 October 31, 2026 Promissory note (20) 400,000 15% January 11, 2023 October 31,2026 Promissory note (20) 400,000 15% February 6, 2023 October 31, 2026 Promissory note (20) 400,000 15% April 5. 2023 October 31, 2026 Promissory note (20) 400,000 15% April 20, 23 October 31, 2026 Promissory note (20) 400,000 15% May 11, 2023 October 31, 2026 Promissory note (20) 400,000 15% $ 32,427,346 Less: current portion of loans payable (17,569,985 ) Less: discount on non-current loans payable (4,973,120 ) Non-current loans payable, net of discount $ 9,884,241 Current portion of loans payable $ 17,569,985 Less: discount on current portion of loans payable (1,348,996 ) Current portion of loans payable, net of discount $ 16,220,989 * In default (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. (2) This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 (3) This promissory note was issued as part of a debt settlement whereby $ 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 (4) This promissory note was issued as part of a debt settlement whereby $ 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 (5) This promissory note was issued as part of a debt settlement whereby $ 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 (6) The note, with an original principal amount of $ 350,000 35,000 50,000,000 0.025 3 271,250 271,250 39,904 153,611 (7) This promissory note was issued as part of a debt settlement whereby $ 9,200 6,944 16,144 25,000 (8) This promissory note was issued as part of a debt settlement whereby $ 79,500 28,925 108,425 145,000 (9) The note, with an original principal amount of $ 550,000 250,000 50,000,000 0.025 3 380,174 380,174 51,045 188,291 (10) The note, with an original principal balance of $ 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 50,000,000 .0164 3 950,000 159,064 953,197 (11) The unsecured note may be pre-payable at any time. Cash proceeds of $ 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 (12) The note, with an original principal balance of $ 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 154,910 639,308 (13) This loan, with an original principal balance of $ 4,000,160 27,000 (14) The note, with an original principal balance of $ 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 86,930 1,27,501 (15) Original $ 170,000 20,000 5,287 3,739 (16) A warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 4,557 26,312 (17) Original $ 400,000 50,000 12,342 15,479 (18) Original $ 475,000 75,000 18,930 17,799 (19) Original $ 350,000 50,000 12,290 20,620 (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. 400,000 50,000 1,866 346,157 400,000 50,000 1,838 346,600 400,000 50,000 16,678 349,214 400,000 50,000 1,881 345,914 400,000 50,000 1,925 345,265 400,000 50,000 1,836 346,590 400,000 50,000 751 345,494 400,000 50,000 196 352,023 400,000 50,000 0 398,983	Loans payable at February 28, 2023 consisted of the following: Annual Date Maturity Description Principal Interest Rate July 18, 2016 July 18, 2017 Promissory note (35) * $ 3,500 22 June 11, 2018 June 11, 2019 Promissory note (2) (#) — 25 January 31, 2019 June 30, 2019 Promissory note (1) (#) — 15 May 9, 2019 June 30, 2019 Promissory note (3) (#) — 15 May 31, 2019 June 30, 2019 Promissory note (4) (#) — 15 June 26, 2019 June 26, 2020 Promissory note (5) (#) — 15 September 24, 2019 June 24, 2020 Promissory note (6) (#) — 15 January 30, 2020 January 30, 2021 Promissory note (7) (#) — 15 February 27, 2020 February 27, 2021 Promissory note (8) (#) — 15 April 16, 2020 April 16, 2021 Promissory note (9) (#) — 15 May 12, 2020 May 12, 2021 Promissory note (11) (#) — 15 May 22, 2020 May 22, 2021 Promissory note (12) (#) — 15 June 2, 2020 June 2, 2021 Promissory note (13) (#) — 15 June 9, 2020 June 9, 2021 Promissory note (14) (#) — 15 June 12, 2020 June 12, 2021 Promissory note (15) (#) — 15 June 16, 2020 June 16, 2021 Promissory note (16) (#) — 15 September 15, 2020 September 15, 2022 Promissory note (17) (#) — 10 October 6, 2020 March 6, 2023 Promissory note (18) (#) — 12 November 12, 2020 November 12, 2023 Promissory note (19) (#) — 12 November 23, 2020 October 23, 2022 Promissory note (20) (#) — 15.5 November 23, 2020 November 23, 2023 Promissory note (21) (#) — 15 December 10, 2020 December 10, 2023 Promissory note (22) (#) — 12 December 10, 2020 December 10, 2023 Promissory note (23) 3,921,168 12 December 10, 2020 December 10, 2023 Promissory note (24) 3,054,338 12 December 10, 2020 December 10, 2023 Promissory note (25) 165,605 12 December 14, 2020 December 14, 2023 Promissory note (26) 310,375 12 December 30, 2020 December 30, 2023 Promissory note (27) 350,000 12 December 31, 2021 December 31, 2024 Promissory note (28) 25,000 12 December 31, 2021 December 31, 2024 Promissory note (29) 145,000 12 January 14, 2021 January 14, 2024 Promissory note (30) 550,000 12 February 22, 2021 February 22, 2024 Promissory note (31) 1,650,000 12 March 1, 2021 March 1, 2024 Promissory note (10) 6,000,000 12 June 8, 2021 June 8, 2024 Promissory note (32) 2,750,000 12 July 12, 2021 July 26, 2026 Promissory note (33) 3,884,360 7 September 14, 2021 September 14, 2024 Promissory note (34) 1,650,000 12 July 28, 2022 July 28, 2023 Promissory note (36) 170,000 15 August 30, 2022 August 30,2024 Promissory note (38) 3,000,000 15 September 7, 2022 September 7, 2023 Promissory note (37) 400,000 15 September 8, 2022 September 8, 2023 Promissory note (39) 475,000 15 October 13, 2022 October 13, 2023 Promissory note (40) 350,000 15 October 28, 2022 October 31, 2026 Promissory note (41) 400,000 15 November 9, 2022 October 31, 2026 Promissory note (41) 400,000 15 November 10, 2022 October 31, 2026 Promissory note (41) 400,000 15 November 15, 2022 October 31, 2026 Promissory note (41) 400,000 15 January 11, 2023 October 31,2026 Promissory note (41) 400,000 15 February 6, 2023 October 31,2026 Promissory note (41) 400,000 15 $ 31,254,346 Less: current portion of loans payable (11,569,986 ) Less: discount on non-current loans payable (4,130,291 ) Non-current loans payable, net of discount $ 15,554,069 Current portion of loans payable $ 11,569,986 Less: discount on current portion of loans payable (1,651,597 ) Current portion of loans payable, net of discount $ 9,918,389 * In default. Default interest rate 22 (#) Loans with a principal balance of $ 1,661,953 342,138 2,004,091 62,979 (1) Original $ 78,432 33 25,882 (2) Repayable in 12 4,562 48,000 (3) Original $ 7,850 33 2,590 (4) Original $ 86,567 33 28,567 (5) Original $ 79,104 33 26,104 (6) Original $ 12,000 3,000 (7) Original $ 11,000 2,450 (8) Original $ 5,000 1,200 (9) Original $ 13,000 3,850 (10) The unsecured note may be pre-payable at any time. Cash proceeds of $ 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 0 0 150,000,000 .0164 3 2,850,000 (11) Original $ 43,500 8,000 (12) Original $ 85,000 15,000 (13) Original $ 62,000 12,000 (14) Original $ 31,000 6,000 (15) Original $ 50,000 10,000 (16) Original $ 42,000 7,000 (17) Original $ 300,000 50,000 (18) Original principal of $ 150,000 2,000 8,500 (19) Original $ 110,000 10,000 70,000,000 0.00165 3 41,176 41,176 (20) Original principal of $ 65,000 4,060 (21) Original $ 300,000 25,000 230,000,000 0.00165 3 125,814 125,814 (22) Original $ 82,500 7,500 100,000,000 0.002 3 54,545 54,545 (23) This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 (24) This promissory note was issued as part of a debt settlement whereby $ 1,460,794 1,593,544 3,054,338 3,054,338 550,000 (25) This promissory note was issued as part of a debt settlement whereby $ 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 (26) This promissory note was issued as part of a debt settlement whereby $ 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 (27) The note, with an original principal amount of $ 350,000 35,000 50,000,000 0.025 3 271,250 271,250 83,338 193,515 (28) This promissory note was issued as part of a debt settlement whereby $ 9,200 6,944 16,144 25,000 (29) This promissory note was issued as part of a debt settlement whereby $ 79,500 28,925 108,425 145,000 (30) The note, with an original principal amount of $ 550,000 250,000 50,000,000 0.025 3 380,174 380,174 127,897 239,336 (31) The note, with an original principal balance of $ 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 2,995,719 1,112,261 50,000,000 .0164 3 950,000 (32) The note, with an original principal balance of $ 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 455,527 794,218 85,000,000 .0164 3 1,615,000 (33) This loan, with an original principal balance of $ 4,000,160 115,800 (34) The note, with an original principal balance of $ 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 188,002 1,214,431 (35) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. (36) Original $ 170,000 20,000 10,974 9,026 (37) Original $ 400,000 50,000 22,179 27,821 (38) A warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 8,632 30,868 (39) Original $ 475,000 75,000 38,271 32,909 (40) Original $ 350,000 50,000 17,091 46,407 (41) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each trance of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. October 28, 2022, $ 400,000 50,000 1,375 348,024 November 9, 2022, $ 400,000 50,000 1,312 348,438 November 10, 2022, $ 400,000 50,000 1,139 350,881 November 15, 2022, $ 400,000 50,000 2,143 347,815 January 11, 2023, $ 400,000 50,000 802 347,189 February 6, 2023, $ 400,000 50,000 100 348,426

STOCKHOLDERS_ EQUITY (DEFICIT)

STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Equity [Abstract]
Summary of Preferred Stock Warrant Activity	Summary of Preferred Stock Warrant Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2023 695 $1.00 10.00 Issued 183 1.00 9.88 Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 878 $1.00 9.75	Schedule of Summary of stock Option Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 329 $1.00 11.50 Issued 366 $1.00 10.00 Exercised — — — Forfeited and cancelled — — — Outstanding at February 28, 2023 695 $1.00 10.00
The table below represent the common shares issued, issuable and outstanding at May 31, 2023 and February 28, 2023:	The table below represent the common shares issued, issuable and outstanding at May 31, 2023 and February 28, 2023: Common shares May 31, 2023 February 28, 2023 Issued 6,117,570,789 5,836,641,599 Issuable 12,100,000 12,100,000 Issued, issuable and outstanding 6,129,670,789 5,848,741,599	The table below represent the common shares issued, issuable and outstanding at February 28, 2023 and February 28, 2022: Common shares February 28, 2023 February 28, 2022 Issued 5,836,641,599 4,733,110,360 Issuable 12,100,000 2,100,000 Issued, issuable and outstanding 5,848,741,599 4,735,210,360
Summary of Common Stock Warrant Activity	Summary of Common Stock Warrant Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28, 2023 314,217,451 $0.114 1.95 Issued — — — Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 314,217,451 $0.114 1.70	Summary of Warrant and Stock Option Activity Number of Weighted Average Weighted Average Outstanding at February 29, 2021 619,523,492 $0.03 2.81 Issued 1,008,324,212 0.06 2.47 Exercised (411,000,000) 0.06 1.70 Forfeited and cancelled (2,043) — — Outstanding at February 28, 2022 1,216,845,661 $0.06 2.38 Adjusted (1) 66,750,000 0.011 1.41 Issued 94,000,000 0.010 4.69 Exercised (108,378,210) (0.011) 2.44 Forfeited and cancelled (955,000,000) (0.008) 1.33 Outstanding at February 28, 2023 314,217,451 $0.114 1.95 __________ (1) Required dilution adjustment per warrant agreement
Summary of Common Stock Option Activity	Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28 , 2023 95,725,000 $0.02 4.75 Issued — — — Exercised — — — Forfeited, extinguished and cancelled (13,025,000 ) $0.02 (4.75) Outstanding at May 31, 2023 82,700,000 $0.02 4.50	Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 — $ — — Issued 100,000,000 $0.02 4.75 Exercised — — — Forfeited, extinguished and cancelled (4,275,000 ) $0.02 (4.75) Outstanding at November 30, 2022 95,725,000 $0.02 4.75

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Commitments and Contingencies Disclosure [Abstract]
Rent expense and operating lease cost was $260,271	The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $ 62,542 69,967 Maturity of Lease Liabilities Operating May 31, 2024 $ 244,169 May 31, 2025 213,711 May 31, 2026 207,558 May 31, 2027 207,557 May 31, 2028 207,558 May 31, 2029 and after 605,378 Total lease payments 1,685,931 Less: Interest (515,488 ) Present value of lease liabilities $ 1,170,443	The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $ 260,271 275,785 Maturity of Lease Liabilities Operating February 28, 2024 $ 248,669 February 28, 2025 219,863 February 28, 2026 207,558 February 28, 2027 207,558 February 28, 2028 207,558 February 28, 2029 and after 657,268 Total lease payments 1,748,474 Less: Interest (549,263 ) Present value of lease liabilities $ 1,199,211

EARNINGS (LOSS) PER SHARE (Tabl

EARNINGS (LOSS) PER SHARE (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Earnings Per Share [Abstract]
The net income (loss) per common share amounts were determined as follows:	The net income (loss) per common share amounts were determined as follows: For the Three Months Ended May 31, 2023 May 31, 2022 Numerator: Net income (loss) available to common shareholders $ (4,555,193 ) $ (4,671,686 ) Effect of common stock equivalents Add: interest expense on convertible debt — — Net income (loss) adjusted for common stock equivalents (4,555,193 ) (4,671,686 ) Denominator: Weighted average shares – basic 5,964,709,322 4,798,657,871 Net income (loss) per share – basic $ (0.00 ) $ (0.00 ) Denominator: Weighted average shares – diluted 5,964,709,322 4,798,657,871 Net income (loss) per share – diluted $ (0.00 ) $ (0.00 )	The net income (loss) per common share amounts were determined as follows: For the Year Ended February 28, February 28, 2023 2022 Numerator: Net income (loss) available to common shareholders $ (18,109,457 ) $ (62,197,484 ) Effect of common stock equivalents Add: interest expense on convertible debt 47,075 24,954 Add (less) loss (gain) on change of derivative liabilities (3,595 ) (372,214 ) Net income (loss) adjusted for common stock equivalents (18,065,977 ) (62,544,744 ) Denominator: Weighted average shares - basic 5,091,857,082 4,029,658,082 Net income (loss) per share – basic $ (0.00 ) $ (0.02 ) Denominator: Weighted average shares – diluted 5,091,857,082 4,029,658,082 Net income (loss) per share – diluted $ (0.00 ) $ (0.02 )
The anti-dilutive shares of common stock equivalents for the years ended February 28, 2023 and February 28, 2022 were as follows	The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2023 and 2022 were as follows: For the Three Months Ended May 31, 2023 May 31, 2022 Convertible notes and accrued interest — 7,093,255 Convertible Series F Preferred Shares — — Stock options and warrants 396,917,451 1,216,845,661 Total 396,917,451 1,223,938,916 * On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at May 31, 2023 and 2022 the dilutive effects would be as follows:	The anti-dilutive shares of common stock equivalents for the years ended February 28, 2023 and February 28, 2022 were as follows For the Year Ended February 28, February 28, 2023 2022 Convertible notes and accrued interest — 4,927,561 Convertible Class F Preferred Shares * — — Stock options and warrants 496,942,251 1,256,845,661 Total 496,942,251 1,261,773,222 __________ * On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at February 28, 2023 and 2022 the dilutive effects would be as follows:
Series F Preferred shares been convertible the dilutive effects would be as follows:	Series F Preferred shares been convertible the dilutive effects would be as follows: For the Three Months Ended May 31, 2023 May 31, 2022 Convertible Series F Preferred Shares 21,147,364,222 16,798,367,179	Series F Preferred shares been convertible the dilutive effects would be as follows: For the Year Ended February 28 2023 2022 Convertible Series F Preferred Shares 20,178,158,517 16,336,475,742

REVENUE EARNING ROBOTS (Tables)

REVENUE EARNING ROBOTS (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Revenue Earning Robots
Revenue earning robots consisted of the following:	Revenue earning devices consisted of the following: May 31, 2023 February 28, 2023 Revenue earning devices $ 2,459,470 $ 2,015,058 Less: Accumulated depreciation (902,680 ) (779,839 ) Total $ 1,556,790 $ 1,235,219	Revenue earning robots consisted of the following: February 28, 2022 February 28, 2021 Revenue earning devices $ 2,015,058 $ 1,143,724 Less: Accumulated depreciation (779,839 ) (434,661 ) $ 1,235,219 $ 709,063

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	12 Months Ended
	Feb. 28, 2023
Debt Disclosure [Abstract]
Convertible notes payable consisted of the following:	Convertible notes payable consisted of the following: Balance Balance Interest Conversion February 28, February 28, Issued Maturity Rate Rate per Share 2023 2022 July 18, 2016 July 18, 2017 * 8% $ 0.003 (1) $ — $ 3,500 August 9, 2022 August 9, 2023 12% $ 0.009 (2) — — $ — $ 3,500 (Less): current portion of convertible notes payable — (3,500 ) (Less): discount on noncurrent convertible notes payable — — Noncurrent convertible notes payable, net of discount $ — $ — Current portion of convertible notes payable $ — $ 3,500 (Less): discount on current portion of convertible notes payable — — Current portion of convertible notes payable, net of discount $ — $ 3,500 * This note was in default as of February 28, 2022. Default interest rate 22% (1) The conversion price was not subject to adjustment from forward or reverse stock splits. Effective in August 2022 this note (and accrued interest) was no longer convertible. (2) Subject to adjustment for dilutive issuances

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Equity [Abstract]
Schedule of Summary of stock Option Activity	Summary of Preferred Stock Warrant Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2023 695 $1.00 10.00 Issued 183 1.00 9.88 Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 878 $1.00 9.75	Schedule of Summary of stock Option Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 329 $1.00 11.50 Issued 366 $1.00 10.00 Exercised — — — Forfeited and cancelled — — — Outstanding at February 28, 2023 695 $1.00 10.00
The table below represent the common shares issued, issuable and outstanding at February 28, 2023 and February 28, 2022:	The table below represent the common shares issued, issuable and outstanding at May 31, 2023 and February 28, 2023: Common shares May 31, 2023 February 28, 2023 Issued 6,117,570,789 5,836,641,599 Issuable 12,100,000 12,100,000 Issued, issuable and outstanding 6,129,670,789 5,848,741,599	The table below represent the common shares issued, issuable and outstanding at February 28, 2023 and February 28, 2022: Common shares February 28, 2023 February 28, 2022 Issued 5,836,641,599 4,733,110,360 Issuable 12,100,000 2,100,000 Issued, issuable and outstanding 5,848,741,599 4,735,210,360
Summary of Warrant and Stock Option Activity	Summary of Common Stock Warrant Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28, 2023 314,217,451 $0.114 1.95 Issued — — — Exercised — — — Forfeited and cancelled — — — Outstanding at May 31, 2023 314,217,451 $0.114 1.70	Summary of Warrant and Stock Option Activity Number of Weighted Average Weighted Average Outstanding at February 29, 2021 619,523,492 $0.03 2.81 Issued 1,008,324,212 0.06 2.47 Exercised (411,000,000) 0.06 1.70 Forfeited and cancelled (2,043) — — Outstanding at February 28, 2022 1,216,845,661 $0.06 2.38 Adjusted (1) 66,750,000 0.011 1.41 Issued 94,000,000 0.010 4.69 Exercised (108,378,210) (0.011) 2.44 Forfeited and cancelled (955,000,000) (0.008) 1.33 Outstanding at February 28, 2023 314,217,451 $0.114 1.95 __________ (1) Required dilution adjustment per warrant agreement
Schedule of valuation techniques		Schedule of valuation techniques Strike price $ 0.008 0.01 Fair value of Company’s common stock $ 0.012 Dividend yield 0.00 Expected volatility 88.2 90.00 Risk free interest rate 2.98 Expected term (years) 5.00 Strike price $ 0.02 Fair value of Company’s common stock $ 0.01 Dividend yield 0.00 Expected volatility 340.9 Risk free interest rate 3.39 Expected term (years) 4.50
Schedule of valuation techniques for warrants		Schedule of valuation techniques for warrants Strike price $ 0.135 0.037 Fair value of Company’s common stock $ 0.146 0.0071 Dividend yield 0.00 Expected volatility 411.0 403.33 Risk free interest rate 0.43 0.27 Expected term (years) 3.00 — in conjunction with debt extensions on notes payable disclosed in Note 12 (10, 43, 44), the Company issued warrants to a lender to purchase a total 285,000,000 0.164 3 5,415,000 Strike price $ 0.0164 Fair value of Company’s common stock $ 0.019 Dividend yield 0.00 Expected volatility 385.60 Risk free interest rate 1.62 Expected term (years) 3.00 — As share issuance costs to a broker the company issued warrants to acquire a total of 3,324,212 21,929 Strike price $ 0.041 0.029 Fair value of Company’s common stock $ 0.039 0.028 Dividend yield 0.00 Expected volatility 35.30 35.90 Risk free interest rate 0.46 0.95 Expected term (years) 3.00
Summary of Common Stock Option Activity	Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28 , 2023 95,725,000 $0.02 4.75 Issued — — — Exercised — — — Forfeited, extinguished and cancelled (13,025,000 ) $0.02 (4.75) Outstanding at May 31, 2023 82,700,000 $0.02 4.50	Summary of Common Stock Option Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2022 — $ — — Issued 100,000,000 $0.02 4.75 Exercised — — — Forfeited, extinguished and cancelled (4,275,000 ) $0.02 (4.75) Outstanding at November 30, 2022 95,725,000 $0.02 4.75

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Feb. 28, 2023
Income Tax Disclosure [Abstract]
Schedule of income tax expense	The income tax expense (benefit) consisted of the following for the fiscal years ended February 28, 2023 and February 28, 2022: Schedule of income tax expense February 28, 2023 February 28, 2023 Total current $ — $ — Total deferred — — Total $ — $ —
Schedule of federal statutory income tax	The following is a reconciliation of the expected statutory federal income tax provision to the actual income tax benefit for the fiscal years ended February 28, 2023 and February 28, 2022: Schedule of federal statutory income tax February 28, 2023 Federal statutory rate $ (3,803,000 ) State income tax benefit, net of federal benefit (859,400 ) Non deductible interest 415,800 Non deductible stock based compensation 155,400 Change in valuation allowance 4,091,200 Total $ — February 28, 2022 Federal statutory rate $ (13,061,500 ) State income tax benefit, net of federal benefit (2,954,400 ) Non deductible interest 4,027,800 Non deductible settlement losses 8,515,100 Non deductible stock based compensation 169,400 Non deductible changes in fair value of instruments (95,800 ) Other non deductible expenses 600 Change in valuation allowance 3,398,800 Total $ —
Schedule of deferred income tax assets	Significant components of the Company’s deferred tax assets and liabilities were as follows for the fiscal years February 28, 2023 and February 28, 2022: Schedule of deferred income tax assets February 28, 2023 February 28, 2022 Deferred tax assets: Net operating loss carryforwards $ 12,651,115 $ 8,445,915 Debt discount 114,000 Total deferred tax assets 12,651,115 8,559,915 Deferred tax liabilities: Depreciation — — Deferred revenue — — Total deferred tax liabilities — — Net deferred tax assets: Less valuation allowance (12,651,115 ) (8,559,915 ) Net deferred tax assets (liabilities) $ — $ —

GENERAL INFORMATION (Details Na

GENERAL INFORMATION (Details Narrative) - shares	Aug. 28, 2017	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022	Jul. 25, 2017
Restructuring Cost and Reserve [Line Items]
Common stock, issued		6,129,670,689	5,848,741,599	4,735,210,360
Robotic Assistance Devices L L C [Member]
Restructuring Cost and Reserve [Line Items]
Common stock, issued					10,000
Robotic Assistance Devices L L C [Member] | Series E Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	3,350,000
Robotic Assistance Devices L L C [Member] | Series F Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	2,450

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	May 31, 2023	Feb. 28, 2023
Cash flow from operating activities			$ 2,991,003	$ 12,577,395
Accumulated deficit			116,808,904	112,253,711
Working capital			21,819,216	12,610,601
Subsequent Event [Member]
Additional issuance costs	$ 3,500,000
Minimum [Member]
Other cost cutting management estimates			200,000	200,000
Maximum [Member]
Other cost cutting management estimates			$ 300,000	$ 300,000
Common Stock [Member]
Purchase of common stock		$ 30,000,000

Fixed assets consisted of the f

Fixed assets consisted of the following: (Details) - USD ($)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023		Feb. 28, 2022
Property, Plant and Equipment [Line Items]
Gross	$ 530,063	$ 497,890		$ 187,017
Less: accumulated depreciation	(227,103)	(182,002)		(49,065)
Fixed assets, net of accumulated depreciation	$ 302,960	$ 315,888	[1]	137,952
Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years	5 years
Computer Equipment And Software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Computer Equipment And Software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years	4 years
Gross	$ 15,312	$ 15,312		15,312
Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	7 years
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years	5 years
Gross	$ 14,561	$ 14,561		11,415
Tooling [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years	4 years
Gross	$ 97,720	$ 69,010		16,539
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years	5 years
Gross	$ 19,031	$ 15,568		5,329
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Gross	101,680	101,680		101,680
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Gross	101,322	101,322
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	8,825	$ 8,825
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life		3 years
Gross	150,387	$ 150,387		36,742
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life		3 years
Gross	$ 21,225	$ 21,225
[1]Derived from audited information

The following table presents in

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: (Details) - USD ($)	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Defined Benefit Plan Disclosure [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 1,042,000	$ 979,000	$ 479,500
Derivative liability - conversion features pursuant to convertible notes payable			7,587
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Derivative liability - conversion features pursuant to convertible notes payable
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Derivative liability - conversion features pursuant to convertible notes payable
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 1,042,000	$ 979,000	479,500
Derivative liability - conversion features pursuant to convertible notes payable			$ 7,587

ACCOUNTING POLICIES (Details Na

ACCOUNTING POLICIES (Details Narrative)	3 Months Ended		12 Months Ended
	May 31, 2023 USD ($) Number	May 31, 2022 Number	Feb. 28, 2023 USD ($) Number		Feb. 28, 2022 USD ($)
Property, Plant and Equipment [Line Items]
Loans payable	$ 32,427,346		$ 31,254,345		$ 26,233,598
Accounts receivable, net	$ 391,823		265,024	[1]	429,469
Percentage of accounts receivable	51%	59%
Inventory valuation reserves	$ 195,000		$ 195,000		65,000
Depreciation life	48 months		48 months
Deferred development costs	$ 0		$ 0		$ 0
Percentage of revenue	57%	29%	45%		43%
Description of deferred tax assets and liabilities	The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.		The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Allowance for Doubtful Accounts Receivable			$ 39,000		$ 33,890
Percentage of accounts receivable			48%		63%
Two Customer [Member]
Property, Plant and Equipment [Line Items]
Number of customers | Number	3	2	2
Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years		3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years		5 years
Controller [Member]
Property, Plant and Equipment [Line Items]
Loans additions	$ 28,090,506		$ 26,540,506		$ 21,709,459
Loans percentage	87%		85%		83%
[1]Derived from audited information

The following table presents re

The following table presents revenues from contracts with customers disaggregated by product/service: (Details) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Revenue from Contract with Customer [Abstract]
Device rental activities	$ 238,149	$ 239,805	$ 754,126	$ 592,401
Direct sales of goods and services	147,059	145,352	577,830	854,708
Revenues	385,208	385,157	1,331,956	1,447,109
Revenues	$ 385,208	$ 385,157	$ 1,331,956	$ 1,447,109

Below is a summary of our lease

Below is a summary of our lease assets and liabilities at May 31, 2023 and February 28, 2023. (Details) - USD ($)	May 31, 2023	Feb. 28, 2023		Feb. 28, 2022
Leases
Operating lease assets	$ 1,179,673	$ 1,208,440		$ 1,331,605
Current operating lease liability	244,169	248,670	[1]	254,027
Noncurrent operating lease liabilities	926,274	950,541	[1]	1,057,579
Total lease liabilities	$ 1,170,443	$ 1,199,211		$ 1,311,606
[1]Derived from audited information

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Leases
Weighted average remaining lease term	12 months		12 months
Operating lease cost	$ 62,542	$ 69,967	$ 260,271	$ 275,785
Rent	$ 62,542	$ 69,967	$ 260,271	$ 275,785

Revenue earning devices consist

Revenue earning devices consisted of the following: (Details) - USD ($)	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2021
Revenue Earning Devices
Revenue earning devices	$ 2,459,470	$ 2,015,058	$ 2,015,058	$ 1,143,724
Less: Accumulated depreciation	(902,680)	(779,839)	(779,839)	(434,661)
Total	$ 1,556,790	$ 1,235,219	$ 1,235,219	$ 709,063

REVENUE EARNING DEVICES (Detail

REVENUE EARNING DEVICES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Restructuring Cost and Reserve [Line Items]
Revenue earning	$ 385,208	$ 385,157	$ 1,331,956	$ 1,447,109
Depreciation expense	167,942	93,995	478,115	232,886
Robotic Assistance Devices L L C [Member]
Restructuring Cost and Reserve [Line Items]
Revenue earning	444,412	174,101	871,334	647,116
Depreciation expense	$ 122,841	$ 71,414	$ 345,178	$ 208,510

FIXED ASSETS (Details Narrative

FIXED ASSETS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Restructuring Cost and Reserve [Line Items]
Vehicle net book value				$ 875
Proceeds on disposal of fixed assets				30,000
Gain on disposal of fixed assets				29,125
Robotic Assistance Devices L L C [Member]
Restructuring Cost and Reserve [Line Items]
Additions to fixed assets	$ 32,173	$ 93,730	258,402	115,493
Assets transfers from inventory	28,710	5,516	52,471	12,868
Depreciation expense	$ 45,101	$ 22,581	$ 132,937	$ 24,376

DEFERRED VARIABLE PAYMENT OBL_2

DEFERRED VARIABLE PAYMENT OBLIGATION (Details Narrative)											3 Months Ended			6 Months Ended	12 Months Ended
	Aug. 09, 2022 $ / shares	Aug. 27, 2020 USD ($)	Jul. 02, 2020 USD ($)	Jul. 01, 2020 USD ($)	Apr. 22, 2020 USD ($)	Feb. 29, 2020 USD ($)	Dec. 30, 2019 USD ($)	Nov. 18, 2019 USD ($)	May 09, 2019 USD ($)	Feb. 01, 2019 USD ($)	May 31, 2023 USD ($)	May 31, 2021 USD ($) shares	May 31, 2021 USD ($) shares	Aug. 27, 2021	Feb. 28, 2023 USD ($)		Feb. 28, 2022 USD ($)	Aug. 30, 2022 USD ($)	May 31, 2022 USD ($)	Mar. 03, 2021 USD ($)	Mar. 02, 2021 USD ($)	May 31, 2019 USD ($)
Principal amount											$ 32,427,346				$ 31,254,346			$ 3,000,000
Accrued payment											388,227				542,177							$ 604,811
Default on payments											388,226				325,600		$ 0
Aggregate investment																				$ 1,925,000	$ 1,925,000
Exercise price | $ / shares	$ 0.01
Fair value of warrants															21,929
Total payment obligation											$ 2,525,000				$ 2,525,000	[1]	2,525,000
Investor [Member]
Maximum amount of debt		$ 1,925,000	$ 800,000	$ 800,000	$ 100,000		$ 100,000			$ 900,000
Percentage of exchange rate		0.1425	0.0275	0.0275	0.0100		0.0100			0.09
Debt instrument, date of first required payment						Feb. 29, 2020
Description of variable payments terms											These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.				These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.
Description of disposition price											The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.			The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%	The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.
Principal amount						$ 109,000		$ 225,000
Advance amount						116,000
Investor [Member] | Series F Preferred Stock [Member]
Purchase of warrant | shares												38	38
Fair value of warrants												$ 33,015,214	$ 33,015,214
Investor [Member] | Agreement [Member]
Maximum amount of debt		$ 900,000
Investor [Member] | Agreement One [Member]
Maximum amount of debt		225,000
Investor [Member] | Agreement Two [Member]
Maximum amount of debt		$ 800,000
Investor One [Member]
Maximum amount of debt						400,000			$ 400,000
Percentage of exchange rate									0.04
Investor Two [Member]
Maximum amount of debt						$ 50,000			$ 50,000
Percentage of exchange rate									0.0111
Investor Four [Member]
Percentage of exchange rate								0.0225
Investor Five [Member]
Description of variable payments terms			If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment	If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment
Investor Eight [Member]
Percentage of assets sold		10%
Investor Eight [Member]
Total payment obligation											$ 2,525,000				$ 2,525,000		2,525,000		$ 2,525,000
Deferred payment obligation											$ 2,525,000				$ 2,525,000		$ 2,525,000
[1]Derived from audited information

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	3 Months Ended		12 Months Ended
	May 31, 2023 USD ($) $ / shares	May 31, 2022 USD ($)	Feb. 28, 2023 USD ($) $ / shares shares	Feb. 28, 2022 USD ($) $ / shares shares
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Net borrowings on loan payable - related party		$ 0	$ 0	$ 803,394
Loan payable - related party	$ 243,256		206,516	193,556
Balance due to related party	139,250		$ 108,000
Interest Expense, Related Party	$ 133,000
Percentage of interest expense due to related party	0.12		0.12
Deferred salary payable to related party			$ 108,000
Interest accrued related party	$ 19,275		15,660	2,700
Consulting fees for research and development	882,015	1,001,734	3,578,981	2,258,819
Deferred salary bearing interest			90,000
Stock based compensation	$ 115,721	161,500	$ 740,050	$ 2,158,050
Series G Preferred Stock [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Redemption shares | shares			1,500
Redemption price			$ 1,500,000
Incentives Compensation Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Share price | $ / shares	$ 1,000		$ 1,000	$ 1,000
Employment Agreement [Member] | Incentives Compensation Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Incentive compensation plan payable	$ 1,042,000		$ 979,000	$ 479,500
Stock based compensation				1,500,000
Redemption price				$ 1,500,000
Chief Executive Officer [Member] | Employment Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Incentive compensation plan payable	$ 63,000	$ 161,500	$ 499,500
Chief Executive Officer [Member] | Employment Agreement [Member] | Series G Preferred Stock [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Redemption shares | shares				1,500

OTHER DEBT _ VEHICLE LOAN (Deta

OTHER DEBT – VEHICLE LOAN (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	12 Months Ended
	Nov. 30, 2017	Dec. 31, 2016	May 31, 2023	Feb. 28, 2023	Aug. 30, 2022	May 31, 2022	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2020	Feb. 28, 2019
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile			$ 32,427,346	$ 31,254,346	$ 3,000,000
Principal repayments of loan							$ 0	$ 0
Proceeds of disposal of vehicle offset against vehicle loan						$ 18,766	18,766
Remaining asset value						5,515	5,515
Reclassification of fixed assets to vehicle for disposal						13,251
Robotic Assistance Devices L L C [Member] | Secured Debt [Member]
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile	$ 47,661	$ 47,704
Term of debt	5 years	5 years
Maturity date	Oct. 24, 2022	Nov. 09, 2020
Payment of debt interest and principal	$ 923	$ 1,019
Outstanding balance of the loan	$ 21,907									$ 21,907
Loss on sale of vehicle			3,257	3,257
Current portion vehicle loan				21,578			21,578	21,578	$ 21,578
Reclassification of fixed assets to vehicle for disposal							13,251
Long-term vehicle loan				16,944			16,944	$ 16,944
Total vehicle loan			$ 38,522	$ 38,522		$ 38,522	$ 38,522

Loans payable at May 31, 2023 c

Loans payable at May 31, 2023 consisted of the following: (Details) - USD ($)

3 Months Ended

12 Months Ended

May 11, 2023

Apr. 20, 2023

Apr. 05, 2023

Feb. 06, 2023

Jan. 11, 2023

Nov. 15, 2022

Nov. 10, 2022

Nov. 09, 2022

Oct. 28, 2022

Feb. 28, 2022

May 31, 2023

May 31, 2022

Feb. 28, 2023

Feb. 28, 2022

Aug. 30, 2022

Feb. 28, 2021

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 32,427,346

$ 31,254,346

$ 3,000,000

Less: current portion of loans payable

(17,569,985)

(11,569,986)

Less: discount on non-current loans payable

(4,973,120)

(4,130,291)

Non-current loans payable, net of discount

9,884,241

15,554,069

Current portion of loans payable

17,569,985

11,569,986

Less: discount on current portion of loans payable

(1,348,996)

(1,651,597)

Current portion of loans payable, net of discount

16,220,989

9,918,389

Common stock issued for debt conversion

$ 898,705

Fair value of warrants

$ 0

0

$ 0

Debt discount

114,000

114,000

Debt instrument, unamortized discount

0

$ 39,500

Interest expenses

$ 1,606,216

$ 1,175,030

$ 5,426,364

$ 16,129,499

Class of warrant or right outstanding

2,960,500

Warrant [Member]

Short-Term Debt [Line Items]

Warrant purchase

3,324,212

411,000,000

Common Stock [Member]

Short-Term Debt [Line Items]

Warrant purchase

1,057,841,576

645,168,473

Proceeds from issuance of debt

$ 821,027

$ 13,108,624

Promissory Note Payable 01 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jul. 18, 2016

[1],[2]

Jul. 18, 2016

[3],[4]

Debt instrument, face amount

$ 3,500

[1],[2]

$ 3,500

[3],[4]

Annual interest rate

22%

[1],[2]

22%

Promissory Note Payable 02 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 10, 2020

Jun. 11, 2018

[5],[6]

Debt instrument, face amount

$ 3,921,168

Annual interest rate

12%

25%

Debt settlement amount

$ 2,683,357

Accrued interest

1,237,811

Promissory Note Payable 02 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 3,921,168

Exercise price

$ 0.002

Fair value of notes

$ 990,000

Promissory Note Payable 03 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 10, 2020

[7]

Jan. 31, 2019

[5],[8]

Debt instrument, face amount

[7]

$ 3,054,338

Annual interest rate

12%

[7]

15%

Debt settlement amount

$ 1,460,794

Accrued interest

1,593,544

Promissory Note Payable 03 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 3,054,338

Exercise price

$ 0.002

Fair value of notes

$ 550,000

Promissory Note Payable04 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 10, 2020

[9]

May 09, 2019

[5],[10]

Debt instrument, face amount

[9]

$ 165,605

Annual interest rate

12%

[9]

15%

Debt settlement amount

$ 103,180

Accrued interest

62,425

Promissory Note Payable04 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 165,605

Exercise price

$ 0.002

Fair value of notes

$ 176,000

Warrant purchase

80,000,000

Promissory Note Payable05 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 14, 2020

[11]

May 31, 2019

[5],[12]

Debt instrument, face amount

[11]

$ 310,375

Annual interest rate

12%

[11]

15%

Debt settlement amount

$ 235,000

Accrued interest

75,375

Promissory Note Payable05 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 310,375

Exercise price

$ 0.002

Fair value of notes

$ 182,500

Warrant purchase

25,000,000

Promissory Note Payable06 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 30, 2020

[13]

Jun. 26, 2019

[5],[14]

Debt instrument, face amount

[13]

$ 350,000

Annual interest rate

12%

[13]

15%

Exercise price

$ 0.025

Discount amount

$ 35,000

Warrants issued

50,000,000

Loan payable term (in years)

3 years

Fair value of warrants

$ 271,250

Debt discount

271,250

Amortization expens

39,904

Debt instrument, unamortized discount

$ 153,611

Promissory Note Payable7 [Member]

Short-Term Debt [Line Items]

Date of issuance

[15]

Jan. 01, 2021

Debt instrument, face amount

[15]

$ 25,000

Annual interest rate

[15]

12%

Debt settlement amount

$ 9,200

Accrued interest

6,944

Promissory Note Payable7 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 16,144

Promissory Note Payable8 [Member]

Short-Term Debt [Line Items]

Date of issuance

[16]

Jan. 01, 2021

Debt instrument, face amount

[16]

$ 145,000

Annual interest rate

[16]

12%

Debt settlement amount

$ 79,500

Accrued interest

28,925

Promissory Note Payable8 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

145,000

Common stock issued for debt conversion

$ 108,425

Promissory Note Payable9 [Member]

Short-Term Debt [Line Items]

Date of issuance

[17]

Jan. 14, 2021

Debt instrument, face amount

[17]

$ 550,000

Annual interest rate

[17]

12%

Exercise price

$ 0.025

Discount amount

$ 250,000

Warrants issued

50,000,000

Loan payable term (in years)

3 years

Fair value of warrants

$ 380,174

Debt discount

380,174

Amortization expens

51,045

Debt instrument, unamortized discount

$ 188,291

Promissory Note Payable10 [Member]

Short-Term Debt [Line Items]

Date of issuance

Feb. 22, 2021

[18]

Apr. 16, 2020

[5],[19]

Debt instrument, face amount

$ 1,650,000

[18]

$ 6,000,000

[20]

Annual interest rate

12%

[18]

15%

Exercise price

$ 0.0164

$ 0.135

$ 0.0164

Discount amount

$ 150,000

Warrants issued

100,000,000

Loan payable term (in years)

3 years

Fair value of warrants

$ 1,342,857

Debt discount

1,342,857

Amortization expens

159,064

Debt instrument, unamortized discount

$ 953,197

Interest expenses

$ 950,000

Promissory Note Payable10 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Warrants issued

50,000,000

Loan payable term (in years)

3 years

Promissory Note Payable11 [Member]

Short-Term Debt [Line Items]

Date of issuance

Mar. 01, 2021

[21]

May 12, 2020

[5],[22]

Debt instrument, face amount

[21]

$ 6,000,000

Annual interest rate

12%

[21]

15%

Exercise price

$ 0.135

Warrants issued

300,000,000

Loan payable term (in years)

3 years

Debt discount

$ 4,749,005

Interest expenses

$ 2,850,000

Proceeds from issuance of debt

5,400,000

Debt conversion original debt amount 1

600,000

Promissory Note Payable11 [Member] | Valuation Technique, Option Pricing Model [Member]

Short-Term Debt [Line Items]

Fair value of warrants

$ 4,749,005

Promissory Note Payable11 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Exercise price

$ 0.0164

0.0164

Warrants issued

150,000,000

Loan payable term (in years)

3 years

Promissory Note Payable12 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jun. 08, 2021

[23]

May 22, 2020

[5],[24]

Debt instrument, face amount

[23]

$ 2,750,000

Annual interest rate

12%

[23]

15%

Exercise price

$ 0.064

Discount amount

$ 50,000

Warrants issued

170,000,000

Loan payable term (in years)

3 years

Fair value of warrants

$ 2,035,033

Debt discount

2,035,033

Amortization expens

154,910

Debt instrument, unamortized discount

$ 639,308

Interest expenses

$ 1,615,000

Promissory Note Payable12 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Exercise price

$ 0.0164

$ 0.0164

Warrants issued

85,000,000

Loan payable term (in years)

3 years

Promissory Note Payable13 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jul. 12, 2021

[25]

Jun. 02, 2020

[5],[26]

Debt instrument, face amount

[25]

$ 3,857,360

Annual interest rate

7%

[25]

15%

Principal ammount

$ 4,000,160

Repayment of notes

$ 27,000

Promissory Note Payable14 [Member]

Short-Term Debt [Line Items]

Date of issuance

Sep. 14, 2021

[27]

Jun. 09, 2020

[5],[28]

Debt instrument, face amount

[27]

$ 1,650,000

Annual interest rate

12%

[27]

15%

Exercise price

$ 0.037

Discount amount

$ 150,000

Warrants issued

250,000,000

Loan payable term (in years)

3 years

Fair value of warrants

$ 1,284,783

Debt discount

1,284,783

Amortization expens

86,930

Debt instrument, unamortized discount

$ 127,501

Promissory Note Payable15 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jul. 28, 2022

[29]

Jun. 12, 2020

[5],[30]

Debt instrument, face amount

[29]

$ 170,000

Annual interest rate

15%

[29]

15%

Discount amount

$ 20,000

Amortization expens

5,287

Debt instrument, unamortized discount

$ 3,739

Promissory Note Payable16 [Member]

Short-Term Debt [Line Items]

Date of issuance

Aug. 30, 2022

[31]

Jun. 16, 2020

[5],[32]

Debt instrument, face amount

[31]

$ 3,000,000

Annual interest rate

15%

[31]

15%

Debt discount

$ 39,500

Amortization expens

4,557

Debt instrument, unamortized discount

$ 26,312

Class of warrant or right outstanding

955,000,000

Rate of interest

15%

Class of warrant or right, outstanding

$ 2,960,500

Promissory Note Payable17 [Member]

Short-Term Debt [Line Items]

Date of issuance

Sep. 07, 2022

[33]

Sep. 15, 2020

[5],[34]

Debt instrument, face amount

[33]

$ 400,000

Annual interest rate

15%

[33]

10%

Discount amount

$ 50,000

Amortization expens

12,342

Debt instrument, unamortized discount

$ 15,479

Promissory Note Payable18 [Member]

Short-Term Debt [Line Items]

Date of issuance

Sep. 08, 2022

[35]

Oct. 06, 2020

[5],[36]

Debt instrument, face amount

$ 475,000

[35]

$ 150,000

Annual interest rate

15%

[35]

12%

Discount amount

$ 75,000

Amortization expens

18,930

Debt instrument, unamortized discount

$ 17,799

Promissory Note Payable19 [Member]

Short-Term Debt [Line Items]

Date of issuance

Oct. 13, 2022

[37]

Nov. 12, 2020

[5],[38]

Debt instrument, face amount

$ 350,000

[37]

$ 110,000

Annual interest rate

15%

[37]

12%

Discount amount

$ 50,000

$ 10,000

Warrants issued

70,000,000

Fair value of warrants

$ 41,176

Debt discount

$ 41,176

Amortization expens

12,290

Debt instrument, unamortized discount

$ 20,620

Promissory Note Payable20 [Member]

Short-Term Debt [Line Items]

Date of issuance

Oct. 28, 2022

[39]

Nov. 23, 2020

[5],[40]

Debt instrument, face amount

$ 400,000

[39]

$ 65,000

Annual interest rate

15%

[39]

15.50%

Line of credit facility

$ 4,000,000

Promissory Note Payable21 [Member]

Short-Term Debt [Line Items]

Date of issuance

Nov. 09, 2022

[39]

Nov. 23, 2020

[5],[41]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

Annual interest rate

15%

[39]

15%

Discount amount

$ 50,000

Fair value of warrants

$ 125,814

Amortization expens

$ 1,866

Debt instrument, unamortized discount

$ 346,157

Promissory Note Payable22 [Member]

Short-Term Debt [Line Items]

Date of issuance

Nov. 10, 2022

[39]

Dec. 10, 2020

[5],[42]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

Annual interest rate

15%

[39]

12%

Discount amount

$ 50,000

Fair value of warrants

$ 54,545

Amortization expens

$ 1,838

Debt instrument, unamortized discount

$ 346,600

Promissory Note Payable23 [Member]

Short-Term Debt [Line Items]

Date of issuance

Nov. 15, 2022

[39]

Dec. 10, 2020

[43]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 3,921,168

[43]

Annual interest rate

15%

[39]

12%

Debt settlement amount

$ 2,683,357

Accrued interest

1,237,811

Discount amount

$ 50,000

Amortization expens

$ 16,678

Debt instrument, unamortized discount

$ 349,214

Promissory Note Payable23 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 3,921,168

Exercise price

$ 0.002

Fair value of notes

$ 990,000

Promissory Note Payable24 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jan. 11, 2023

[39]

Dec. 10, 2020

[44]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 3,054,338

[44]

Annual interest rate

15%

[39]

12%

Debt settlement amount

$ 1,460,794

Accrued interest

1,593,544

Discount amount

$ 50,000

Amortization expens

$ 1,881

Debt instrument, unamortized discount

$ 345,914

Promissory Note Payable24 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

3,054,338

Fair value of notes

$ 550,000

Promissory Note Payable25 [Member]

Short-Term Debt [Line Items]

Date of issuance

Feb. 06, 2023

[39]

Dec. 10, 2020

[45]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 165,605

[45]

Annual interest rate

15%

[39]

12%

Debt settlement amount

$ 103,180

Accrued interest

62,425

Discount amount

$ 50,000

Amortization expens

$ 1,925

Debt instrument, unamortized discount

$ 345,265

Promissory Note Payable25 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 165,605

Exercise price

$ 0.002

Fair value of notes

$ 176,000

Warrant purchase

80,000,000

Promissory Note Payable26 [Member]

Short-Term Debt [Line Items]

Date of issuance

Apr. 05, 2023

[39]

Dec. 14, 2020

[46]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 310,375

[46]

Annual interest rate

15%

[39]

12%

Debt settlement amount

$ 235,000

Accrued interest

75,375

Discount amount

$ 50,000

Amortization expens

$ 1,836

Debt instrument, unamortized discount

$ 346,590

Promissory Note Payable26 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 310,375

Exercise price

$ 0.002

Fair value of notes

$ 182,500

Warrant purchase

25,000,000

Promissory Note Payable27 [Member]

Short-Term Debt [Line Items]

Date of issuance

Apr. 20, 2023

[39]

Dec. 30, 2020

[47]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 350,000

[47]

Annual interest rate

15%

[39]

12%

Exercise price

$ 0.025

Discount amount

$ 50,000

$ 35,000

Warrants issued

50,000,000

Loan payable term (in years)

3 years

Fair value of warrants

$ 271,250

Debt discount

271,250

Amortization expens

$ 751

83,338

Debt instrument, unamortized discount

$ 345,494

$ 193,515

Promissory Note Payable28 [Member]

Short-Term Debt [Line Items]

Date of issuance

May 11, 2023

[39]

Dec. 31, 2021

[48]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 25,000

[48]

Annual interest rate

15%

[39]

12%

Debt settlement amount

$ 9,200

Accrued interest

6,944

Discount amount

$ 50,000

Amortization expens

$ 196

Debt instrument, unamortized discount

352,023

Promissory Note Payable28 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 16,144

Promissory Note Payable29 [Member]

Short-Term Debt [Line Items]

Date of issuance

[49]

Dec. 31, 2021

Debt instrument, face amount

$ 400,000

$ 145,000

[49]

Annual interest rate

12%

Debt settlement amount

$ 79,500

Accrued interest

28,925

Discount amount

$ 50,000

Amortization expens

0

Debt instrument, unamortized discount

$ 398,983

Promissory Note Payable29 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 108,425

[1]In default[2]This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.[3]In default. Default interest rate 22 1,661,953 342,138 2,004,091 62,979 12 4,562 48,000 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 78,432 33 25,882 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 7,850 33 2,590 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 86,567 33 28,567 350,000 35,000 50,000,000 0.025 3 271,250 271,250 39,904 153,611 79,104 33 26,104 9,200 6,944 16,144 25,000 79,500 28,925 108,425 145,000 550,000 250,000 50,000,000 0.025 3 380,174 380,174 51,045 188,291 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 50,000,000 .0164 3 950,000 159,064 953,197 13,000 3,850 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 0 0 150,000,000 .0164 3 2,850,000 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 43,500 8,000 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 154,910 639,308 85,000 15,000 4,000,160 27,000 62,000 12,000 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 86,930 1,27,501 31,000 6,000 170,000 20,000 5,287 3,739 50,000 10,000 955,000,000 3,000,000 15 2,960,500 39,500 4,557 26,312 42,000 7,000 400,000 50,000 12,342 15,479 300,000 50,000 475,000 75,000 18,930 17,799 150,000 2,000 8,500 350,000 50,000 12,290 20,620 110,000 10,000 70,000,000 0.00165 3 41,176 41,176 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. 400,000 50,000 1,866 346,157 400,000 50,000 1,838 346,600 400,000 50,000 16,678 349,214 400,000 50,000 1,881 345,914 400,000 50,000 1,925 345,265 400,000 50,000 1,836 346,590 400,000 50,000 751 345,494 400,000 50,000 196 352,023 400,000 50,000 0 398,983 65,000 4,060 300,000 25,000 230,000,000 0.00165 3 125,814 125,814 82,500 7,500 100,000,000 0.002 3 54,545 54,545 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 1,460,794 1,593,544 3,054,338 3,054,338 550,000 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 350,000 35,000 50,000,000 0.025 3 271,250 271,250 83,338 193,515 9,200 6,944 16,144 25,000 79,500 28,925 108,425 145,000

Summary of Preferred Stock Warr

Summary of Preferred Stock Warrant Activity (Details) - Preferred Stock [Member] - Warrant [Member] - $ / shares	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning	695	329
Weighted average exercise price at beginning	$ 1	$ 1
Weighted average remaining years beginning	10 years	11 years 6 months
Issued	183	366	100,000,000
Issued	$ 1	$ 1	$ 0.02
Issued	9 years 10 months 17 days	10 years	4 years 9 months
Exercised	0	0
Exercised
Forfeited and cancelled	0	0	(4,275,000)
Forfeited and cancelled			$ 0.02
Outstanding at ending	878	695	329
Weighted average exercise price at ending	$ 1	$ 1	$ 1
Weighted average remaining years ending	9 years 9 months	10 years

The table below represent the c

The table below represent the common shares issued, issuable and outstanding at May 31, 2023 and February 28, 2023: (Details) - shares	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	6,129,670,689	5,848,741,599	4,735,210,360
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	6,117,570,789	5,836,641,599	4,733,110,360
Issuable	12,100,000	12,100,000	2,100,000
Issued, issuable and outstanding	6,129,670,789	5,848,741,599	4,735,210,360

Summary of Common Stock Warrant

Summary of Common Stock Warrant Activity (Details) - Common Stock [Member] - Warrant [Member] - $ / shares	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning	314,217,451	1,216,845,661	619,523,492
Weighted average exercise price at beginning	$ 0.114	$ 0.06	$ 0.03
Outstanding at beginning (in years)	1 year 11 months 12 days	2 years 4 months 17 days	2 years 9 months 22 days
Issued		94,000,000	1,008,324,212
Issued		$ 0.010	$ 0.06
Exercised		(108,378,210)	(411,000,000)
Exercised		$ (0.011)	$ 0.06
Forfeited and cancelled		(955,000,000)	(2,043)
Forfeited and cancelled		$ (0.008)
Outstanding at ending	314,217,451	314,217,451	1,216,845,661
Weighted average exercise price at ending	$ 0.114	$ 0.114	$ 0.06
Outstanding at ending (in years)	1 year 8 months 12 days	1 year 11 months 12 days	2 years 4 months 17 days

Summary of Common Stock Option

Summary of Common Stock Option Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Preferred Stock [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning		95,725,000	0
Outstanding at beginning		$ 0.02
Weighted average remaining years			4 years 9 months
Issued	183	366	100,000,000
Issued	$ 1	$ 1	$ 0.02
Exercised	0	0
Exercised
Forfeited, extinguished and cancelled	0	0	(4,275,000)
Forfeited, extinguished and cancelled			$ 0.02
Weighted average remaining years			4 years 9 months
Outstanding at ending			95,725,000
Outstanding at ending			$ 0.02
Weighted average remaining years	9 years 10 months 17 days	10 years	4 years 9 months
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning	95,725,000
Outstanding at beginning	$ 0.02
Weighted average remaining years	4 years 6 months	4 years 9 months
Issued
Issued
Exercised
Exercised
Forfeited, extinguished and cancelled	(13,025,000)
Forfeited, extinguished and cancelled	$ 0.02
Weighted average remaining years	4 years 9 months
Outstanding at ending	82,700,000	95,725,000
Outstanding at ending	$ 0.02	$ 0.02

STOCKHOLDERS_ EQUITY (DEFICIT_2

STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)	3 Months Ended			12 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2021	Feb. 28, 2023	Feb. 28, 2022	Aug. 09, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Relative fair value						$ 393,949
Share based compensation				$ 0	$ 0
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of shares	280,929,190
Gross proceeds	$ 1,400,094
Issuance costs	1,318,809
Net proceeds	81,285
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Relative fair value	$ 947,447
Issuance of shares				3,324,212	411,000,000
Share based compensation		$ 0	$ 0

The Company_s leases are accoun

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. (Details) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Commitments and Contingencies Disclosure [Abstract]
Rent expense and operating lease cost	$ 62,542	$ 69,967	$ 260,271	$ 275,785
May 31, 2024	244,169		248,669
May 31, 2025	213,711		219,863
May 31, 2026	207,558		207,558
May 31, 2027	207,557		207,558
May 31, 2028	207,558		207,558
May 31, 2029 and after	605,378		657,268
Total lease payments	1,685,931		1,748,474
Less: Interest	(515,488)		(549,263)
Present value of lease liabilities	$ 1,170,443		$ 1,199,211

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)				3 Months Ended	12 Months Ended
	Jan. 28, 2022	Mar. 10, 2021	Dec. 18, 2020	May 31, 2023	Feb. 28, 2023		Feb. 28, 2022
Commitments and Contingencies Disclosure [Abstract]
Entity address				the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $3,859 per month.	the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $3,859 per month.
Security deposit	$ 1,500	$ 15,880	$ 3,859	$ 21,239	$ 21,239	[1]	$ 21,239
Entity address				the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month.	the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month.
Annual rent	$ 1,500	$ 15,880	$ 3,859
Entity address				the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.	the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.
Entity address				the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month.	the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024
[1]Derived from audited information

The net income (loss) per commo

The net income (loss) per common share amounts were determined as follows: (Details) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Earnings Per Share [Abstract]
Net income	$ (4,555,193)	$ (4,671,686)	$ (18,109,457)	$ (62,197,484)
Add: interest expense on convertible debt			47,075	24,954
Net income (loss) adjusted for common stock equivalents	$ (4,555,193)	$ (4,671,686)	$ (18,065,977)	$ (62,544,744)
Weighted average shares basic	5,964,709,322	4,798,657,871
Net income (loss) per share – basic	$ 0	$ 0	$ 0	$ (0.02)
Weighted average shares diluted	5,964,709,322	4,798,657,871	5,091,857,082	4,029,658,082
Weighted average shares diluted		4,798,657,871
Net income (loss) per share – diluted	$ 0	$ 0	$ 0	$ (0.02)
Add (less) loss (gain) on change of derivative liabilities			$ (3,595)	$ (372,214)
Weighted average shares basic	5,964,709,322	4,798,657,871	5,091,857,082	4,029,658,082

The anti-dilutive shares of com

The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2023 and 2022 were as follows: (Details) - shares	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023		Feb. 28, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	396,917,451	1,223,938,916	496,942,251		1,261,773,222
Series F Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total				[1]		[1]
Stock Options and Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	396,917,451	1,216,845,661	496,942,251		1,256,845,661
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total		7,093,255			4,927,561
[1]On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at February 28, 2023 and 2022 the dilutive effects would be as follows:

Series F Preferred shares been

Series F Preferred shares been convertible the dilutive effects would be as follows: (Details) - shares	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Earnings Per Share [Abstract]
Convertible series F preferred shares	21,147,364,222	16,798,367,179	20,178,158,517	16,336,475,742

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)			1 Months Ended
	Jun. 05, 2023	Mar. 22, 2023	Jul. 14, 2023	May 31, 2023	Mar. 19, 2023	Feb. 28, 2023	Feb. 28, 2022
Subsequent Event [Line Items]
Increase to its authorized common stock				7,225,000,000		7,225,000,000	7,225,000,000
Convertible Notes Payable [Member] | Lender [Member]
Subsequent Event [Line Items]
Gross proceeds	$ 1,400,194
Subsequent Event [Member]
Subsequent Event [Line Items]
Increase to its authorized common stock					1,225,000,000
Subsequent event, description		on March 22, 2023 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $30,000,000 over the course of twenty four (24) month at a purchase price of eighty percent (80%) of the lowest trade price in the 9 day preceding period. If the average Closing Price for the Common Stock during the three (3) trading days preceding a purchase is equal to or greater than one cent ($.01) per share, the applicable purchase price shall equal eighty five percent (85%) of the lowest trade price in the 9 day preceding period. Following an up-list to the NASDAQ or an equivalent national exchange by the Company, the purchase price shall equal ninety percent (90%) of the lowest Volume Weighted Average Price (“VWAP”) for the Common Stock during the 9 day preceding period subject to a floor of $4.50 per share, below which the Company shall not be required to sell shares. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement
Subsequent Event [Member] | Share Purchase Agreement [Member]
Subsequent Event [Line Items]
Issuance of shares	280,929,190		441,502,460
Gross proceeds			$ 2,922,520
Issuance costs	$ 81,285		132,591
Net proceeds	$ 1,318,909		$ 2,789,929

Major repairs or improvements a

Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. (Details)	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023
Computer Equipment [Member]
Fixed assets, useful life		3 years
Furniture and Fixtures [Member]
Fixed assets, useful life		3 years
Office Equipment [Member]
Fixed assets, useful life	4 years	4 years
Warehouse Equipment [Member]
Fixed assets, useful life	5 years	5 years
Demo Devices [Member]
Fixed assets, useful life	4 years	4 years
Vehicles [Member]
Fixed assets, useful life	3 years	3 years
Leasehold Improvements [Member]
Fixed assets, useful life	5 years	5 years
Minimum [Member]
Fixed assets, useful life	3 years	3 years
Maximum [Member]
Fixed assets, useful life	5 years	5 years

Below is a summary of our lea_2

Below is a summary of our lease assets and liabilities at February 28, 2023 and February 28, 2022. (Details) - USD ($)	May 31, 2023	Feb. 28, 2023		Feb. 28, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Operating lease assets	$ 1,179,673	$ 1,208,440		$ 1,331,605
Current operating lease liability	244,169	248,670	[1]	254,027
Noncurrent operating lease liabilities	926,274	950,541	[1]	1,057,579
Total lease liabilities	$ 1,170,443	$ 1,199,211		$ 1,311,606
[1]Derived from audited information

GENERAL INFORMATION AND GOING_2

GENERAL INFORMATION AND GOING CONCERN (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended	12 Months Ended
	Aug. 28, 2017	Mar. 31, 2023	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022	Jul. 25, 2017
Common stock, issued			6,129,670,689	5,848,741,599	4,735,210,360
Cash flow from operating activities			$ 2,991,003	$ 12,577,395
Accumulated deficit			116,808,904	112,253,711
Working capital			21,819,216	12,610,601
Minimum [Member]
Other cost cutting management estimates			200,000	200,000
Maximum [Member]
Other cost cutting management estimates			$ 300,000	$ 300,000
Common Stock [Member]
Common stock, issued			6,117,570,789	5,836,641,599	4,733,110,360
Purchase of common stock		$ 30,000,000
Robotic Assistance Devices L L C [Member]
Common stock, issued						10,000
Robotic Assistance Devices L L C [Member] | Series E Preferred Stock [Member]
Number of shares isuued under acquisition	3,350,000
Robotic Assistance Devices L L C [Member] | Series F Preferred Stock [Member]
Number of shares isuued under acquisition	2,450

INVESTMENT (Details Narrative)

INVESTMENT (Details Narrative)	Dec. 23, 2022 USD ($)
Simple Agreement for Future Equity [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Capital stock discount	$ 50,000

Revenue earning robots consiste

Revenue earning robots consisted of the following: (Details) - USD ($)	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2021
Revenue Earning Robots
Revenue earning devices	$ 2,459,470	$ 2,015,058	$ 2,015,058	$ 1,143,724
Less: Accumulated depreciation	(902,680)	(779,839)	(779,839)	(434,661)
	$ 1,556,790	$ 1,235,219	$ 1,235,219	$ 709,063

REVENUE EARNING ROBOTS (Details

REVENUE EARNING ROBOTS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Restructuring Cost and Reserve [Line Items]
Revenue earning	$ 385,208	$ 385,157	$ 1,331,956	$ 1,447,109
Depreciation expense	167,942	93,995	478,115	232,886
Robotic Assistance Devices L L C [Member]
Restructuring Cost and Reserve [Line Items]
Revenue earning	444,412	174,101	871,334	647,116
Iinventory transfers				647,116
Deferred gain on disposal				3,255
Depreciation expense	$ 122,841	$ 71,414	$ 345,178	208,510
Robotic Assistance Devices L L C [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Disposed of a revenue earning device				3,255
Robotic Assistance Devices L L C [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Disposed of a revenue earning device				$ 30,600

Convertible notes payable consi

Convertible notes payable consisted of the following: (Details) - USD ($)		6 Months Ended	12 Months Ended
		Jul. 18, 2016	Feb. 28, 2023	Aug. 30, 2022	Feb. 28, 2022
Short-Term Debt [Line Items]
Total convertible notes payable					$ 3,500
Less: current portion of convertible notes payable					(3,500)
Less: discount on noncurrent convertible notes payable
Noncurrent convertible notes payable, net of discount
Current portion of convertible notes payable					3,500
Less: discount on current portion of convertible notes payable			0	$ (39,500)
Current portion of convertible notes payable, net of discount					3,500
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Debt instrument, issuance date		Jul. 18, 2016
Debt instrument, maturity date	[1]		Jul. 18, 2017
Conversion rate per share	[2]		$ 0.003
Convertible Notes Payable 12 [Member]
Short-Term Debt [Line Items]
Total convertible notes payable					3,500
Convertible Notes Payable1 [Member]
Short-Term Debt [Line Items]
Debt instrument, issuance date		Aug. 09, 2022
Debt instrument, maturity date	[1]		Aug. 09, 2023
Conversion rate per share	[3]		$ 0.009
Total convertible notes payable
[1]This note was in default as of February 28, 2022. Default interest rate 22%[2]The conversion price was not subject to adjustment from forward or reverse stock splits. Effective in August 2022 this note (and accrued interest) was no longer convertible.[3]Subject to adjustment for dilutive issuances

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Debt Disclosure [Abstract]
Original issue discounts	$ 75,000	$ 0
Derivative liabilities	393,949	438,835
Amortization of debt discount interest expense	524,699	775,986
Accrued interest payable	$ 28,104	$ 28,104
Description of business activity	The Company transferred the above July 18, 2016 $3,500 note to loans payable as the note was no longer convertible. This was a result of an SEC action against the debt holder who was also a common stockholder.
Description of business activity	On August 9, 2022 the Company entered into a new convertible note for $750,000 with a one year maturity, interest rate of 12%, with a warrant (Warrant 1) to purchase 47,000,000 common shares with a five year maturity and an exercise price of $0.01, and an additional warrant (Warrant 2) to purchase 47,000,000 common shares with a five year maturity and an exercise price of $0.008 to be cancelled and extinguished if the note balance is $375,000 or less by February 9. 2023. The Company received $619,250 in cash proceeds, recorded an original issue discount of $75,000, recognized $393,949 based on a relative fair value calculation as debt discount with a corresponding adjustment to paid-in capital for the attached warrants, and transaction fees of $55,750. The discount is amortized over the term of the loan. This note and related accrued interest have been fully repaid at February 28, 2023.
Description of business activity	the Company amended the January 27, 2021 agreement with the lender whereby the conversion rate was changed from $0.10 to $0.03 as a result of a dilutive issuance. This resulted a derivative discount of $438,835 and a loss on extinguishment of $360,125.
Description of business activity	holders of certain convertible notes payable elected to convert a total of $825,000 of principal and $71,955 accrued interest, and $1,750 of fees into 31,042,436 shares of common stock. No gain or loss was recognized on conversions as these conversions occurred within the terms of the agreement that provided for conversion.
Description of business activity	the conversion rate of the January 19, 2021 note included above was reduced to $0.027 due to the dilutive issuance provision in the January 19, 2021 agreement.

Loans payable at February 28, 2

Loans payable at February 28, 2023 consisted of the following: (Details) - USD ($)

3 Months Ended

12 Months Ended

May 11, 2023

Apr. 20, 2023

Apr. 05, 2023

Feb. 06, 2023

Jan. 11, 2023

Nov. 15, 2022

Nov. 10, 2022

Nov. 09, 2022

Oct. 28, 2022

Feb. 28, 2022

Sep. 16, 2018

Aug. 11, 2018

May 31, 2023

Aug. 31, 2022

May 31, 2022

Feb. 28, 2023

Feb. 28, 2022

Aug. 30, 2022

Jan. 11, 2022

Feb. 28, 2021

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 32,427,346

$ 31,254,346

$ 3,000,000

Less: current portion of loans payable

(17,569,985)

(11,569,986)

Less: discount on non-current loans payable

(4,973,120)

(4,130,291)

Non-current loans payable, net of discount

9,884,241

15,554,069

Current portion of loans payable

17,569,985

11,569,986

Less: discount on current portion of loans payable

(1,348,996)

(1,651,597)

Current portion of loans payable, net of discount

16,220,989

9,918,389

Debt Instrument accrued interest

342,138

Total debt instrument face ammount

2,004,091

Accrued Liabilities

62,979

Debt discount

$ 114,000

$ 114,000

Debt instrument, unamortized discount

0

$ 39,500

Interest expenses

$ 1,606,216

$ 1,175,030

5,426,364

16,129,499

Interest payable, current

28,104

28,104

28,104

Fair value of warrants

$ 0

0

$ 0

Common stock issued for debt conversion

898,705

Class of Warrant or Right, Outstanding

2,960,500

Common Stock [Member]

Short-Term Debt [Line Items]

Proceeds from Issuance of Debt

$ 821,027

$ 13,108,624

Stock Issued During Period, Shares, New Issues

1,057,841,576

645,168,473

Warrant [Member]

Short-Term Debt [Line Items]

Stock Issued During Period, Shares, New Issues

3,324,212

411,000,000

Promissory Note Payable 01 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jul. 18, 2016

[1],[2]

Jul. 18, 2016

[3],[4]

Debt instrument, face amount

$ 3,500

[1],[2]

$ 3,500

[3],[4]

Annual interest rate

22%

[1],[2]

22%

Default interest rate

22%

Promissory Note Payable 02 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 10, 2020

Jun. 11, 2018

[5],[6]

Debt instrument, face amount

$ 3,921,168

Annual interest rate

12%

25%

Convertible Debt

$ 2,683,357

Interest Payable Current and Noncurrent 1

$ 1,237,811

Promissory Note Payable 02 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 3,921,168

Fair Value of Notes

$ 990,000

Promissory Note Payable 03 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 10, 2020

[7]

Jan. 31, 2019

[5],[8]

Debt instrument, face amount

[7]

$ 3,054,338

Annual interest rate

12%

[7]

15%

Convertible Debt

$ 1,460,794

Interest Payable Current and Noncurrent 1

$ 1,593,544

Promissory Note Payable 03 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 3,054,338

Fair Value of Notes

$ 550,000

Promissory Note Payable04 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 10, 2020

[9]

May 09, 2019

[5],[10]

Debt instrument, face amount

[9]

$ 165,605

Annual interest rate

12%

[9]

15%

Convertible Debt

$ 103,180

Interest Payable Current and Noncurrent 1

$ 62,425

Promissory Note Payable04 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 165,605

Fair Value of Notes

$ 176,000

Stock Issued During Period, Shares, New Issues

80,000,000

Promissory Note Payable05 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 14, 2020

[11]

May 31, 2019

[5],[12]

Debt instrument, face amount

[11]

$ 310,375

Annual interest rate

12%

[11]

15%

Convertible Debt

$ 235,000

Interest Payable Current and Noncurrent 1

$ 75,375

Promissory Note Payable05 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 310,375

Fair Value of Notes

$ 182,500

Stock Issued During Period, Shares, New Issues

25,000,000

Promissory Note Payable06 [Member]

Short-Term Debt [Line Items]

Date of issuance

Dec. 30, 2020

[13]

Jun. 26, 2019

[5],[14]

Debt instrument, face amount

[13]

$ 350,000

Annual interest rate

12%

[13]

15%

Debt Conversion Original Debt Amount 2

$ 35,000

Number of Warrants Issued

50,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.025

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 271,250

Interest Expense, Debt, Excluding Amortization

39,904

Debt instrument, unamortized discount

153,611

Fair value of warrants

$ 271,250

Promissory Note Payable 07 [Member]

Short-Term Debt [Line Items]

Date of issuance

[5],[15]

Sep. 24, 2019

Annual interest rate

15%

Promissory Note Payable 08 [Member]

Short-Term Debt [Line Items]

Date of issuance

[5],[16]

Jan. 30, 2020

Annual interest rate

15%

Promissory Note Payable 09 [Member]

Short-Term Debt [Line Items]

Date of issuance

[5],[17]

Feb. 27, 2020

Annual interest rate

15%

Promissory Note Payable10 [Member]

Short-Term Debt [Line Items]

Date of issuance

Feb. 22, 2021

[18]

Apr. 16, 2020

[5],[19]

Debt instrument, face amount

$ 1,650,000

[18]

$ 6,000,000

[20]

Annual interest rate

12%

[18]

15%

Debt Conversion Original Debt Amount 2

$ 150,000

Number of Warrants Issued

100,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.0164

$ 0.135

$ 0.0164

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 1,342,857

Interest Expense, Debt, Excluding Amortization

159,064

Debt instrument, unamortized discount

953,197

Interest expenses

$ 950,000

Fair value of warrants

$ 1,342,857

Promissory Note Payable10 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Number of Warrants Issued

50,000,000

Class of Warrant Or Right Warrants Term

3 years

Promissory Note Payable11 [Member]

Short-Term Debt [Line Items]

Date of issuance

Mar. 01, 2021

[21]

May 12, 2020

[5],[22]

Debt instrument, face amount

[21]

$ 6,000,000

Annual interest rate

12%

[21]

15%

Debt Conversion, Original Debt, Amount

$ 600,000

Proceeds from Issuance of Debt

$ 5,400,000

Number of Warrants Issued

300,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.135

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 4,749,005

Interest expenses

$ 2,850,000

Promissory Note Payable11 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Number of Warrants Issued

150,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.0164

0.0164

Class of Warrant Or Right Warrants Term

3 years

Promissory Note Payable11 [Member] | Valuation Technique, Option Pricing Model [Member]

Short-Term Debt [Line Items]

Fair value of warrants

$ 4,749,005

Promissory Note Payable12 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jun. 08, 2021

[23]

May 22, 2020

[5],[24]

Debt instrument, face amount

[23]

$ 2,750,000

Annual interest rate

12%

[23]

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Number of Warrants Issued

170,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.064

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 2,035,033

Interest Expense, Debt, Excluding Amortization

154,910

Debt instrument, unamortized discount

639,308

Interest expenses

$ 1,615,000

Fair value of warrants

$ 2,035,033

Promissory Note Payable12 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Number of Warrants Issued

85,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.0164

0.0164

Class of Warrant Or Right Warrants Term

3 years

Promissory Note Payable13 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jul. 12, 2021

[25]

Jun. 02, 2020

[5],[26]

Debt instrument, face amount

[25]

$ 3,857,360

Annual interest rate

7%

[25]

15%

Principal ammount

$ 4,000,160

Repayment of notes

$ 27,000

Promissory Note Payable14 [Member]

Short-Term Debt [Line Items]

Date of issuance

Sep. 14, 2021

[27]

Jun. 09, 2020

[5],[28]

Debt instrument, face amount

[27]

$ 1,650,000

Annual interest rate

12%

[27]

15%

Debt Conversion Original Debt Amount 2

$ 150,000

Number of Warrants Issued

250,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.037

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 1,284,783

Interest Expense, Debt, Excluding Amortization

86,930

Debt instrument, unamortized discount

127,501

Fair value of warrants

$ 1,284,783

Promissory Note Payable15 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jul. 28, 2022

[29]

Jun. 12, 2020

[5],[30]

Debt instrument, face amount

[29]

$ 170,000

Annual interest rate

15%

[29]

15%

Debt Conversion Original Debt Amount 2

$ 20,000

Interest Expense, Debt, Excluding Amortization

5,287

Debt instrument, unamortized discount

$ 3,739

Promissory Note Payable16 [Member]

Short-Term Debt [Line Items]

Date of issuance

Aug. 30, 2022

[31]

Jun. 16, 2020

[5],[32]

Debt instrument, face amount

[31]

$ 3,000,000

Annual interest rate

15%

[31]

15%

Debt discount

$ 39,500

Interest Expense, Debt, Excluding Amortization

4,557

Debt instrument, unamortized discount

$ 26,312

Class of Warrant or Right, Outstanding

955,000,000

Rate of interest

15%

Class of warrant or right, outstanding

$ 2,960,500

Promissory Note Payable17 [Member]

Short-Term Debt [Line Items]

Date of issuance

Sep. 07, 2022

[33]

Sep. 15, 2020

[5],[34]

Debt instrument, face amount

[33]

$ 400,000

Annual interest rate

15%

[33]

10%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

12,342

Debt instrument, unamortized discount

$ 15,479

Promissory Note Payable18 [Member]

Short-Term Debt [Line Items]

Date of issuance

Sep. 08, 2022

[35]

Oct. 06, 2020

[5],[36]

Debt instrument, face amount

$ 475,000

[35]

$ 150,000

Annual interest rate

15%

[35]

12%

Debt Conversion Original Debt Amount 2

$ 75,000

Interest Expense, Debt, Excluding Amortization

18,930

Debt instrument, unamortized discount

$ 17,799

Interest payable, current

$ 2,000

Interest payable, non current

$ 8,500

Promissory Note Payable19 [Member]

Short-Term Debt [Line Items]

Date of issuance

Oct. 13, 2022

[37]

Nov. 12, 2020

[5],[38]

Debt instrument, face amount

$ 350,000

[37]

$ 110,000

Annual interest rate

15%

[37]

12%

Debt Conversion Original Debt Amount 2

$ 50,000

$ 10,000

Number of Warrants Issued

70,000,000

Debt discount

$ 41,176

Interest Expense, Debt, Excluding Amortization

12,290

Debt instrument, unamortized discount

$ 20,620

Fair value of warrants

$ 41,176

Promissory Note Payable20 [Member]

Short-Term Debt [Line Items]

Date of issuance

Oct. 28, 2022

[39]

Nov. 23, 2020

[5],[40]

Debt instrument, face amount

$ 400,000

[39]

$ 65,000

Annual interest rate

15%

[39]

15.50%

Interest payable, non current

$ 4,060

Line of credit facility

$ 4,000,000

Promissory Note Payable21 [Member]

Short-Term Debt [Line Items]

Date of issuance

Nov. 09, 2022

[39]

Nov. 23, 2020

[5],[41]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

Annual interest rate

15%

[39]

15%

Debt Conversion Original Debt Amount 2

50,000

Interest Expense, Debt, Excluding Amortization

$ 1,866

Debt instrument, unamortized discount

$ 346,157

Fair value of warrants

$ 125,814

Promissory Note Payable22 [Member]

Short-Term Debt [Line Items]

Date of issuance

Nov. 10, 2022

[39]

Dec. 10, 2020

[5],[42]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

50,000

Interest Expense, Debt, Excluding Amortization

$ 1,838

Debt instrument, unamortized discount

$ 346,600

Fair value of warrants

$ 54,545

Promissory Note Payable23 [Member]

Short-Term Debt [Line Items]

Date of issuance

Nov. 15, 2022

[39]

Dec. 10, 2020

[43]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 3,921,168

[43]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

50,000

Interest Expense, Debt, Excluding Amortization

$ 16,678

Debt instrument, unamortized discount

$ 349,214

Convertible Debt

$ 2,683,357

Interest Payable Current and Noncurrent 1

$ 1,237,811

Promissory Note Payable23 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 3,921,168

Fair Value of Notes

$ 990,000

Promissory Note Payable24 [Member]

Short-Term Debt [Line Items]

Date of issuance

Jan. 11, 2023

[39]

Dec. 10, 2020

[44]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 3,054,338

[44]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

50,000

Interest Expense, Debt, Excluding Amortization

$ 1,881

Debt instrument, unamortized discount

$ 345,914

Convertible Debt

$ 1,460,794

Interest Payable Current and Noncurrent 1

1,593,544

Promissory Note Payable24 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

3,054,338

Fair Value of Notes

$ 550,000

Promissory Note Payable25 [Member]

Short-Term Debt [Line Items]

Date of issuance

Feb. 06, 2023

[39]

Dec. 10, 2020

[45]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 165,605

[45]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

50,000

Interest Expense, Debt, Excluding Amortization

$ 1,925

Debt instrument, unamortized discount

$ 345,265

Convertible Debt

$ 103,180

Interest Payable Current and Noncurrent 1

$ 62,425

Promissory Note Payable25 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 165,605

Fair Value of Notes

$ 176,000

Stock Issued During Period, Shares, New Issues

80,000,000

Promissory Note Payable26 [Member]

Short-Term Debt [Line Items]

Date of issuance

Apr. 05, 2023

[39]

Dec. 14, 2020

[46]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 310,375

[46]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

50,000

Interest Expense, Debt, Excluding Amortization

$ 1,836

Debt instrument, unamortized discount

$ 346,590

Convertible Debt

$ 235,000

Interest Payable Current and Noncurrent 1

$ 75,375

Promissory Note Payable26 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Common stock issued for debt conversion

$ 310,375

Fair Value of Notes

$ 182,500

Stock Issued During Period, Shares, New Issues

25,000,000

Promissory Note Payable27 [Member]

Short-Term Debt [Line Items]

Date of issuance

Apr. 20, 2023

[39]

Dec. 30, 2020

[47]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 350,000

[47]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

$ 50,000

$ 35,000

Number of Warrants Issued

50,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.025

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 271,250

Interest Expense, Debt, Excluding Amortization

$ 751

83,338

Debt instrument, unamortized discount

$ 345,494

193,515

Fair value of warrants

$ 271,250

Promissory Note Payable28 [Member]

Short-Term Debt [Line Items]

Date of issuance

May 11, 2023

[39]

Dec. 31, 2021

[48]

Debt instrument, face amount

$ 400,000

$ 400,000

[39]

$ 25,000

[48]

Annual interest rate

15%

[39]

12%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

$ 196

Debt instrument, unamortized discount

352,023

Convertible Debt

$ 9,200

Interest Payable Current and Noncurrent 1

6,944

Promissory Note Payable28 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 16,144

Promissory Note Payable29 [Member]

Short-Term Debt [Line Items]

Date of issuance

[49]

Dec. 31, 2021

Debt instrument, face amount

$ 400,000

$ 145,000

[49]

Annual interest rate

12%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

0

Debt instrument, unamortized discount

$ 398,983

Convertible Debt

$ 79,500

Interest Payable Current and Noncurrent 1

28,925

Promissory Note Payable29 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Common stock issued for debt conversion

$ 108,425

Promissory Note Payable30 [Member]

Short-Term Debt [Line Items]

Date of issuance

[50]

Jan. 14, 2021

Debt instrument, face amount

[50]

$ 550,000

Annual interest rate

12%

Debt Conversion Original Debt Amount 2

$ 250,000

Number of Warrants Issued

50,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.025

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 380,174

Interest Expense, Debt, Excluding Amortization

127,897

Debt instrument, unamortized discount

239,336

Fair value of warrants

$ 380,174

Promissory Note Payable31 [Member]

Short-Term Debt [Line Items]

Date of issuance

[51]

Feb. 22, 2021

Debt instrument, face amount

[51]

$ 1,650,000

Annual interest rate

12%

Debt Conversion Original Debt Amount 2

$ 150,000

Number of Warrants Issued

100,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.0164

$ 0.135

$ 0.0164

Class of Warrant Or Right Warrants Term

3 years

3 years

Debt discount

$ 1,342,857

Interest Expense, Debt, Excluding Amortization

2,995,719

Debt instrument, unamortized discount

1,112,261

Interest expenses

$ 950,000

Fair value of warrants

$ 1,342,857

Promissory Note Payable31 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Number of Warrants Issued

50,000,000

Promissory Note Payable32 [Member]

Short-Term Debt [Line Items]

Date of issuance

[20]

Mar. 01, 2021

Debt instrument, face amount

[52]

$ 2,750,000

Annual interest rate

12%

Debt Conversion Original Debt Amount 2

$ 50,000

Number of Warrants Issued

170,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.0164

$ 0.064

$ 0.0164

Class of Warrant Or Right Warrants Term

3 years

3 years

Debt discount

$ 2,035,033

Interest Expense, Debt, Excluding Amortization

455,527

Debt instrument, unamortized discount

794,218

Interest expenses

$ 1,615,000

Fair value of warrants

$ 2,035,033

Promissory Note Payable32 [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Number of Warrants Issued

85,000,000

Promissory Note Payable33 [Member]

Short-Term Debt [Line Items]

Date of issuance

[52]

Jun. 08, 2021

Debt instrument, face amount

[53]

$ 3,884,360

Annual interest rate

12%

Promissory Note Payable34 [Member]

Short-Term Debt [Line Items]

Date of issuance

[53]

Jul. 12, 2021

Debt instrument, face amount

$ 1,650,000

Annual interest rate

7%

Debt Conversion Original Debt Amount 2

$ 150,000

Number of Warrants Issued

250,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.037

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 1,284,783

Interest Expense, Debt, Excluding Amortization

188,002

Debt instrument, unamortized discount

1,214,431

Fair value of warrants

1,284,783

Principal ammount

4,000,160

Repayment of notes

$ 115,800

Promissory Note Payable35 [Member]

Short-Term Debt [Line Items]

Date of issuance

[54]

Sep. 14, 2021

Debt instrument, face amount

[54]

$ 1,650,000

Annual interest rate

12%

Promissory Note Payable36 [Member]

Short-Term Debt [Line Items]

Date of issuance

[55]

Jul. 28, 2022

Debt instrument, face amount

[55]

$ 170,000

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 20,000

Interest Expense, Debt, Excluding Amortization

10,974

Debt instrument, unamortized discount

$ 9,026

Promissory Note Payable37 [Member]

Short-Term Debt [Line Items]

Date of issuance

[56]

Aug. 30, 2022

Debt instrument, face amount

[57]

$ 400,000

Annual interest rate

15%

Debt discount

$ 39,500

Interest Expense, Debt, Excluding Amortization

8,632

Debt instrument, unamortized discount

$ 30,868

Promissory Note Payable38 [Member]

Short-Term Debt [Line Items]

Date of issuance

[57]

Sep. 07, 2022

Debt instrument, face amount

[56]

$ 3,000,000

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

22,179

Debt instrument, unamortized discount

$ 27,821

Rate of interest

15%

Class of warrant or right, outstanding

$ 2,960,500

Promissory Note Payable38 [Member] | Warrant [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Outstanding

955,000,000

Promissory Note Payable39 [Member]

Short-Term Debt [Line Items]

Date of issuance

[58]

Sep. 08, 2022

Debt instrument, face amount

[58]

$ 475,000

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 75,000

Interest Expense, Debt, Excluding Amortization

38,271

Debt instrument, unamortized discount

$ 32,909

Promissory Note Payable40 [Member]

Short-Term Debt [Line Items]

Date of issuance

[59]

Oct. 13, 2022

Debt instrument, face amount

[59]

$ 350,000

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

17,091

Debt instrument, unamortized discount

$ 46,407

Promissory Note Payable41 [Member]

Short-Term Debt [Line Items]

Date of issuance

[60]

Oct. 28, 2022

Debt instrument, face amount

[60]

$ 400,000

Annual interest rate

15%

Promissory Note Payable42 [Member]

Short-Term Debt [Line Items]

Date of issuance

[60]

Nov. 09, 2022

Debt instrument, face amount

400,000

$ 400,000

[60]

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

$ 1,312

Debt instrument, unamortized discount

$ 348,438

Promissory Note Payable43 [Member]

Short-Term Debt [Line Items]

Date of issuance

[60]

Nov. 10, 2022

Debt instrument, face amount

400,000

$ 400,000

[60]

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

$ 1,139

Debt instrument, unamortized discount

$ 350,881

Promissory Note Payable44 [Member]

Short-Term Debt [Line Items]

Date of issuance

[60]

Nov. 15, 2022

Debt instrument, face amount

400,000

$ 400,000

[60]

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

$ 2,143

Debt instrument, unamortized discount

$ 347,815

Promissory Note Payable45 [Member]

Short-Term Debt [Line Items]

Date of issuance

[60]

Jan. 11, 2023

Debt instrument, face amount

$ 400,000

[60]

$ 400,000

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

$ 802

Debt instrument, unamortized discount

$ 347,189

Promissory Note Payable46 [Member]

Short-Term Debt [Line Items]

Date of issuance

[60]

Feb. 06, 2023

Debt instrument, face amount

400,000

$ 400,000

[60]

Annual interest rate

15%

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

$ 100

Debt instrument, unamortized discount

348,426

Principal Balance [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

1,661,953

Promissory Notes Payable 958 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 78,432

Debt Conversion, Converted Instrument, Rate

33%

Debt Conversion, Original Debt, Amount

$ 25,882

Promissory Notes Payable 7010 [Member]

Short-Term Debt [Line Items]

Debt Instrument, Payment Terms

12

Promissory Note Payable 3030 [Member]

Short-Term Debt [Line Items]

Debt instrument, periodic payment

$ 4,562

Long-term Debt

$ 48,000

Promissory Notes Payable 968 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 7,850

Debt Conversion, Converted Instrument, Rate

33%

Debt Conversion, Original Debt, Amount

$ 2,590

Promissory Notes Payable 977 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 86,567

Debt Conversion, Converted Instrument, Rate

33%

Debt Conversion Original Debt Amount 2

$ 28,567

Promissory Note Payable 303022 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 79,104

Debt Conversion, Converted Instrument, Rate

33%

Debt Conversion Original Debt Amount 2

$ 26,104

Promissory Note Payable 303 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

12,000

Debt Conversion Original Debt Amount 2

3,000

Promissory Note Payable 304 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

11,000

Debt Conversion Original Debt Amount 2

2,450

Promissory Note Payable 305 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

5,000

Debt Conversion Original Debt Amount 2

1,200

Promissory Note Payable 306 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

13,000

Debt Conversion Original Debt Amount 2

3,850

Promissory Note Payable [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

6,000,000

Debt Conversion, Original Debt, Amount

600,000

Proceeds from Issuance of Debt

$ 5,400,000

Number of Warrants Issued

300,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.0164

$ 0.135

$ 0.0164

Class of Warrant Or Right Warrants Term

3 years

3 years

Debt discount

$ 4,749,005

Interest Expense, Debt, Excluding Amortization

$ 0

Debt instrument, unamortized discount

0

Interest expenses

$ 2,850,000

Promissory Note Payable [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Number of Warrants Issued

150,000,000

Promissory Note Payable [Member] | Valuation Technique, Option Pricing Model [Member]

Short-Term Debt [Line Items]

Fair value of warrants

4,749,005

Promissory Note Payable 307 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

43,500

Debt Conversion Original Debt Amount 2

8,000

Promissory Note Payable308 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

85,000

Debt Conversion Original Debt Amount 2

15,000

Promissory Note Payable309 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

62,000

Debt Conversion Original Debt Amount 2

12,000

Promissory Note Payable 310 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

31,000

Debt Conversion Original Debt Amount 2

6,000

Promissory Note Payable 311 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

50,000

Debt Conversion Original Debt Amount 2

10,000

Promissory Note Payable 312 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

42,000

Debt Conversion Original Debt Amount 2

7,000

Promissory Note Payable 316 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

300,000

Debt Conversion Original Debt Amount 2

$ 50,000

Promissory Note Payable 319 [Member]

Short-Term Debt [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.00165

Class of Warrant Or Right Warrants Term

3 years

Promissory Note Payable 321 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

$ 300,000

Debt Conversion Original Debt Amount 2

$ 25,000

Number of Warrants Issued

230,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.00165

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 125,814

Promissory Note Payable 322 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

82,500

Debt Conversion Original Debt Amount 2

$ 7,500

Number of Warrants Issued

100,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.002

Class of Warrant Or Right Warrants Term

3 years

Debt discount

$ 54,545

Promissory Note Payable041 [Member]

Short-Term Debt [Line Items]

Debt instrument, face amount

400,000

Debt Conversion Original Debt Amount 2

$ 50,000

Interest Expense, Debt, Excluding Amortization

1,375

Debt instrument, unamortized discount

348,024

Line of credit facility

$ 4,000,000

[1]In default[2]This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.[3]In default. Default interest rate 22 1,661,953 342,138 2,004,091 62,979 12 4,562 48,000 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 78,432 33 25,882 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 7,850 33 2,590 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 86,567 33 28,567 350,000 35,000 50,000,000 0.025 3 271,250 271,250 39,904 153,611 79,104 33 26,104 12,000 3,000 11,000 2,450 5,000 1,200 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 50,000,000 .0164 3 950,000 159,064 953,197 13,000 3,850 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 0 0 150,000,000 .0164 3 2,850,000 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 43,500 8,000 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 154,910 639,308 85,000 15,000 4,000,160 27,000 62,000 12,000 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 86,930 1,27,501 31,000 6,000 170,000 20,000 5,287 3,739 50,000 10,000 955,000,000 3,000,000 15 2,960,500 39,500 4,557 26,312 42,000 7,000 400,000 50,000 12,342 15,479 300,000 50,000 475,000 75,000 18,930 17,799 150,000 2,000 8,500 350,000 50,000 12,290 20,620 110,000 10,000 70,000,000 0.00165 3 41,176 41,176 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. 400,000 50,000 1,866 346,157 400,000 50,000 1,838 346,600 400,000 50,000 16,678 349,214 400,000 50,000 1,881 345,914 400,000 50,000 1,925 345,265 400,000 50,000 1,836 346,590 400,000 50,000 751 345,494 400,000 50,000 196 352,023 400,000 50,000 0 398,983 65,000 4,060 300,000 25,000 230,000,000 0.00165 3 125,814 125,814 82,500 7,500 100,000,000 0.002 3 54,545 54,545 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 1,460,794 1,593,544 3,054,338 3,054,338 550,000 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 350,000 35,000 50,000,000 0.025 3 271,250 271,250 83,338 193,515 9,200 6,944 16,144 25,000 79,500 28,925 108,425 145,000 550,000 250,000 50,000,000 0.025 3 380,174 380,174 127,897 239,336 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 2,995,719 1,112,261 50,000,000 .0164 3 950,000 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 455,527 794,218 85,000,000 .0164 3 1,615,000 4,000,160 115,800 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 188,002 1,214,431 170,000 20,000 10,974 9,026 955,000,000 3,000,000 15 2,960,500 39,500 8,632 30,868 400,000 50,000 22,179 27,821 475,000 75,000 38,271 32,909 350,000 50,000 17,091 46,407 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each trance of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity.

OTHER DEBT _ VEHICLE LOANS (Det

OTHER DEBT – VEHICLE LOANS (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	12 Months Ended
	Nov. 30, 2017	Dec. 31, 2016	May 31, 2023	Feb. 28, 2023	Aug. 30, 2022	May 31, 2022	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2020	Feb. 28, 2019
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile			$ 32,427,346	$ 31,254,346	$ 3,000,000
Proceeds of disposal of vehicle offset against vehicle loan						$ 18,766	$ 18,766
Remaining asset value						5,515	5,515
Reclassification of fixed assets to vehicle for disposal						13,251
Robotic Assistance Devices L L C [Member] | Secured Debt [Member]
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile	$ 47,661	$ 47,704
Term of debt	5 years	5 years
Payment of debt interest and principal	$ 923	$ 1,019
Maturity date	Oct. 24, 2022	Nov. 09, 2020
Outstanding balance of the loan	$ 21,907									$ 21,907
Loss on sale of vehicle			3,257	3,257
Current portion vehicle loan				21,578			21,578	$ 21,578	$ 21,578
Reclassification of fixed assets to vehicle for disposal							13,251
Long-term vehicle loan				16,944			16,944	$ 16,944
Total vehicle loan			$ 38,522	$ 38,522		$ 38,522	$ 38,522

DERIVATIVE LIABILITIES (Details

DERIVATIVE LIABILITIES (Details Narrative) - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Derivative Liabilities
Derivative liability	$ 0	$ 7,587
Change in fair value of derivative liabilities	0	3,595
Gain on settlement of debt	$ 0	3,992
Change in fair value of derivative liabilities		372,214
Gain on settlement of debt		$ 81,228

Schedule of Summary of stock Op

Schedule of Summary of stock Option Activity (Details) - Preferred Stock [Member] - Warrant [Member] - $ / shares	3 Months Ended	12 Months Ended
	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning	695	329
Weighted average exercise price at beginning	$ 1	$ 1
Weighted average remaining years beginning	10 years	11 years 6 months
Issued	183	366	100,000,000
Issued	$ 1	$ 1	$ 0.02
Issued	9 years 10 months 17 days	10 years	4 years 9 months
Exercised	0	0
Exercised
Forfeited and cancelled	0	0	(4,275,000)
Forfeited and cancelled			$ 0.02
Outstanding at ending	878	695	329
Weighted average exercise price at ending	$ 1	$ 1	$ 1
Weighted average remaining years ending	9 years 9 months	10 years

The table below represent the_2

The table below represent the common shares issued, issuable and outstanding at February 28, 2023 and February 28, 2022: (Details) - shares	May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	6,129,670,689	5,848,741,599	4,735,210,360
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	6,117,570,789	5,836,641,599	4,733,110,360
Issuable	12,100,000	12,100,000	2,100,000
Issued, issuable and outstanding	6,129,670,789	5,848,741,599	4,735,210,360

Summary of Warrant and Stock Op

Summary of Warrant and Stock Option Activity (Details) - Common Stock [Member] - Warrant [Member] - $ / shares		3 Months Ended	12 Months Ended
		May 31, 2023	Feb. 28, 2023	Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning		314,217,451	1,216,845,661	619,523,492
Weighted average exercise price at beginning		$ 0.114	$ 0.06	$ 0.03
Outstanding at beginning (in years)		1 year 11 months 12 days	2 years 4 months 17 days	2 years 9 months 22 days
Issued			94,000,000	1,008,324,212
Issued			$ 0.010	$ 0.06
Issued (in years)			4 years 8 months 9 days	2 years 5 months 20 days
Exercised			(108,378,210)	(411,000,000)
Exercised			$ (0.011)	$ 0.06
Exercised (in years)			2 years 5 months 9 days	1 year 8 months 12 days
Forfeited and cancelled			(955,000,000)	(2,043)
Forfeited and cancelled			$ (0.008)
Adjusted	[1]		66,750,000
Adjusted	[1]		$ 0.011
Adjusted (in years)	[1]		1 year 4 months 28 days
Forfeited and cancelled (in years)			1 year 3 months 29 days
Outstanding at ending		314,217,451	314,217,451	1,216,845,661
Weighted average exercise price at ending		$ 0.114	$ 0.114	$ 0.06
Outstanding at ending (in years)		1 year 8 months 12 days	1 year 11 months 12 days	2 years 4 months 17 days
[1]Required dilution adjustment per warrant agreement

Schedule of valuation technique

Schedule of valuation techniques (Details)	Sep. 01, 2022 $ / shares	Aug. 09, 2022 $ / shares
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	0.02
Measurement Input, Share Price [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate		0.008
Measurement Input, Share Price [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate		0.01
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	0.01	0.012
Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	0	0
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	340.9
Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate		90
Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate		88.2
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	3.39	2.98
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected term (years)	4 years 6 months	5 years

Schedule of valuation techniq_2

Schedule of valuation techniques for warrants (Details)	12 Months Ended
	Feb. 28, 2023 USD ($) $ / shares shares	Feb. 28, 2022 $ / shares shares	Sep. 01, 2022 $ / shares	Aug. 09, 2022 $ / shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant term				5 years
Fair value of warrants | $	$ 21,929
Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued | shares	285,000,000
Warrants issued	$ 0.164
Warrant term	3 years
Fair value of warrants | $	$ 5,415,000
Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate			0.02
Measurement Input, Share Price [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate				0.008
Measurement Input, Share Price [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate				0.01
Measurement Input, Exercise Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate			0.01	0.012
Dividend Yield [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate			0	0
Measurement Input, Price Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate			340.9
Measurement Input, Price Volatility [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate				90
Measurement Input, Price Volatility [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate				88.2
Measurement Input, Risk Free Interest Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate			3.39	2.98
Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term (years)			4 years 6 months	5 years
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant purchase | shares	3,324,212	411,000,000
Warrant [Member] | Measurement Input, Share Price [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.135
Warrant [Member] | Measurement Input, Share Price [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.037
Warrant [Member] | Measurement Input, Exercise Price [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.0071
Warrant [Member] | Measurement Input, Exercise Price [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.146
Warrant [Member] | Dividend Yield [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0
Warrant [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		403.33
Warrant [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		411
Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.27
Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.43
Warrant [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term (years)		3 years
Warrant 1 [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.0164
Warrant 1 [Member] | Measurement Input, Exercise Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.019
Warrant 1 [Member] | Dividend Yield [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0
Warrant 1 [Member] | Measurement Input, Price Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		385.60
Warrant 1 [Member] | Measurement Input, Risk Free Interest Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		1.62
Warrant 1 [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term (years)		3 years
Warrant2 [Member] | Measurement Input, Share Price [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.029
Warrant2 [Member] | Measurement Input, Share Price [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Strike price		$ 0.041
Warrant2 [Member] | Measurement Input, Exercise Price [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.039
Warrant2 [Member] | Dividend Yield [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0
Warrant2 [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		35.90
Warrant2 [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		35.30
Warrant2 [Member] | Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.95
Warrant2 [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.46
Warrant2 [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term (years)		3 years
Warrant2 [Member] | Measurement input Exercise Price one [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk free interest rate		0.028

Rent expense and operating leas

Rent expense and operating lease cost was $260,271 (Details) - USD ($)	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Equity [Abstract]
Rent expense and operating lease cost	$ 62,542	$ 69,967	$ 260,271	$ 275,785
August 31, 2023	244,169		248,669
August 31, 2024	213,711		219,863
August 31, 2025	207,558		207,558
August 31, 2026	207,557		207,558
August 31, 2027	207,558		207,558
August 31, 2028 and after	605,378		657,268
Total lease payments	1,685,931		1,748,474
Less: Interest	(515,488)		(549,263)
Present value of lease liabilities	$ 1,170,443		$ 1,199,211

The anti-dilutive shares of c_2

The anti-dilutive shares of common stock equivalents for the years ended February 28, 2023 and February 28, 2022 were as follows (Details) - shares	3 Months Ended		12 Months Ended
	May 31, 2023	May 31, 2022	Feb. 28, 2023		Feb. 28, 2022
Class of Stock [Line Items]
Total	396,917,451	1,223,938,916	496,942,251		1,261,773,222
Series F Preferred Stock [Member]
Class of Stock [Line Items]
Total				[1]		[1]
Stock Options and Warrants [Member]
Class of Stock [Line Items]
Total	396,917,451	1,216,845,661	496,942,251		1,256,845,661
Convertible Debt Securities [Member]
Class of Stock [Line Items]
Total		7,093,255			4,927,561
[1]On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at February 28, 2023 and 2022 the dilutive effects would be as follows:

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative)								3 Months Ended			12 Months Ended		14 Months Ended
	Sep. 02, 2022	Aug. 11, 2022	Aug. 09, 2022 USD ($) $ / shares shares	Aug. 24, 2021	Jul. 12, 2021	Apr. 09, 2021 $ / shares shares	Mar. 23, 2021	May 31, 2022 USD ($)	May 31, 2021 USD ($)	May 31, 2021 USD ($)	Feb. 28, 2023 USD ($) $ / shares shares	Feb. 28, 2022 USD ($) $ / shares shares	Feb. 28, 2023 USD ($) $ / shares shares	May 31, 2023 USD ($) $ / shares shares	Mar. 19, 2023 shares	Sep. 01, 2022 $ / shares	Aug. 30, 2022 USD ($) shares	Jul. 08, 2022 shares	Jun. 30, 2021 USD ($)	Feb. 29, 2020 USD ($)	Nov. 18, 2019 USD ($)
Class of Stock [Line Items]
Preferred stock, authorized maximum											20,000,000		20,000,000
Preferred stock, authorized | $ / shares											$ 0.001		$ 0.001
Preferred stock, authorized											15,545,650	15,545,650	15,545,650	15,545,650
Preferred stock, shares outstanding											0	0	0	0
Preferred stock, shares issued											0	0	0	0
Warrants exercise price increase | $ / shares			$ 0.01
Fair value of warrants | $											$ 21,929
Preferred Stock, Convertible, Shares Issuable											78		78
Description of common stock conversion basis				On August 24, 2021the Series F preferred warrant holder agreed to not exercise his warrant privileges on his remaining 329 warrant shares before September 1, 2023.	On July 12, 2021, the former director agreed to surrender his remaining 184 Series F preferred shares in exchange for a note payable from the Company of $4,000,160 bearing interest at 7% per annum with a 5 year term, maturing July 12, 2026.		Two Series F Preferred shareholders exchanged 83 Series F Preferred Shares for two promissory notes on March 23, 2021. The notes are non-interest bearing, have a one-year maturity and total $7,546,775. These notes were subsequently exchanged on June 2, 2021 for a total of 116,104.232 common shares.
Increase in shares authorization											7,225,000,000	7,225,000,000	7,225,000,000	7,225,000,000
Stock issued during period value issued for services | $												$ 3,244,740
Convertible notes payable | $												$ 3,500
Common stock, shares, issued											5,848,741,599	4,735,210,360	5,848,741,599	6,129,670,689
Principal amount | $											$ 31,254,346		$ 31,254,346	$ 32,427,346			$ 3,000,000
Net book value | $												$ 875
Stock based compensation, share												2,100,000
Stock based compensation, value | $												$ 109,200
Stock based payments for warrants | $											0	0
Stock based compensation for options and shares | $											240,550	1,678,550
Other stock based compensation | $											499,500	479,500
Warrant holder exchange			47,000,000														955,000,000
Bearing interest																	15%
Fair value warrants																	2,960,500
Debt discount | $											0		$ 0				$ 39,500
Warrants exercise price decrease | $ / shares			$ 0.008
Warrants exercise price term			5 years
Relative fair value | $			$ 393,949
Share based compensation | $											1,979,500
Incentive compensation plan payable | $											499,500
Stock-based compensation | $											122,050
Options Held [Member]
Class of Stock [Line Items]
Stock-based compensation | $											4,275,000
Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares																0.02
Measurement Input, Exercise Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares			0.012													0.01
Dividend Yield [Member]
Class of Stock [Line Items]
Risk free interest rate			0													0
Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Risk free interest rate																340.9
Measurement Input, Risk Free Interest Rate [Member]
Class of Stock [Line Items]
Risk free interest rate			2.98													3.39
Measurement Input, Expected Term [Member]
Class of Stock [Line Items]
Expected term (years)			5 years													4 years 6 months
Chief Executive Officer [Member] | Stock Option one [Member]
Class of Stock [Line Items]
Stock granted to employee						10,000,000
Stock granted to employee (in dollers per shares) | $ / shares						$ 0.15
Stock granted to employee (in dollers per shares) | $ / shares						$ 0.30
Chief Executive Officer [Member] | Stock Option Two [Member]
Class of Stock [Line Items]
Stock granted to employee						30,000,000
Stock granted to employee (in dollers per shares) | $ / shares						$ 0.25
Stock granted to employee (in dollers per shares) | $ / shares						$ 0.50
Convertible Debt [Member]
Class of Stock [Line Items]
Common stock, shares, issued												116,104,232
Principal amount | $																			$ 7,546,775
Net book value | $																			6,894,099
Fair value | $																			6,455,396
Gain on settlement of debt | $																			$ 438,703
Purchase Agreement [Member]
Class of Stock [Line Items]
Fair value of warrants | $											$ 5,415,000
Warrants exercise price term											3 years		3 years
Description of debt												the Company issued warrants to a lender to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033, in conjunction with debt disclosed in Note 11 (10), the Company issued warrants to a lender to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005,and in conjunction with debt disclosed in Note 11 (46), the Company issued warrants to a lender to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783
Minimum [Member]
Class of Stock [Line Items]
Increase in shares authorization															6,000,000,000			5,000,000,000
Minimum [Member] | Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares			0.01
Minimum [Member] | Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Risk free interest rate			88.2
Maximum [Member]
Class of Stock [Line Items]
Increase in shares authorization															7,225,000,000			6,000,000,000
Maximum [Member] | Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares			0.008
Maximum [Member] | Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Risk free interest rate			90
Incentives Compensation Plan [Member]
Class of Stock [Line Items]
Accrued value | $												$ 1,979,500
Description of plan	the Company as part of the afore-mentioned Incentive Stock Option Plan issued 100,000,000 shares to 64 employees. The shares were issued with an exercise price of  $0.02, vest after 4 years with a 5 year term having a fair value of $1,020,000
Plan2021 [Member]
Class of Stock [Line Items]
Description of plan		the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 5,000,000 to 100,000,000.
Investor [Member]
Class of Stock [Line Items]
Principal amount | $																				$ 109,000	$ 225,000
Warrant [Member]
Class of Stock [Line Items]
Preferred stock, shares issued											366	367	366
Warrant purchase											3,324,212	411,000,000
Shares cashless exercise												395,022,447
Stock based payments for warrants | $								$ 0	$ 0
Relative fair value | $														$ 947,447
Cashless exercise of stock												411,000,000
Warrant [Member] | Dividend Yield [Member]
Class of Stock [Line Items]
Risk free interest rate												0
Warrant [Member] | Measurement Input, Expected Term [Member]
Class of Stock [Line Items]
Expected term (years)												3 years
Warrant [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares												0.037
Warrant [Member] | Minimum [Member] | Measurement Input, Exercise Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares												0.146
Warrant [Member] | Minimum [Member] | Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Risk free interest rate												411
Warrant [Member] | Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Class of Stock [Line Items]
Risk free interest rate												0.43
Warrant [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares												0.135
Warrant [Member] | Maximum [Member] | Measurement Input, Exercise Price [Member]
Class of Stock [Line Items]
Risk free interest rate | $ / shares												0.0071
Warrant [Member] | Maximum [Member] | Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Risk free interest rate												403.33
Warrant [Member] | Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Class of Stock [Line Items]
Risk free interest rate												0.27
Common Stock [Member]
Class of Stock [Line Items]
Stock issued during period shares shareholder cancelled												17,116,894
Warrant purchase											1,057,841,576	645,168,473
Proceeds from issuance of debt | $											$ 821,027	$ 13,108,624
Net proceeds | $											7,771,169	12,521,932
Issuance costs | $											$ 447,858	586,692
Stock issued during period value issued for services | $
Common stock, shares, issued											5,836,641,599	4,733,110,360	5,836,641,599	6,117,570,789
Common Stock [Member] | Convertible Debt [Member]
Class of Stock [Line Items]
Preferred stock, shares issued												316,345,998
Convertible notes payable | $												$ 825,000
Principal value | $												71,955
Accrued interest | $												$ 1,750
Common stock, shares, issued												31,042,436
Common Stock [Member] | Lender [Member]
Class of Stock [Line Items]
Stock issued during period shares shareholder cancelled												10,000,000
Stock issued during period value issued for services | $												$ 118,500
Common Stock [Member] | Purchase Agreement [Member]
Class of Stock [Line Items]
Warrant purchase											17,500,000
Additional Paid-in Capital [Member]
Class of Stock [Line Items]
Stock issued during period value issued for services | $												$ 3,244,700
Share based compensation | $											$ 69,350
Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, authorized | $ / shares											$ 0.001	$ 0.001	$ 0.001	$ 0.001
Preferred stock, authorized											4,350,000	4,350,000	4,350,000	4,350,000
Preferred stock, shares outstanding											3,350,000	3,350,000	3,350,000	3,350,000
Stock issued during period shares shareholder cancelled												1,000,000
Preferred stock, shares issued											3,350,000	3,350,000	3,350,000	3,350,000
Stock issued during period value issued for services | $
Series F Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, authorized | $ / shares											$ 1	$ 1	$ 1	$ 1
Preferred stock, authorized											4,350	4,350	4,350	4,350
Preferred stock, shares outstanding											2,533	2,532	2,533	2,533
Preferred stock, shares issued											1	40
Preferred stock, shares issued											2,533	2,532	2,533	2,533
Description of unissued stock												19 shares of issuable Series F preferred stock having a value of $ 74,984 for $500,000, with the difference of $425,016 recorded as a dividend. On October 28, 2022 as part of a $4,000,000 loan facility (described in Note 12) the Company extended the maturity date of the 329 existing Series F Preferred Warrants currently held by the lender to October 31, 2033 from October 31, 2026.
Stock issued during period value issued for services | $												$ 40
Cashless exercise of stock												38
Series F Preferred Stock [Member] | Convertible Debt [Member]
Class of Stock [Line Items]
Preferred stock, shares issued												78
Series F Preferred Stock [Member] | Investor [Member]
Class of Stock [Line Items]
Fair value of warrants | $									$ 33,015,214	$ 33,015,214
Series G Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, authorized | $ / shares											$ 0.001	$ 0.001	$ 0.001	$ 0.001
Preferred stock, authorized											100,000	100,000	100,000	100,000
Preferred stock, shares outstanding											0	0	0	0
Preferred stock redeemable | $													$ 1,000
Preferred stock, shares issued											0	0	0	0
Preferred Stock, Conversion Basis												On achievement of objectives 3,4,5 and 8 of the equity awards described below the CEO was granted 1500 Series G Preferred shares which were redeemed immediately for $1,500,000
Stock issued during period value issued for services | $
Preferred stock redeemed (in shares)											1,500
Preferred stock redeemed, value | $											$ 1,500,000
Series F Preferred Stock 1 [Member]
Class of Stock [Line Items]
Preferred stock, shares issued											38		38

Schedule of income tax expense

Schedule of income tax expense (Details) - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Income Tax Disclosure [Abstract]
Total current
Total deferred
Total

Schedule of federal statutory i

Schedule of federal statutory income tax (Details) - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Income Tax Disclosure [Abstract]
Federal statutory rate	$ (3,803,000)	$ (13,061,500)
State income tax benefit, net of federal benefit	(859,400)	(2,954,400)
Non deductible interest	415,800	4,027,800
Non deductible stock based compensation	155,400	169,400
Change in valuation allowance	4,091,200	3,398,800
Total
Non deductible settlement losses		8,515,100
Non deductible changes in fair value of instruments		(95,800)
Other non deductible expenses		$ 600

Schedule of deferred income tax

Schedule of deferred income tax assets (Details) - USD ($)	Feb. 28, 2023	Feb. 28, 2022
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 12,651,115	$ 8,445,915
Debt discount		114,000
Total deferred tax assets	12,651,115	8,559,915
Depreciation
Deferred revenue
Total deferred tax liabilities
Less valuation allowance	(12,651,115)	(8,559,915)
Net deferred tax assets (liabilities)

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Income Tax Disclosure [Abstract]
Statutory rate	21%
Operating loss carryforwards	$ 44,448,800	$ 28,200,000
Expire date	2030